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Abstract 
Fungi are associated with a wide range of diseases from superficial skin 
syndromes to invasive life-threating conditions. Furthermore, exposure to non-
infectious fungal components in the context of agricultural work or in water-
damaged houses has been associated to illnesses in the respiratory tract. The 
inadequate knowledge of the immune mechanisms behind these illnesses has 
triggered an intense research effort attempting to understand how fungi can 
activate the defense mechanisms of immune system. 
Vertabrates have a two-tiered immune system consisting of innate immunity 
and adaptive immunity. Their purpose is to protect the body from disease-causing 
microorganisms, physical stress or tissue damage.  The innate immune system is 
the first to be activated; it facilitates the direct elimination of pathogens as well as 
initiating the inflammatory response. It also provides the necessary signals to 
trigger adaptive immunity if the pathogens evade or overwhelm innate immunity. 
Macrophages are leukocytes; these are cells which play a major role in triggering 
the innate immune response. They recognize pathogen specific structures 
(pathogen-associated molecular patterns, PAMPs) via their pathogen recognition 
receptors (PRRs), which trigger the rapid secretion of pro-inflammatory cytokines 
and chemokines and other pathogen eliminating actions.  
This thesis focused on the inflammation triggered by the fungal components. 
The inflammatory response and related mechanisms were studied in vitro in the 
key defense cell of innate immunity, the macrophage, which were treated with a 
central cell wall component of fungi, (1,3)- β-glucan. In addition, we were also 
able to characterize the microbial component-related defense of lungs in a real-life 
situation, by studying the proteomic changes in bronchoalveolar lavage obtained 
from patients with illnessess associated with exposure of inhaled fungal and other 
microbial particles.  
In these studies, we utilized the methods, where broad spectrum of parameters 
can be followed such as quantitative proteomics (iTRAQ, 2D-DIGE) and 
transcriptomics (microarray) together with traditional biomolecular techniques 
such as western blotting or RT-PCR.   
One major outcome of this thesis project was the finding that β-glucan evokes 
a strong pro-inflammatory response via the IL-1 family cytokines in human 
macrophages. These cytokines are crucial mediators of inflammation, thus their 
secretion is highly regulated. Our study produced the first evidence that on its own 
β-glucan could cause the secretion of functional IL-1β by activating both dectin-1/ 
Syk –signaling pathway and NLRP3 inflammasome. Beta-glucan-induced 
production of reactive oxygen species (ROS), cathepsin release and potassium 
efflux were required for activation of the NLRP3 inflammasome. Furthermore, we 
revealed that the secretion of IL-36γ in β-glucan stimulated macrophages was not 
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dependent on activation of NLRP3 inflammasome. These results indicate that 
cytokines of the IL-1 family play a role in inflammatory response induced by 
fungi, even in situations when the activation of the inflammasome is impaired.  
Most of the members in IL-1 family lack the signal peptide and thus are not 
released via the classical protein secretion pathway. In addition to IL-1 cytokines, 
dectin-1 activation evoked an efficient unconventional secretion of other mediators 
of inflammation, which are secreted via vesicles, such as damage-associated 
molecules or integrins. Both IL-1β and vesicle-mediated protein secretions were 
suppressed by inhibition of inflammasome activity or by preventing the process of 
autophagy. Although the activation of protein secretion or inflammasome was 
prominent, the latter structure being known to facilitate pyroptosis, no significant 
cell death was observed after β-glucan stimulation. This indicates either the 
constituitive presence or the activation of cell viability sustaining factors. One of 
these factors could be the well-known myeloid cell growth factor, granulocyte-
macrophage colony-stimulating factor, GM-CSF. This growth factor also seems to 
be one of the factors boosting the inflammatory response triggered by β-glucan, 
thus GM-CSF-generated macrophages displayed a more efficient secretion of IL-1 
and other unconventionally secreted proteins than M-CSF-generated macrophages 
after β-glucan stimulation.  
The results of this thesis highlight the potential of a major fungal cell wall 
component, β-glucan for initiating inflammation in human macrophages. Thus, the 
possibility of using β-glucan as a potential adjuvant in vaccines or treatments 
should be explored.  
In an attempt to obtain direct information about conditions caused by the 
exposure to fungal and other microbial particles, we characterized the proteomic 
changes present in the bronchoalveolar lavage obtained from patients suffering 
illnesses associated with exposure to inhaled fungal and other microbial particles. 
The proteomic profiles of acute type of hypersensitivity pneumonitis (HP) were 
different from the profile of damp building-related illness (DBRI), indicating that 
these conditions are not closely associated. However, the increase in the levels of 
two well-known markers of inflammation (α-1-antitrypsin, galectin-3) was 
observed in both HP and DBRI, evidence for the activation of inflammatory 
mechanisms in both of these conditions. 
This thesis provides novel knowledge concerning the inflammatory response 
and related mechanisms triggered by fungal components. These results may help 
to clarify the mechanisms behind the inflammatory symptoms experienced by 
individuals with fungal infections or exposure to fungal particles and will provide 
future tools for the treatment of fungal-related disorders.     
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Tiivistelmä 
Sienet aiheuttavat monenlaisia tauteja vaihdellen ihon pintainfektioista 
hengenvaarallisiin syviin sieni-infektioihin. Syvät sieni-infektiot ovat uhka 
erityisesti ihmisille, jotka kärsivät immuunipuutoksesta sairauden tai hoidollisen 
tilan takia. Sienialtistuksesta johtuvia hengitystieoireita on tavattu myös 
henkilöillä, jotka ovat altistuneet sienen ei-infektiivisille rakennekomponenteille 
tehdessään maataloustöitä homeisen heinän parissa, tai työskennellessään tai 
asuessaan rakennuksissa, joissa on todettu kosteusvaurioista johtuvaa 
sienikasvustoa.   
Sieni-infektion tai sienikomponenttialtistuksen yhteydessä aktivoituvista 
immuunipuolustusjärjestelmän mekanismeista tiedetään vielä sangen vähän. Jotta 
sienten aiheuttamien tautien hoitoa ja ennaltaehkäisyä voitaisiin parantaa on 
ensiarvoisen tärkeää ymmärtää  sienen käynnistämä immmuunipuolustusreaktio ja 
siihen vaikuttavat tekijät elimistössämme.   
Selkärankaisten immuunipuolustus koostuu kahdesta osasta, luontaisesta ja 
hankitusta immuniteetista, joiden tehtävä on suojella elimistöä tautia aiheuttavilta 
mikrobeilta, sekä fyysisiltä stressitiloilta, että kudosvaurioilta. Ensimmäisenä 
aktivoituvat luontaisen immuniteetin mekanismit, jotka tähtäävät tautimikrobin 
hävittämiseen ja käynnistävät tulehdusreaktion. Jos infektiota ei pystytä näin 
estämään, hankitun immuunipuolustuksen järjestelmät käynnistyvät. Makrofagit 
ovat valkosoluja, joilla on merkittävä rooli luontaisen immuniteetin  vasteen 
säätelyssä. Ne tunnistavat pinnallaan olevien hahmotunnistereseptorien 
välityksellä vain tautimikrobeille ominaisia rakenteita, mikä aktivoi niissä 
tulehdusta ja mikrobin hävittämistä edistäviä toimintoja kuten 
tulehdusvälittäjäaineiden (kemokiinien ja sytokiinien) erityksen ja solusyömisen.   
Tässä väitöskirjassa on keskitytty tutkimaan sienikomponentin aiheuttamaa 
tulehdusvastetta. Tulehdusvastetta ja sen mekanismeja on karakterisoitu luontaisen 
immuniteetin keskeisimmässä puolustussolussa, makrofagissa sen altistuttua 
sienen seinämäkomponentille, (1,3)-β-glukaanille. Lisäksi olemme tutkineet 
hengitysteihin kohdistuvaa mikrobikomponenttialtistumista  ja sen seurauksena 
keuhkoissa käynnistynyttä immuunireaktiota määrittämällä proteiinimuutoksia 
keuhkohuuhtelunäytteistä, jotka on kerätty henkilöiltä, joiden on todettu 
sairastuneen mikrobikomponenttialtistumisen seurauksena.  
Tutkimuksissa hyödynnettiin systeemibiologisia menetelmiä kuten 
kvantitatiivista proteomiikkaa (iTRAQ, 2D-DIGE) ja transkriptomiikkaa (RNA-
siru), sekä näiden lisäksi perinteisiä molekyylibiologian menetelmiä kuten western 
blotting- ja RT-PCR -analyysejä. 
 Beta-glukaanin aktivoima voimakas IL-1 perheen tulehdussytokiinivaste on 
tämän väitöskirjan yksi keskeisimmistä tuloksista. IL-1 sytokiinit ovat tärkeitä 
tulehdusta edistäviä sytokiineja, minkä takia niiden tuotanto soluissa on tiukasti 
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säädeltyä.  Tutkimuksemme oli ensimmäinen, joka raportoi β-glukaanin yksistään 
pystyvän aktivoimaan signaalireitit, jotka tarvitaan biologisesti aktiivisen IL-1β 
tulehdussytokiinin eritykseen ihmisen makrofagissa. Dektiini-1 –reseptorin 
tunnistaessa β-glukaanin aktivoitui  signaaliketju, joka johti IL-1β geeniluentaan ja 
proteiinin esimuodon syntymiseen solussa, sekä  NLRP3 inflammasomin eli 
tulehdusjyväsen aktivaation, jonka seurauksena  inflammasomin entsyymiosa, 
kaspaasi-1 muokkasi IL-1β sytokiinin sen biologisesti aktiiviseen muotoon. Beta-
glukaanin indusoimat solureaktiot, kuten reaktiivisten happiyhdisteiden tuotanto, 
katepsiinientsyymien vapautuminen solulimaan ja kaliumin ulosvirtaus solusta, 
todettiin tarvittavan NLRP3 inflammasomin aktivatioon makrofagissa. Beta-
glukaanin aktivoima IL-36γ -eritys taas oli riippumaton NLRP3 inflammasomin 
aktivaatiosta. Tuloksemme viittaavat siihen, että IL-1 perheen sytokiineillä on 
keskeinen rooli sienen aiheuttamassa tulehdusreaktiossa,  ja tämä IL-1 eritysvaste 
voi olla riippuvainen tai riippumaton NLRP3 inflammasomin aktivaatiosta.    
Dektiini-1 signaalireitin aktivaatio johti voimakkaaseen tulehdusproteiinien 
eritykseen, sekä klassista, että epätyypillisiä eritysreittejä pitkin. Signaalipeptidi, 
joka tarvitaan proteiinin eritykseen klassista proteiinieristysreittiä pitkin puuttuu 
suurimmalta osalta IL-1 sytokiineista. IL-1 sytokiinien lisäksi dektiini-1 -
reseptorin aktivaatio johti myös muiden tulehdusproteiinien kuten DAMP:n ja 
integriinien eritykseen epätyypillistä, vesikkeleitä hyödyntävää eritysreittiä pitkin. 
Inflammasomin tai autofagiaprosessin toiminnan estäminen farmakologisilla 
inhibiittoreilla tai SiRNA-käsittelyllä tyrehdyttivät, sekä IL-1β sytokiinin, että 
vesikkelivälitteisten proteiinien erityksen. Beta-glukaani ei käynnistänyt 
makrofageissa huomattavaa solukuolemaa runsaasta proteiinierityksestä ja 
inflammasomin aktivaatiosta huolimatta. Tämän perusteella voidaan olettaa, että 
soluissa on aktivoitunut tai solun ympäristössä on solukuolemalta suojaavia 
mekanismeja tai tekijöitä. Yksi tälläinen tekijä voi olla myeloidisten solujen 
kasvua ja erilaistumista edistävä GM-CSF-kasvutekijä. Tutkimuksissamme 
huomasimme, että β-glukaanistimulaation jälkeen GM-CSF-kasvatetut makrofagit 
erittivät enemmän IL-1 sytokiineja ja muita tulehdusproteiineja, jotka hyödyntävät 
erityksessään epätyypillisiä proteiinieristysreittejä, kuin M-CSF-kasvutekijällä 
kasvatetut makrofagit. GM-CSF –kasvutekijä tehostaa siis β-glukaanin 
aiheuttamaa tulehdusvastetta ihmisen makrofagissa.  
Väitöskirjani tulokset korostavat β-glukaanin olevan sienen keskeinen 
immuunipuolustusta aktivoiva rakenneosa,  joka saa aikaan erittäin voimakkaan 
tulehdusreaktion ihmisen makrofagissa. Näiden tulosten valossa β-glukaanin 
käyttömahdollisuutta adjuvanttina rokotteissa tai hoidoissa pitäisi  tutkia 
enemmän.  
Saadaksemme informaatiota home- ja muu mikrobialtistumisen aihettamista 
tautiloista karakterisoimme keuhkohuuhtelunesteessä tapahtuneita 
proteiinimuutoksia mikrobikomponenttialtistumiseen liittyvien sairausten kuten 
allergisen alveoliitin (hypersensitiivinen pneumoniitti) tai 
kosteusvauriorakennuksiin liittyvän sairastelun (damp building-related illness) 
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yhteydessä. Näiden kahden sairauden proteiiniprofiili erosi huomattavasti 
toisistaan viitaten siihen, että kyseessä on erilaiset tautiprosessit.  Kummassakin 
tautitilassa havaittiin kuitenkin kahden tunnetun tulehdusproteiinimarkkerin (α-1-
antitrypsiini, galektiini-3) nousu, mikä viittaa tulehdusmekanismien 
käynnistymiseen molemmissa sairauksissa.  
Tämä väitöskirjatyö on tuottanut uutta tietoa liittyen sienen vaikutuksesta 
immuunipuolustukseemme ja karakterisoinut sienen rakennekomponenttien 
käynnistämää tulehdusvastetta. Nämä tulokset auttavat meitä ymmärtämään 
elimistössämme käynnistyviä immuunipuolustuksen mekanismeja, jotka johtavat 
tulehduksellisten oireiden ilmaantumiseen sieni-infektioiden ja sienikomponenttien 
aiheuttamien sairauksien yhteydessä. Tämä edesauttaa myös hoitojen ja 
diagnostiikan kehittymistä.  
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1.INTRODUCTION 
Microscopic organisms, microbes, such as bacteria and fungal yeasts and 
molds are an intrinsic part of our everyday life. They are found in soil, water, and 
air and they compose the normal flora of our body. According to the latest 
knowledge, they seem to have a fundamental role in maintaining our health. This 
ubiquitousness of microbes means that we are exposed continuously to a low level 
of microbes and their components - this is usually harmless. On some occasions, 
for example due to some alteration in the normal flora or a breach in the 
integumentary barrier, microbes manage to cause an infection. Furthermore, in 
certain occupations and surroundings, an individual’s exposure to microbes can be 
significant, either in terms of quantity or quality, and these situations have been 
shown to associate with adverse health effects.   
The innate immune system is the first line of defense against pathogens, 
facilitating their direct elimination and regulating the initiation of inflammation. It 
also provides the necessary signals to trigger the adaptive immunity. The crucial 
cellular players in innate immunity are leukocytes such as macrophages and 
dendritic cells, which recognize conserved structures of pathogens (pathogen-
associated molecular patterns, PAMPs) via their pathogen recognition receptors 
(PRRs). This ligand recognition by receptor may stimulate the rapid activation of 
defense responses; production of cytokines, chemokines and reactive oxygen 
species (ROS), phagocytosis as well as antigen presentation to the cells of the 
adaptive immune system. The response of innate immune system was originally 
thought to be rather invariable and straightforward. According to recent 
knowledge, the mechanisms leading to innate immune response are much more 
complex and multifactorial than traditionally believed. Furthermore, innate 
immunity was recently shown to have its own immunologic memory, which was 
previously thought to be only a feature of adaptive immunity. 
A decreased immune response due to advanced age, immunosuppressive 
medication, or congenital defects in immune mechanisms is known to increase the 
susceptibility to fungal infections. Immune-related mechanisms have been 
suggested to play a role in evoking the symptoms experienced by individuals 
exposed to non-infective fungal components. However, these mechanisms have 
remained poorly characterized.  
This thesis focused on the characterization of the immune reaction triggered by 
fungal- associated molecular pattern, β-glucan. We studied the β-glucan-activated 
innate immune response and related mechanisms in the key innate immune 
defence cell, the macrophage. Furthermore, the immune response of the lungs was 
characterized by examining the proteomic changes in bronchoalveolar lavage 
collected from patients with illnessess related to exposure of fungal and other 
microbial components. 
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2.REVIEW OF THE LITERATURE 
2.1. Innate immunity: the first line of defense  
We encounter microorganisms constantly in our daily life, but they cause disease 
only occasionally. Vertebrates have developed a two-tiered immune system, 
consisting of innate immunity and adaptive immunity to protect the body from 
disease-causing microorganisms, pathogens (Figure 1).  
 
pathogen
INNATE IMMUNITY
-recognition of PAMPs, DAMPs by PRRs
-trained immunity
1. LINE
-PHYSICAL
• skin
-MICROBIOLOGICAL
• normal flora
-CHEMICAL
• stomach acids, antimicrobial peptides
2. LINE
-COMPLEMENT CASCADE
- CELLS OF INNATE IMMUNITY
• macrophages
• dendritic cells
• granulocytes
• mast cells
• innate lymphoid cells
ADAPTIVE IMMUNITY
-specific recognition of antigen
-immunological memory
1. B-CELL IMMUNITY
-HUMORAL IMMUNITY
• plasma-, memory -B-cells
2. T-CELL IMMUNITY
-CELL-MEDIATED IMMUNITY
• cytotoxic-, helper-, suppressor -T-cells
 
Figure 1. The innate and adaptive immunity. The responses of innate immunity are rapid 
and non-specific. Innate immunity functions as the first line of defence against infection 
consisting physical barriers and bloodbourne factors resisting the invasion and spreading 
of the pathogen. The cellular defence is mainly dependent on PRRs, which recognize 
PAMPs present on a variety of microorganisms or danger-associated molecular patterns 
(DAMPs) released during cellular damage or stress. Innate immunity is recently proposed 
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to have its own immunological memory termed “trained immunity”. The adaptive immune 
response is slower to develop. The full development of adaptive immunity response 
requires the engagement of receptors (T-cell and immunoglobulin receptors from T- and 
B-cells, respectively) with their spesific antigens, the expansion and differentiation of the 
responder cells, and the development of a memory for the specific antigen response. 
 
In addition to pathogens, internal signal molecules emitted by our body during the 
stress or tissue damage (danger-associated molecular patterns, DAMPs) activate 
protective responses in our immune system. Innate immunity is the first system to 
become activated. Usually this response is sufficient on its own to eradicate the 
pathogen, however occasionally a pathogen will evade or overwhelm innate 
immunity and the adaptive immunity system has to be triggered by innate 
immunity. One important feature of both of the immune systems is that they can 
distinguish between self and non-self molecules or when the self molecule is 
located in places it normally should not exist, but these systems differ in the ways 
they perform this function. 
The innate immune system comprises two types of defenses against invading 
pathogens: constantly present physical, microbiological and chemical barriers of 
the skin and mucosal epithelia in the airways, gut and urogenital tract and then the 
molecular and cellular responses, which are induced if a pathogen breaches these 
first barriers (Murphy, 2012). Thus, the response of innate immunity can be 
immediate or when induced, responses occur within a few hours with a duration of 
several days. The response of innate immunity is non-specific in its nature, similar 
kinds of defence mechanisms are activated against broad classes of pathogens 
(viruses, bacteria, fungi and parasites).  
Epithelial cells, which are joined together by tight junctions, and the secretion 
of mucus and its outward flow driven by ciliated cells, provide the mechanical 
barrier against pathogens. The presence of the normal microbiota prevents 
colonization of pathogens e.g. by limiting the availability of nutrients and 
attachment sites on the epithelia. Previous studies have highlighted the crucial 
influence of the intestinal microbiota to the host`s immune system and its potential 
effect in the development of several diseases in addition to its important role in 
sustaining homeostasis (Cerf-Bensussan and Gaboriau-Routhiau, 2010). Chemical 
defense mounted by the epithelia refers to the secretion of antimicrobial peptides 
such as defensins, cathelicidins and histatins. These agents are released by 
epithelia, innate immune cells or salivary glands. Most of these peptides need 
proteolytic steps to achieve their active stage when they can disrupt the cell 
membrane of the microbe. (De Smet and Contreras, 2005). In addition, the acidic 
pH of the stomach and digestive enzymes of the upper gastrointestinal tract, 
lysozyme in tears and saliva represent chemical barriers to infection.  
Microorganisms that breach these defenses are met by molecules of the 
complement system, which have a major role in the humoral defense of innate 
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immunity. Complement is a system of plasma proteins, which are constantly 
present in blood and other body fluids in their inactive form. Complement proteins 
can be activated via three different pathways: directly by pathogens or indirectly 
by pathogen-bound antibody (classical pathway), via spontaneous hydrolysis of C3 
and its binding to bacterial surface sites (alternative pathway) and via mannose-
binding lectins and ficolins binding to carbohydrate structures on the bacterial cell 
wall (lectin pathway) (Gasque, 2004). An encounter with a pathogen triggers the 
complement cascade, where the consecutive complement molecules starting from 
C3 are activated by cleavage, leading directly to lysis of the pathogen by 
disrupting its cell membrane or opsonization of the pathogen with C3b and C5a 
components, which signal the innate immune cells to first engulf and then 
eradicate the pathogen.  
There are three types of phagocytosing cells in the innate immune system: 
monocytes and macrophages, granulocytes and dendritic cells; these will be 
discussed in more detail in the following chapter. The innate immune cells identify 
microbes by a limited number of germline coded receptors called pattern 
recognition receptors (PRRs) (Medzhitov and Janeway, 2000). These receptors 
recognize regular molecular patterns present on many microorganisms which do 
not occur on the body`s own cells. Some of these receptors induce the secretion of 
effector molecules such as cytokines and chemokines in the cells of innate 
immunity, which convey the signal to other immune cells and/or affect the 
function of the original cell. These cytokines and chemokines released by activated 
innate immune cells, especially macrophages, initiate the process known as 
inflammation. As a part of the inflammation defense, related proteins and cells are 
recruited from the blood into infected tissue to destroy the pathogen, this process is 
an important means to combat the infection. Inflammation also increases the flow 
of lymph from infected area to nearby lymphoid tissue carrying pathogens and 
antigen-presenting cells such as dendritic cells, where they activate lymphocytes 
and initiate the adaptive immune response. This highlights the crucial role of the 
innate immune system, in addition to providing early defense against infections, it 
also triggers and drives the adaptive immunity to respond effectively to infection 
(Medzhitov and Janeway, 2002).  
Once adaptive immunity has been triggered, the next step in inflammation is 
recruiting the antibody molecules and effector-T cells to the site of infection. This 
response may take days to develop because the few B- and T-lymphocytes specific 
for that pathogen must first undergo clonal expension before they differentiate into 
the effector cells that migrate to the site of infection. This specific recognition of 
antigens via antigen receptors on the B- and T -lymphocytes is generated through 
somatic gene rearrangements and hypermutation, allowing adaptive immunity to 
specifically recognize many types of microorganisms. In this way, adaptive 
immunity posssesses more specific defense mechanisms to overcome invading 
pathogens that have evaded or overwhelmed innate immunity. The antibodies 
produced and the activated lymphocytes can persist after the original infection has 
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been eliminated, thus they help to prevent immediate reinfection as well as 
ensuring long-lasting immunity should a second infection occur many years later. 
Thus, the response against the same pathogen is usually faster and more intense. 
This immunological memory of adaptive immunity can last for a lifetime (Bonilla 
and Oettgen, 2010, Murphy, 2012). Previously, the innate immune system was not 
considered to possess an immunologic memory and its actions were generally 
thought to be identical with every encounter with a pathogen. This assumption has 
now been challenged with recent results suggesting that certain infections or 
vaccines are able to induce reprogramming of the innate immune system, leading 
to protection against reinfection. This shows a new type of immunological 
memory in a process proposed to be called trained immunity (Quintin et al., 2014, 
Netea et al., 2016).  
Over time, it has became clear that components of the innate immune response 
have a major role in sustaining the normal homeostasis of the body but when 
functioning in an improper manner, they participate in the pathogenesis of many of 
the illnesses classified as autoinflammatory diseases. These autoinflammatory 
diseases (e.g. gout) differ from autoimmune diseases (e.g. lupus) usually in a way 
that the classical hallmarks of autoimmunity, namely high-titer autoantibodies and 
antigen specific-T-cells, the components of adaptive immunity, are absent. 
(Masters et al., 2009).   
 
2.1.1. Cells of innate immunity 
 
Innate immune cells comprise a set of tissue resident, circulating or recruited 
leukocytes, which mediate the process of inflammation when sensing a pathogen 
or tissue damage through their germline encoded receptors in order to eliminate 
the infection. These defense cells of innate immunity consist of macrophages, 
monocytes, granulocytes (neutrophils, basophils, eosinophils), mast cells, dendritic 
cells, and innate lymphoid cells (ILC).  At the onset of infection, usually tissue-
resident cells such as macrophages, dendritic cells and mast cells are the first cells 
to encounter the pathogen. They respond to the pathogen by initiating the process 
of inflammation and produce potent inflammatory mediators: cytokines and 
chemotactic proteins to recruit the circulating neutrophils and monocytes into the 
affected tissue. Through the increased release of antimicrobial proteins, more 
efficient phagocytosis, and possibly the activation of adaptive immune responses, 
the activities of innate immune cells are directed to eliminate the infection and 
restore the tissue homeostasis. 
Leukocytes of the immune system develop from pluripotent hematopoietic 
stem cells in bone marrow, passing through different developing steps and 
progenitor stages. There are two main progenitor types for leukocytes in the 
immune response: lymphoid and myeloid cells (Kondo, 2010). Recently, it has 
also been postulated that there is a lineage of myeloid cells with an independent 
origin from hematopoietic stem cells (Schulz et al., 2012). The common myeloid 
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progenitor is a precursor for most of the innate immune cells such as monocytes, 
macrophages, granulocytes and dendritic cells. It is possible that a minor subset of 
dendritic cells arises also from the common lymphoid progenitor (Manz et al., 
2001). Most of the leukocytes in adaptive immunity, T-and B-lymphocytes, 
develop from the other branch, from the common lymphoid progenitor. There is 
also a subset of cells, ILCs, that are functionally grouped into the innate immunity, 
but known initially to develop in the fetal liver and in the later stages from 
common lymphoid progenitors (Spits et al., 2013, Sonnenberg and Artis, 2015).  
In contrast with adaptive immune cells, innate immune leukocytes have a 
reduced proliferative capacity, and during infection, they are mainly replenished 
by controlling the proliferation and differentiation of hematopoietic stem and 
leukocyte progenitor cells, which are then mobilized  and transported in the 
bloodstream into the affected tissues (Takizawa et al., 2012). It is also known that 
a distinct process exists in which tissue-resident macrophages undergo in situ 
(local) proliferation in order to increase the local population density during the 
immune response of T-helper 2-type cells (Jenkins et al., 2011).    
Despite the limited capacity of proliferation, mature innate defense cells 
display remarkable plasticity towards diverse cellular functions by changing their 
phenotype or function when they are exposed to different microenvironmental 
factors during the inflammation or steady-state conditions. This represents one 
crucial mechanism for modulating the immune response that immune cells are 
capable of adapting to the prevalent situation by modifying their function (Galli et 
al., 2011).  
Macrophages are the one of the key defense cells in innate immunity, they are 
long-lived and resident cells in almost all tissues, thus being the first cells to 
encounter the invading pathogen. Their role in innate immunity will be discussed 
in more detail in the following chapter. Monocytes circulate in blood and when 
migrating to the tissues, they differentiate into macrophages, thus replenishing the 
macrophage population in the infected tissue. The phagocytic uptake of pathogens 
is a crucial step in innate immune defense. Both of these cell types are able to 
recognize, engulf and kill the invading pathogens. This initial contact with the 
pathogen activates multiple antimicrobial mechanisms in these phagocytes, leading 
to secretion of signaling molecules, which trigger inflammation and recruit other 
type of immune cells such as granulocytes to the site of infection. Neutrophils are 
short-lived but numerically they are the most common cells from the group of 
granylocytes circulating in blood; they are quickly recruited to the infected site. 
They are capable of phagocytosing pathogens and once the pathogen has been 
engulfed, it is moved into intracellular vesicles where it is destroyed by 
degradative enzymes. (Kumar and Sharma, 2010). The action of inflammatory 
cells causes inflammatory tissue damage, in particular neutrophils are considered 
to be tissue-destructive cells since they release many degradative components in 
their environment during their activation. Thus phagocytes have also a crucial role 
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in restoring tissue homeostasis by engulfing and clearing the cellular debris and 
apoptotic cells. This task mainly falls on the shoulders of macrophages.  
Basophils and eosinophils are other, less abundant groups of granulocytes 
circulating in the blood. Their cytotoxic products form a host-defence that is 
mainly involved in protection against multicellular parasites, such as helminths. 
They are also known to participate in allergic responses. Mast cells have also large 
granules in their cytoplasm that are released when they are activated. The blood-
borne progenitor for mast cell is not well defined. In contrast to granulocytes, 
which circulate in the blood, mast cells are located in mucosal and connective 
tissues. They comprise one part of the defense against parasites, but they are also 
known to be activated during bacterial infection and having a crucial role in 
orchestrating allergic responses. The components released by mast cells and 
basophils seem to more directly act on the mucosal epithelia, smooth muscles and 
vasculature by limiting the spread of parasites and promoting their expulsion from 
the host rather than harming the parasite itself (Voehringer, 2013).       
ILCs are important effector cells in the innate immune system; they belong to 
the lymphoid lineage, but lack expression of specific antigen-receptors. They act in 
the early stages of infection and tissue damage by secreting cytokines. In addition, 
they function in lymphoid organogenesis and tissue remodeling (Spits et al., 2013). 
One subset of ILCs is called the natural killer (NK) -cells, which are cytotoxic and 
specialized ILCs for combatting intracellular pathogens, mainly viruses. NK -cells 
have two main functions: inducing the apoptosis of infected cells and producing 
cytokines, especially large quantities of interferon-γ (IFN-γ) (Lanier, 2005).  
Like macrophages and neutrophils, dendritic cells (DC) are phagocytic cells 
that are able to degrade the pathogens they take up as well as producing the 
cytokines involved in host defense. Nonetheless, their main task is not the 
clearance of microorganisms. Instead, DCs initiate the adaptive response acting as 
professional antigen-presenting cells (APCs) (Mellman and Steinman, 2001). 
Furthermore, macrophages can act as an antigen-presenting cell. Both cell types 
possess the ability to engulf pathogens, process them to antigens, which they can 
present through their major histocompatibility complex (MHC) class I or II 
proteins, with the class type depending on the pathogen, to the cells of adaptive 
immunity. Activated APCs express also other cell-surface associated molecules 
and secrete cytokines which help to trigger the activation of adaptive immune 
system.   
The function of innate immune cells forms the cornerstone for an efficiently 
working innate immune system. In addition, these cells can activate adaptive 
immunity, thus achieving more efficient elimination of pathogens by linking 
together the responses of innate and adaptive immune systems, especially when 
innate immunity has not been successful in eradicating the pathogen on its own. 
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2.1.1.1. Macrophages: more than just "big eaters" 
 
Macrophages are key players in innate immunity. These cells were first identified 
by Elie Metchnikoff late in the 19th century on account of their phagocytic nature 
(macrophage meaning “the big eater” in Greek) (Cavaillon, 2011). Metchnikoff 
proposed that macrophages would be able of discriminating self from non-self and 
thus they could be capable of recognizing invading pathogens i.e. the crucial 
insight that subsequently led to concept of innate immunity. He was awarded the 
Nobel Prize in 1908 with Paul Erlich due to their work and pivotal conclusions in 
cellular and humoral immunity contributing to the fight against pathogens.   
Macrophages have an essential role in both inflammatory and anti-
inflammatory responses of innate immunity evoked by invading pathogen or 
damaged tissue. In addition, they are involved in the repair of damaged tissue, thus 
maintaining tissue homeostasis. They also affect tissue development during 
morphonogenesis. 
One key feature of macrophages is their ability to engulf solid particles and 
then to destroy and eliminate them in their internal vesicles called phagosomes. 
This process is called phagocytosis. Phagosomes fuse with other intracellular 
vacuoles, such as lysosomes. Inside these phagolysysomes, particles are degraded 
in very acidic environments with the help of ROS and nitric oxide (NO), as well as 
antimibrobial enzymes such as cathepsins (Flannagan et al., 2012). During 
homeostasis, macrophages serve as a common “janitorial” cell of the body, 
phagocytosing and removing the cellular debris and dead, apoptotic cells. This 
kind of clearance function does not activate the inflammatory mechanisms of 
macrophages, especially if other inflammatory stimuli are missing from the 
environment (Mosser and Edwards, 2008). Encounters with the pathogen or 
substances leaking from damaged tissue are needed to activate the macrophages. 
This may initiate the other crucial function performed by the macrophages, 
secretion of inflammatory mediators. These cytokines promote inflammation by 
recruiting and activating other defense cells, which may lead to the manifestation 
of typical inflammatory symptoms: swelling and redness in the infected site or 
even to systemic symptoms like fever. An encounter with pathogen may also 
trigger the activation of adaptive immunity. Macrophages are able to present 
antigens from phagocytosed pathogens on their surface MHC-molecules to the 
cells of adaptive immunity and thus they act as APCs.  Nonetheless, other defense 
cells of innate immunity, i.e. dendritic cells, are more potent at triggering 
activation of T-cells and adaptive immunity.  
In adult mammals, tissue macrophages are found in virtually all tissues, where 
they display great phenotypical and functional diversity. On the one hand, tissue 
macrophages exhibit tissue specific morphological and functional phenotypes, thus 
macrophages have been given different names according to the tissue in which 
they reside, such as osteoclasts (bone), alveolar macrophages (lung), microglia 
(brains), Kupffer cells (liver) and Langerhans cells (skin) etc. On the other hand, 
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tissue macrophages share some common functions in all tissues such as 
maintaining the tissue homeostasis (clearance of damaged and defective cells) and 
have an important role in initiating, developing and resolving the inflammatory 
response during the infection (Wynn et al., 2013, Ginhoux et al., 2016).     
Recent studies have led to the development of the hypothesis of dual origin for 
tissue macrophages (Schulz et al., 2012, Gomez Perdiguero et al., 2015). 
According to work emerging from a murine model, it seems that during 
embryogenesis, tissue macrophages are derived from the yolk sac and fetal liver 
progenitors. Populations of tissue-resident macrophages (such as F4/80 bright 
resident macrophages) in many organs, such as liver, skin and brain, seem to have 
a prenatal origin and persist throughout life. The first identified molecule as 
controlling the migration of fetal macrophage progenitors to their final destination 
was just recently revealed. The endothelium-specific molecule, plasmalemma 
vesicle-associated protein (PLVAP), regulated the migration of fetal monocyte-
derived macrophages to tissues in mice (Rantakari et al., 2016). After birth and in 
adulthood, the hematopoiesis passes from the yolk sac and fetal liver to the bone 
marrow. Monocyte-derived macrophages originate from the pluripotent 
hematopoietic stem cells in bone marrow. These macrophage precursors, 
monocytes, constantly replenish tissue macrophages in various organs, such as 
intestine (Bain et al., 2014). The numbers of tissue macrophages can increase 
during inflammation (Italiani and Boraschi, 2014). This is mainly due to a 
replenishment of the tissue macrophage population by circulating monocytes 
which migrate to the infected tissue and develop into macrophages. However, 
there is a consensus that some tissue resident macrophages are also able to 
proliferate and although it is not clear how this occurs, it has been suggested to 
take place through self-renewal or through the proliferation of local progenitors 
(Gentek et al., 2014).  
Another way to classify macrophages, in addition to their origin, is through 
their functional status. In their basal state during the homeostasis, resident tissue 
macrophages show great diversity in their functional capabilities, morphologies, 
and transcriptional profiles i.e they have adapted to their environment (Gautier et 
al., 2012, Wynn et al., 2013). The term polarization describes the capacity of 
macrophages to modify their function in a plastic manner in response to changes in 
their microenvironment. In general, macrophages can change their activation states 
in response to microbial components,  damage-associated  components, growth 
factors, other cytokines and potentially any other entity that they are capable of 
recognizing with their receptors. This explains how macrophages are able to adapt 
to different conditions and respond with appropriate functions to distinct 
situations. This functional diversity is a key feature for macrophages. In principle, 
macrophages can modify their function from a wound-healing and tissue repairing 
type (commonly called M2 or alternatively activated macrophages) to a killing and 
microbicidal active type, which causes tissue damage (commonly called M1 or 
classical activated macrophages) (Sica and Mantovani, 2012). An encounter with a 
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pathogen or with environmental irritants, or tissue injury are all factors that may 
trigger the phenotypic change in local tissue macrophages to adopt an 
‘inflammatory phenotype’, M1 type. Classical activation of the macrophages is 
induced by exposure to IFN-γ and/or recognition of Toll-like receptor ligands, 
leading to the activation of the NF-kB and STAT1 signalling pathways. This, in 
turn, enhances the response of antimicrobial defense by increasing the production 
of reactive oxygen and nitrogen species, and proinflammatory cytokines, such as 
TNFα, IL-1 and IL-6 (Wynn et al., 2013).    
In contrast, some epithelium-derived alarmins and IL-4 and IL-13 cytokines 
produced by Th2 cells, may trigger so called ‘alternative activation’ in 
macrophages. These cells have been especially associated with wound healing and 
tissue repair, as well as the formation of fibrosis. They participate in the 
remodeling of the extracellular matrix by scavenging collagen and extracellular 
matrix components. In addition, alternatively-activated macrophages express 
immunoregulatory functions by producing a variety of immunomodulatory 
proteins such as arginase-1 and IL-10 that regulate the magnitude and duration of 
immune responses. Therefore, in contrast to classically-activated macrophages that 
activate immune defense and promote inflammation, alternatively-activated 
macrophages are typically involved in the re-establishment of homeostasis and 
suppression of inflammatory responses (Wynn et al., 2013).  
This M1/M2 classification is a very simplistic way to describe the functional 
plasticity of macrophages. This binary classification is unable to represent the 
complex in vivo environment in which numerous cytokines and other factors 
interact simultaneously and thus it is not capable of defining the polarization steps 
or the final differentiated state of macrophages. It is also noted that macrophages 
can change their function when responding to the external challenges (such as a 
pathogen) on a second occasion: they can become less reactive (tolerance) or then 
display enhanced inflammatory response (trained immunity) (Netea et al., 2016). 
The molecular mechanisms to explain these diverse properties have not yet been 
elucidated. Epigenetic reprogramming has been suggested to be one of the main 
reasons for these changes (Netea et al., 2016). Another interesting mechanism 
possibly involved in innate memory involves changes in metabolic processes 
(Italiani and Boraschi, 2015).  
 The presence and function of macrophages are central to many diseases. They 
are important for tissue morphogenesis and thus the lack of macrophages or their 
dysfunction may lead to developmental abnormalities (Pollard, 2009). 
Macrophages, as professional phagocytes, have a crucial role in clearing the dead 
cells during homeostasis, and since they are non-responsive to self-antigens that 
may arise during the clearance process, they suppress the possibility of 
inflammation and autoimmunity (Savill et al., 2002). Since macrophages are also 
essential promoters of inflammatory response, they have been suggested to play a 
role in several inflammatory diseases such as atherosclerosis, asthma, 
inflammatory bowel disease, rheumatoid arthritis and fibrosis (Murray and Wynn, 
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2011). Their contribution in these diseases is usually related to their pro-
inflammatory potential, especially to their ability to secrete powerful inflammatory 
mediators, which promote inflammation causing collateral tissue damage.  
However, it is important to remember, that in addition to promoting inflammation, 
macrophages are involved in the recovery phase of many diseases.  In fibrosis, 
macrophages participate in ECM remodelling and dampen the immune response 
that contributes to tissue injury.   
 
2.1.2. Sensing of foreign or danger 
 
Innate immunity is an ancient part of the host defense system against infection. 
The same molecular mechanisms are exploited by many organisms, from plants to 
animals, whereas adaptive immune system, as a relative newcomer, arises as late 
in the evolutionary scale as in the phylum of vertebrates. The recognition in the 
innate immune system relies on a limited number of germline-encoded receptors, 
PRRs. These PRRs recognize structures, PAMPs that are conserved features of 
microbial pathogens such as viral nucleic acids or bacterial and fungal cell wall 
components, consisting of repeated sequences of carbohydrates, lipids and proteins 
- patterns not found in the host. PAMPs usually represent molecules that are 
essential for the viability of the microbes, thus it is very improbable that pathogens 
could avoid detection by simply altering their PAMPs. The recognition of these 
PAMPs allows the innate immune system to distinguish infectious non-self from 
non-infectious self. This innate immunity recognition theory of PRRs and PAMPs 
was first introduced by Charles Janeway Jr. in 1989 (Janeway, 1989).  
 However, this theory could not explain why non-pathogenic microbes did not 
cause activation of the innate immunity or why the immune system is activated 
after tissue transplantation or in autoimmune disease when there is no infective 
pathogen present. 
Polly Matzinger presented “The danger hypothesis” in 1994 (Matzinger, 1994). 
She suggested that in addition to PAMPs, the innate immunity system relies on the 
recognition of signal molecules released during conditions of cell distress or 
injury. These endogeous signal molecules are called danger – or damage-
associated molecular patterns (DAMPs).  
DAMPs are host molecules, which are normally found inside the cells, but they 
can passively leak out of the damaged tissue into the extracellular space if there is 
tissue injury or cellular distress (Matzinger, 1994, Matzinger, 2002, Kono and 
Rock, 2008). In addition to their release from necrotic cells and injured tissue, 
several DAMP molecules are also secreted from activated inflammatory cells in 
response to microbial components or cytokines via nonclassical protein secretion 
pathway (Bianchi, 2007).  
DAMPs can be recognized by the same pattern-recognition receptors as 
PAMPs such as Toll-like receptors (TLRs) or by specialized receptors such as 
RAGE (Bierhaus et al., 2005). PAMP or DAMP recognition may stimulate cell 
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differentiation, cell death, or the secretion of inflammatory or anti-inflammatory 
cytokines, depending on the cell expressing the receptor and the other signals, 
which the cell gathers from its environment. As an example of the different effects 
of DAMPs, ATP (adenosine triphosphate) is known to stimulate inflammation, 
while adenosine can behave in an opposite way, acting as an inhibitor of 
inflammation (Sitkovsky and Ohta, 2005, Ferrari et al., 2006).   
  
2.1.2.1. Pattern recognition receptors 
 
The initial sensing of pathogens or tissue injury is mediated by innate germline-
encoded PRRs, expressed not only by professional immune cells such as 
macrophages and DCs, but also by other cell types such as epithelial cells, 
endothelial cells and fibroblasts (Takeuchi and Akira, 2010).  
Several classes of PRR families have been identified. These include Toll-like 
receptors (TLRs), C-type lectin receptors (CLRs), nucleotide-binding 
oligomerization domain, leucine-rich repeat–containing receptors (NLRs) and 
RIG-I-like receptors (RLRs). In addition, a family of enzymes, such as 
oligoadenylate synthase (OAS) proteins and cyclic GMP-AMP synthase (cGAS), 
which function as intracellular sensors of nucleic acids are included into the PRRs 
(Takeuchi and Akira, 2010, Wu and Chen, 2014).  
 PRRs can be characterized by their structure and specificity. They can also be 
classified into two groups according to their cellular localization: plasma 
membrane-bound receptors or cytosolic receptors. In the cytosol, these receptors 
can be found in membrane-bound compartments such as endosomes or lysosomes. 
The detection of extracellular pathogens is mediated mainly by PRRs expressed on 
the plasma membranes including CLRs and TLRs, which are specialized in the 
recognition of common components of fungal and bacterial cell walls. CLRs 
comprise a group of membrane-bound receptors characterized by the presence of 
carbohydrate-binding domain, which detects carbohydrate structures on fungi, 
bacteria and viruses (Takeuchi and Akira, 2010). They play a crucial role in 
antifungal immunity, thus these receptors and their function will be decribed in 
detail in chapter 2.2.2.  
TLRs are among of the best characterized PRR families; in humans there are 
10 identified and in mice 12 TLRs have been found (Takeuchi and Akira, 2010). 
The membrane-bound TLRs, including TLR1, TLR2, TLR4, TLR5 and TLR6, are 
specialized in the recognition of common components of bacteria, viruses, fungi 
and parasites (Takeuchi and Akira, 2010, Becker et al., 2015).  
The innate recognition of viruses is mediated by a group of endosomal TLRs 
(TLR3, TLR7, TLR8, and TLR9) detecting viral nucleic acids. Another group of 
PRRs, which were mentioned earlier, RIG-I-like receptors, are intracellular 
receptors, which are specialized in detecting viral nucleic acids (Pichlmair and 
Reis e Sousa, 2007).  
25 
 
Membrane-bound TLR4 is the main receptor for lipopolysaccharides (LPS) 
(Poltorak et al., 1998). They are major components of the outer membrane of 
gram-negative bacteria, which makes them one of the prime bacterial PAMPs 
recognized by the immune system. LPS is an endotoxin; during a bacterial 
infection, LPS may be responsible for the dangerously reduced blood pressure that 
occurs in conjunction with septic shock (Beutler and Rietschel, 2003). In addition 
to TLR4, LPS stimulation occurs through a series of interactions with several co-
receptors and proteins including CD14, MD-2 and the LPS binding protein 
(Miyake, 2007). TLRs are composed of a leucine?rich repeats (LRRs), which are 
involved in ligand binding such as PAMP, and a cytoplasmic Toll/interleukin?1 
(IL?1) receptor, the (TIR) domain, that interacts with TIR domain?containing 
adaptor molecules such as myeloid differentiation?primary response gene 88 
(MyD88), TIR domain-containing adaptor inducing IFN-b (TRIF), TIRAP/Mal, 
TRIF-related adaptor molecule (TRAM), and Sterile-alpha and Armadillo motif-
containing protein (SARM)(O'Neill and Bowie, 2007). TLR signaling is usually 
divided into two distinct and main pathways, which depend on the usage of the 
following adaptor molecules, MyD88 and TRIF. Most TLRs, with the exception of 
TLR3, seem to be dependent on the expression of MyD88 for their functions 
(Takeuchi and Akira, 2010). The LPS activated signaling cascade through TLR4 
induces the activation of transcription factor NF?κB, which subsequently 
translocates from the cytoplasm into the nucleus and triggers the transcription of 
specific genes involved in the production of proinflammatory cytokines and other 
immune response related genes. One feature of MyD88-independent signaling is 
the induction of Type I interferons and interferon-inducible genes (Lu et al., 2008).   
The cytoplasmic receptors of NLR family are emerging as important regulators 
of immunity as they are involved in detecting and mediating the immune response 
to a broad variety of pathogens and damage- and stress-associated substances. At 
present, a total of 22 NLR genes have been identified in humans (Bauernfeind et 
al., 2011). Members of the NLR family share a similar pattern of domain 
organization. They are composed of a central nucleotide-binding domain (NBD), 
and different kinds of N-terminal regions; in most NLRs, these harbor protein-
binding motifs, such as CARD in NLRCs, pyrin (PYD) domain in NLRPs or a 
baculovirus inhibitor of apoptosis protein repeat (BIR) in NLRBs. In addition, 
there are NLRs with an acidic activation domain (NLRAs) and a family with no 
strong homology to the N-terminal domain of any other NLR subfamily member 
(NLRXs) (Ting et al., 2008). At the other end of the receptor, C-terminal leucine-
rich repeats (LRR) motifs are believed to be involved in sensing microbial and 
danger-associated molecules and modulating the NLR activity. The precise 
mechanisms to explain how LRRs sense their ligands are still largely unknown. 
Two intensively studied members of NLRCs, NOD1 and NOD2, initiate NF-kB 
signaling, leading to the transcription of proinflammatory cytokines and the 
activation of antimicrobial responses. These receptors recognize the distinct 
fragments of bacterial peptidoglycans (PGN), gamma-D-glutamyl-meso-
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diaminopimelic acid (iE-DAP) and muramyl dipeptide (MDP), respectively 
(Caruso et al., 2014).  
Several NLRPs harboring a pyrin domain or NLRBs harboring a BIR domain 
in their N- terminus are not involved in the transcriptional activation of pro-
inflammatory cytokines. They are components of the cytosolic macromolecular 
protein complexes termed ‘inflammasomes” that regulate caspase-1 (cysteinyl 
aspartic protease-1) activation and activation of the inflammatory responses 
(Martinon et al., 2002, Man and Kanneganti, 2015).  
Innate immune system is able to recognize multiple PAMPs and DAMPs, 
expressed by a pathogen or released due to ongoing infection or a stress situation, 
through the PRRs which exhibit different specificities and cellular locations. This 
enables effective detection and successful combatting of the microbial challenge 
with as few side effects as possible to the host.  
 
2.1.2.2. The inflammasomes 
 
Inflammasomes are crucial receptors and sensors of innate immune system for 
recognizing invading pathogens, host-derived danger signals and environmental 
irritants. They are involved in the production of biologically active 
proinflammatory cytokines of IL-1 family, thus they promote the generation of an 
inflammatory response (Man and Kanneganti, 2015). Inflammasomes are cytosolic 
multimeric complexes that comprise three main structures: a sensor protein 
belonging to the NLR (nucleotide-binding domain (NBD) and leucine-rich repeat 
(LRR)-containing) family, or non-NLR PRRs, such as AIM2 (absent in melanoma 
2)-like receptor or interferon, gamma inducible protein 16 (IFI16), an adaptor 
protein ASC (apoptosis-associated speck-like protein containing a CARD) and an 
inactive cysteine-protease enzyme, procaspase-1 (Latz et al., 2013).  
 Several sensor proteins can trigger the formation of inflammasomes and the 
amount of different sensor molecules behaving in such a manner may still grow in 
the future as more research is conducted. Inflammasomes are designated according 
to their sensor molecules. Most of the inflammasomes that have been described to 
date contain a NOD-like receptor (NLR) sensor molecule, with the structure of 
NOD-, LRR- and pyrin domain or NOD-, LRR- and CARD -domain. These 
include NLRP1, NLRP3, NLRP6, NLRP7 and NLRP12 inflammasomes or the 
NLRC4 inflammasome (also called IPAF), respectively (Latz et al., 2013). Two 
other non-NLR containing inflammasomes have been described, absent in 
melanoma 2 (AIM2) and IFNγ-inducible protein 16 (IFI16) both belong to PYHIN 
(pyrin and HIN domain-containing protein) family (Hornung and Latz, 2010). 
AIM2 possesses a pyrin domain to recruit ASC and a HIN domain for DNA-
binding, whereas IFI16 has two DNA-binding HIN domains instead of one.  
In the NLR family of the inflammasomes, the NLRP3 (previously called 
“NALP3”, “PYPAF1”, or “cryopyrin”) has been the most intensively studied 
inflammasome, which plays a crucial role in innate immunity by sensing a wide 
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range of multiple pathogen (bacterial, fungal, viral)-, environmental- and host-
derived factors (Table 1. on page 19). NLRP3 has also been implicated in the 
pathogenesis of several inflammatory diseases such as atherosclerosis and gout 
(Martinon et al., 2006, Duewell et al., 2010). 
NLRP1 was the first described member of NLR family to be part of the 
inflammasome complex and caspase-1 activation (Martinon et al., 2002). The 
trigger for oligomerization and activation for NLRP1 has been suggested to be the 
bacterial cell wall component, muramyl dipeptide, along with the simultaneous 
detection of host ribonucleoside triphosphates (Faustin et al., 2007). In contrast, 
one of the murine NLRP1 isoforms, NLRP1b, is activated by the Bacillus 
anthracis lethal toxin (Boyden and Dietrich, 2006). The structure that triggers 
NLRP6 has remained unknown, but the function of NLRP6 is associated in 
maintaining the intestinal health and homeostasis (Elinav et al., 2011).  
NLRP6 deficiency results in impaired mucin granule exocytosis from goblet 
cells (Wlodarska et al., 2014), defective mucus secretion is known to increase 
susceptibility to persistent microbial infections. The NLRP7-containing 
inflammasome is found in humans, is activated by bacterial lipopeptides and it is 
not expressed in mice (Khare et al., 2012) and furthermore, the specific factors 
triggering NLRP12 have not been characterized. It has been shown to play a role 
in Yersinia pestis infection via activating production of IL-18, which is a crucial 
cytokine for clearance of the Yersinia infection (Vladimer et al., 2012).  
NLRC4 is critical in anti-bacterial defenses; it is activated by components of 
bacterial type III secretion system and flagellin. Unlike other inflammasomes, 
NLRC4 activation requires additional host molecules, NAIPs, which has been 
postulated to function as an actual receptor for the inflammasome, which then 
triggers NLRC4 (Zhao and Shao, 2015).  
Even though the NLRs are categorized as PRRs, in most cases, the mechanisms 
of direct interaction between NLRs and their activating stimuli have not been 
clarified and in some cases, NLRs seem to function rather as adaptors of 
inflammasome.  Unlike NLRs, AIM2 and IFIT16 directly bind to their ligand. 
AIM2 is typically activated by viral or bacterial double –stranded (ds) DNA in the 
cytosol originating from viruses such as mouse cytomegalovirus and vaccinia virus 
or cytosolic bacteria such as Francisella tularensis and Listeria monocytogenes 
(Hornung et al., 2009, Fernandes-Alnemri et al., 2010, Rathinam et al., 2010). The 
IFIT16 inflammasome is located in the nucleus; it is activated by DNA from 
Kaposi sarcoma-associated herpes virus (Kerur et al., 2011).  
Upon activation, using the NLRP3 inflammasome as an example, 
oligomerization of NLRP3 leads to recruitment of the adaptor protein, ASC, 
through interaction between the pyrin structure (PYD) of ASC and the N-terminal 
pyrin (PYD) of the NLRP3. This oligomerization requires ATP to bind to the NBD 
structure of the NLRP3 (Duncan et al., 2007). ASC in turn brings monomers of 
procaspase-1 into close proximity with its CARD domain, forming a multimeric 
complex termed the inflammasome and initiating the self-cleavage of procaspase-1 
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into its active form. Active caspase-1 proteolytically cleaves two essential pro-
inflammatory cytokines, pro-IL-1β and pro-IL-18, into their biologically active 
forms (Latz et al., 2013). Recently, it has been shown that the recruitment of ASC 
and the formation of the ASC oligomers, so-called ASC specks, is one the most 
important phenomena in inflammasome assembly and activation of caspase-1. The 
formation of ASC specks and inflammasome activity are regulated via ASC 
phosphorylation (Hara et al., 2013). These ASC specks act also in cell-to-cell 
communication. Inflammasome activation has been shown to accumulate ASC 
oligomers in the extracellular space, where they continue to process extracellular 
pro-IL-1β. Phagocytosis of these extracellular ASC specks by macrophages 
induces lysosomal damage and IL-1β production in the recipient cells, indicating 
that ASC specks can function as danger signals (Franklin et al., 2014). 
In addition to the production of active IL-1 family cytokines, inflammasome 
dependent caspase-1 activity can occasionally trigger the form of cell death known 
as pyroptosis, and thus affect the survival of myeloid cells during inflammation 
(Bergsbaken et al., 2009). Pyroptosis shares characteristics with both apoptosis, 
such as DNA fragmentation and necrosis, such as cellular swelling and plasma 
membrane rupture and the release of proinflammatory intracellular content. 
Pyroptosis occurs independently of proapoptotic caspases (caspase-3, caspase-6, 
caspase-8) (Bergsbaken et al., 2009) In other respects, the regulation of pyroptosis 
is not well defined. However, increased inflammasome activity appears to increase 
the extent of pyroptosis. 
The proinflammatory cytokine IL-1β can also be processed by non-canonical 
pathways involving other caspase types. In mice, it has been demonstrated that 
NLRP3-dependent caspase-1 activation and IL-1β processing can also be triggered 
by an indirect, non-canonical pathway downstream of caspase-11. Activation of 
caspase-11 (caspase-4 and caspase-5, human orthologues) is triggered by cytosolic 
LPS and it seems to occur independently of all known inflammasomes. It is still 
unclear how caspase-11 mediates the caspase-1 activation downstream of the 
NLRP3 inflammasome (Lamkanfi and Dixit, 2014). In addition, the non-canonical 
caspase-8 inflammasome composed of mucosa-associated lymphoid tissue 
lymphoma translocation protein 1 (MALT1), adaptor protein ASC and caspase-8 
mediates IL-1β maturation after sensing fungal components via the dectin-1 
receptor on human dendritic cells (Gringhuis et al., 2012).  
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Table 1. Multiple signals lead to NLRP3 inflammasome assembly and caspase-1 
activation 
 
NLRP3 activator Reference     
PAMPs 
Microbial cell wall components 
Bacterial muramyl dipeptide (MDP) (Martinon et al., 2004)  
Microbial nucleotides 
Bacterial and viral DNA, RNA (Kanneganti et al., 2006, Muruve et al., 2008) 
(Kailasan Vanaja et al., 2014) 
Microbial pore-forming toxins 
Hemolysins (from Staphylococcus aureus) (Munoz-Planillo et al., 2009) 
Nigericin (from Streptomyces hygroscopicus) (Mariathasan et al., 2006)  
Streptolysin (from Streptococcus pyogenes) (Harder et al., 2009) 
DAMPs 
Ion channel activator 
ATP (ligand for P2RX7) (Mariathasan et al., 2006) 
Disease associated crystalline material, 
particles, 
protein aggregates 
Amyloid-β (Alzheimer`s disease) (Halle et al., 2008) 
Calcium pyrophosphate dihydrate (CPPD) 
(pseudogout) (Martinon et al., 2006) 
Cholesterol crystals (atherosclerosis) (Duewell et al., 2010, Rajamäki et al., 2010) 
Monosodium urate, MSU (gout) (Martinon et al., 2006) 
Mediators of acute inflammation 
Serum amyloid A (SAA, acute-phase protein) (Niemi et al., 2011) 
C3a (complement protein) (Asgari et al., 2013) 
ENVIRONMENTAL IRRITANTS 
Alum (vaccine adjuvant) (Hornung et al., 2008, Li et al., 2008) 
Inorganic compounds: asbestos, silica  (Dostert et al., 2008, Hornung et al., 2008) 
Long needle-like carbon nanotubes (Palomäki et al., 2011) 
Urban air pollutants: dust and emission particles (Hirota et al., 2012) 
The majority of the data derived from (Bauernfeind et al., 2011) 
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2.1.2.3. Regulation of NLRP3 inflammasome activation and 
secretion of IL-1β 
 
NLRP3 inflammasome is activated by a wide range of different substances. The 
exact mechanisms through which these ligands activate the canonical NLRP3 are 
largely unknown. Even although the NLRP3 is categorized as a PRR, it is believed 
that rather than having a direct interaction between NLRP3 and its activating 
ligand, NLRP3 activators induce cellular events that lead to assembly of NLRP3 
inflammasome and caspase-1 activation. Currently, there are some generally 
agreed-upon events known to activate NLRP3 inflammasome i.e. potassium efflux 
(K+) out of the cell (Munoz-Planillo et al., 2013), generation of mitochondrial ROS 
(Zhou et al., 2011), the release of mitochondrial DNA or cardiolipin (Shimada et 
al., 2012, Iyer et al., 2013), the secretion of cathepsins into the cytosol as a result 
of phagolysosomal membrane destabilization (Hornung et al., 2008) and the 
translocation of NLRP3 to the mitochondria (Zhou et al., 2011, Subramanian et al., 
2013).   
However, not all of these mechanisms are accepted by all investigators in this 
field, such as involvement of cathepsin B or ROS in NLRP3 activation (Dostert et 
al., 2009, Munoz-Planillo et al., 2013). Thus the precise activation mechanism of 
NLRP3 is still unclear.  
Recently, several regulators have been suggested to be involved in NLRP3 
inflammasome activation; these include double-stranded RNA-dependent protein 
kinase (PKR), guanylate-binding protein 5 (GBP5) and NIMA (never in mitosis 
gene a)-related kinase 7 (Nek7). PKR, originally studied as an intracellular 
receptor for viral dsRNA, was shown to have a broader role and interact physically 
with inflammasome components and to mediate the activation of inflammasomes 
(NLRP1, NLRP3, NLRC4, AIM2) in its response to a wide array of stimuli such 
as double-stranded RNA, ATP, monosodium urate (MSU), aluminium or anthrax 
lethal toxin (Lu et al., 2012). GBP5 has been reported to promote NLRP3 
inflammasome activation in response to soluble substances (ATP, nigericin) and 
bacteria, but not to particulate matter (Shenoy et al., 2012). Nek7 is a part of the 
NIMA -related kinase family, which is involved in the regulation of mitotic 
progression and the response to DNA damage. Nek7 was shown to be required for 
NLRP3 inflammasome activation in a response to ATP, nigericin, MSU crystals 
and alum (He et al., 2016, Shi et al., 2016). The catalytic domain of Nek7 interacts 
with the LRR domain of NLRP3 inflammasome, although the kinase activity was 
not required for activation of the Nek7-mediated inflammasome (He et al., 2016, 
Shi et al., 2016).   
The most prominent outcome of NLRP3 inflammasome signaling, along with 
the induction of pyroptosis, is considered to be the secretion of biologically active 
proinflammatory cytokines, IL-1β and IL-18 (Lamkanfi and Dixit, 2012). These 
cytokines exert systemic effects and they promote a wide range of inflammatory 
responses (Lamkanfi and Dixit, 2012). Therefore, these cytokines are largely 
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beneficial to the host during an infection. Thus, activation of the inflammasome, 
which leads to secretion of these cytokines, must be kept silent during the normal 
homeostasis and even during an infection, it must be finely controlled to avoid 
excessive tissue damage.      
It has been postulated that the full activation of NLRP3 inflammasome in 
macrophages involves two-steps (Bauernfeind et al., 2011) (Figure 2). The first is 
a priming step; the prototypical example is the binding of bacterial 
lipopolysaccharide (LPS) to TLR4 that leads through NF-κB signaling to 
upregulation of pro-IL-1β and onwards to an increase in the cellular expression of 
NLRP3 components (Bauernfeind et al., 2009). The production of pro-IL-18 does 
not require this first step as it is expressed constitutively in many leukocytes 
(Puren et al., 1999). Post-translational modifications are known to be crucial in 
almost every step of inflammasome activity, including ubiquitination, 
deubiquitination, phosphorylation, and degradation. Even priming can induce 
deubiquitination of NLRP3, which is essential for its assembly and activation 
(Juliana et al., 2012, Lopez-Castejon et al., 2013). Inflammasome activation 
requires also a post-translational modification of the adaptor protein ASC, this 
needs to become linearly ubiquitinated and phosphorylated before inflammasome 
assembly can occur (Hara et al., 2013, Rodgers et al., 2014).  
Once primed, the activation of NLRP3 requires a second, distinct stimulus such 
as the presence of a microbial toxin or a DAMP before the second step is taken, 
where the components are assembled into the inflammasome structure followed by 
the secretion of IL-1β and IL-18.  
The requirement of two signals for NLRP3 inflammasome activation suggests 
that macrophages do not activate their production of proinflammatory cytokine IL-
1β when receiving only the second stimulus. Requirement of the crucial priming 
signal via other PRRs, that indicates either the presence of infection or the 
presence of other activated defence cells (via activation of PRRs by microbial 
products or danger signals, or receptors recognizing pro-inflammatory cytokines), 
along with the second signal may have the purpose of preventing accidental 
NLRP3 activation. Uncontrolled activation of NLRP3 can have devastating 
consequences for the host such as triggering of an autoinflammatory disease 
(Bauernfeind et al., 2011). 
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Figure 2. Two distinct signals (priming and activation) are needed for activation of 
NLRP3 inflammasome and production of biologically active IL-1β. 
 
 
2.1.2.4. NLRP3 -associated diseases 
 
Our knowledge of how inflammasomes contribute to the pathology of many 
autoinflammatory diseases has significantly increased in recent years. 
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Inflammasomes mediate the effective and rapid innate immune response against 
the infectious or non-infectious agents, leading to the elimination of the threat. 
Inflammasomes have also been suggested to play a role in the development of 
adaptive immunity (Dostert et al., 2013). Therefore, any uncontrolled function of 
the inflammasome, such as continuous production of proinflammatory cytokines 
may be harmful since it can lead to severe outcomes for the host. In this chapter, 
the focus will be placed on the NLRP3 inflammasome and diseases associated 
with its dysfunction.     
Several inherited autoinflammatory disorders are caused by gain of function 
mutations in NLRP3, thus highlighting its importance in the inflammatory process 
(Masters et al., 2009). There are several well known examples e.g. the cryopyrin-
associated periodic fever syndromes (CAPS, also called cryopyrinopathies), which 
include Muckle-Wells syndrome (MWS), familial cold autoinflammatory 
syndrome (FCAS), and neonatal onset multi-system inflammatory disease 
(NOMID) (Hoffman et al., 2001, Feldmann et al., 2002). The cryopyrin (or 
CIAS1) was the name formerly used for NLRP3, which was given to the gene and 
its protein product because of its role in cold-induced fevers (Hoffman et al., 2001, 
Feldmann et al., 2002, Ting et al., 2008). These cryopyrinopathies differ in the 
level of symptom severity, but their general symptoms are urticarial skin rashes, 
prolonged episodes of fever, arthritis, and other types of localized inﬂammation 
(Hoffman et al., 2001, Feldmann et al., 2002, Masters et al., 2009). It has been 
postulated that the CAPS-associated mutations may cause conformational changes 
and trigger the spontaneous assembly of NLRP3, which lead to persistent 
activation of caspase-1 and the disproportionate production of IL-1β (Dowds et al., 
2004).  
   There is evidence accumulating from the majority of knockout mouse studies 
with some supporting human data, implicating NLRP3 in the pathogenesis of 
several complex diseases. It is notable that many of these diseases such as 
metabolic disorders (atherosclerosis, gout, type 2 diabetes) and neurogenerative 
diseases (Alzheimer`s disease) have a high impact on public health. One common 
feature of these diseases is aberrant accumulation of certain metabolites, such as 
cholesterol crystals in atherosclerosis, MSU crystals in gout or islet amyloid 
polypeptides (IAPP) in type 2 diabetes, or the presence of misfolded protein 
aggregates such as amyloid-β peptide plaques in Alzheimer`s disease (Martinon et 
al., 2006, Halle et al., 2008, Duewell et al., 2010, Masters et al., 2010, Rajamäki et 
al., 2010, Heneka et al., 2013). These components have been proved to function as 
endogenous DAMPS and activators of the NLRP3 inflammasome. Thus, they 
activate IL-1β signaling, leading to inflammation and cell death, the general 
phenomena encountered in these diseases (Chen et al., 2006, Halle et al., 2008, 
Duewell et al., 2010, Masters et al., 2010).  
The NLRP3 is activated also by a variety of exogenous agents, ranging from 
microbes (e.g. viruses, bacteria, fungi) and their components to certain inorganic 
particles found in the environment (e.g. minerals). The data from patients with 
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lung diseases and animal knockout studies suggests that a number of inhaled 
inorganic particles can cause NLRP3 inﬂammasome activation in the lung; these 
particles include asbestos, silica and bleomycin, this last compound is exploited in 
an experimental model of idiopathic pulmonary fibrosis. The production of IL-1β 
and IL-18 cytokines via activated NLRP3 inflammasome recruits additional 
immune cells into the lung and boosts the inflammatory response, potentially 
leading to initiation or progression of the pulmonary disease (De Nardo et al., 
2014).   
IL-1β plays a major role in NLRP3 activated inflammatory response. Thus IL-1 
antagonism has been found to be successful in the treatment of many IL-1 
associated diseases. Inhibition of IL-1 signaling with the recombinant IL-1 
receptor antagonist, anakinra, or with the soluble decoy IL-1 receptor, rilonacept, 
or with the neutralizing IL-1 antibody, canakinumab, has proven extremely 
beneficial in CAPS patients and metabolic disorders such as type 2 diabetes and 
gout (Dinarello and van der Meer, 2013). There has also been intense research into 
the molecules inhibiting NLRP3 directly, as this may be one way to avoid the side 
effects which may occur when IL-1 signaling is totally blocked. One of these side 
effects is excessive immunosuppression, which may lead to an increased risk of 
infection, because the IL-1 response triggered by other antimicrobial 
inflammasomes, such as NLRP1 and NLRC4, is also inhibited. Recently, MCC90, 
a highly potent specific inhibitor of the activation of canonical and non-canonical 
NLRP3 has been characterized (Coll et al., 2015). Treatment with MCC90 
decreased neonatal lethality in a mouse model of CAPS and inhibited NLRP3 in ex 
vivo samples collected  from patients with Muckle-Wells syndrome (Coll et al., 
2015). Future trials with these direct NLRP3 inhibitors will determine whether 
they represent a new, more efficient, treatment for NLRP3 associated diseases.  
 
2.1.2.5. Proinflammatory cytokines of IL-1 family 
 
Interleukin-1 family cytokines are central mediators of innate immunity and 
inducers of local and systemic inflammation. The IL-1 family also includes 
members which suppress inflammation (Dinarello, 2013). Their production is part 
of the defense response of host against invading pathogens and other noxious 
agents. These cytokines play key roles in the function and differentiation of cells 
from both innate and adaptive immunity system (Garlanda et al., 2013). Because 
of their wide-scale impact, activation and signaling of IL-1 family cytokines are 
tightly regulated at many levels: gene transcription, protein processing, receptor 
binding, balancing between the expression of receptor agonists and antagonists, 
and post-receptor signaling by naturally occurring inhibitors (Palomo et al., 2015).  
The IL-1 family consists of seven ligands with agonist activity (IL-1α, IL-1β, 
IL-18, IL-33, IL-36α, IL-36β and IL-36γ), three receptor antagonists (IL-1Ra, IL-
36Ra, IL-38) and one cytokine with anti-inflammatory features (IL-37) (Garlanda 
et al., 2013). They share a common C-terminal three-dimensional protein structure 
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and most of them are synthezised as precursor proteins, with non-existent or very 
little biological activity and thus to achieve their full biological potential, they 
require proteolytic processing, which is one crucial step in the control of the 
activation of IL-1 cytokines (Sims and Smith, 2010, Dinarello, 2013, Garlanda et 
al., 2013). All the IL-1 family members, with the exception of the IL-1Ra, lack an 
N-terminal hydrophobic signal sequence and thus are not secreted via the 
conventional endoplasmic reticulum-golgi pathway (Sims and Smith, 2010, 
Garlanda et al., 2013). Unconventional secretion mechanisms of IL-1 cytokines are 
still mainly remained uncharacterized. This chapter will focus on the function of 
proinflammatory agonists of IL-1 family (Table 2). 
 
Table 2. Proinflammatory cytokines of IL-1 family and their main functions  
 
Cytokine 
Alternative 
 name Receptor Activity 
IL-1α IL-1F1 IL-1R1, IL-1R2 DAMP, Th17 responses, inflammation 
IL-1β IL-1F2 IL-1R1, IL-1R2 Antimicrobial resistance, Th17 responses, inflam. 
IL-18 IL-1F4 IL-18Rα Antiviral resistance, Th1 responses, inflammation 
IL-33 IL-1F11 ST2 DAMP, Th2 responses, inflammation 
IL-36α IL-1F6 IL-1Rrp2 (IL-36R) Tissue-restricted inflammations (skin, lung) 
IL-36β IL-1F7 IL-1Rrp2 (IL-36R) Tissue-restricted inflammations (skin, lung) 
IL-36γ IL-1F8 IL-1Rrp2 (IL-36R) Tissue-restricted inflammations (skin, lung) 
The majority of the data derived from (Garlanda et al., 2013) 
 
IL-1β is a highly inflammatory cytokine and it has been the most extensively 
studied member of the IL-1 family. IL-1 exerts systemic effects, it can affect 
virtually nearly every organ or cell. It is involved in a wide range of biological 
activities including development of fever, vasodilation, angiogenesis, 
hematopoiesis, leukocyte recruitment, function and survival and it also have a role 
in the adaptive immunity system by affecting lymphocyte activation and antibody 
synthesis (Dinarello, 2009, Garlanda et al., 2013). It has been reported that IL-1β 
induces the development of Th17 cells (Sims and Smith, 2010, Garlanda et al., 
2013), the subclass of activated CD4+ helper T-cells in adaptive immunity which 
are associated with the immune response against extracellular bacteria and fungi 
(Luckheeram et al., 2012). IL-1β has been implicated in a wide range of 
inflammatory diseases such as type 2 diabetes and gout (Dinarello and van der 
Meer, 2013). IL-1β is primarily a product of innate immune defense cells such as 
monocytes, macrophages and dendritic cells, released mostly in response to 
inflammatory stimuli such as PAMPs or proinflammatory cytokines e.g. TNF or 
IL-1 itself (Dinarello, 2009). IL-1β and IL-18 are produced as biologically inert 
pro-peptides that need to be cleaved in their N-terminal region before they can 
bind to their receptors and induce cellular responses. As demonstrated in a 
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previous chapter, the preform of IL-1β, as is also the case with IL-18, must be 
cleaved by caspase-1 enzyme, which in turn needs the assembly and activation of 
intracellular protein complex named the inflammasome for its activation (Schroder 
and Tschopp, 2010). In addition, pro-IL-1β or IL-18 can also be cleaved 
independently of caspase-1 activation by neutrophil serine proteases, such as 
proteinase 3 and elastase and proteases released by invading microorganisms or 
mast cell-derived chymase and NK cell-derived granzyme B (Netea et al., 2015).  
In contrast to IL-1β, IL-18 precursor is constitutively expressed in most cells, it 
is not pyrogenic (a fever inducer) and it does not induce the production of acute-
phase proteins or proinflammatory cytokines such as TNF or IL-6 (Novick et al., 
2013). IL-18 has been associated with the Th1 polarized cell-response, which 
contributes to the immune response by inducing the production of IFN-γ and 
activation of natural killer cells (NK cells) (Garlanda et al., 2013). The Th1 type 
response is usually encountered in viral infections, but may also be seen in the 
presence of intracellular pathogen (Luckheeram et al., 2012). Clearly elevated 
levels of serum IL-18 are detected in patients with infections caused by viruses 
such as Epstein-Barr virus, cytomegalovirus and human immunodeficiency virus 
(ten Oever et al., 2012, van de Veerdonk et al., 2012). However, depending on the 
surrounding cytokine milieu, IL-18 can display various inflammatory activities, 
e.g. in the absence of the IL-12 or IL-15 cytokines, it can promote Th2 responses 
(Nakanishi et al., 2001). A role for IL-18 has been postulated in several 
autoimmune diseases, such as Crohn`s disease and psoriasis and other diseases 
such as myocardial dysfunction, metabolic syndromes, macrophage activation 
syndrome, and acute kidney injury (Novick et al., 2013). In addition to IL-18’s 
proinflammatory role of, it has displayed protective features in some models of 
diseases and has been suggested to act also as an important regulator of 
homeostasis (Novick et al., 2013). This proposal is supported by the finding that 
IL-18 deficiency in mice results in development of the metabolic syndrome with 
obesity and lipid abnormalities (Netea et al., 2006) as well as the fact that 
administration of exogenous IL-18 promoted mucosal healing in caspase-1 
knockout mice subjected to dextran sulfate sodium (DSS) induced colitis (Dupaul-
Chicoine et al., 2010).  
   IL-1α and IL-33 are the IL-1 family members, which have a dual function, 
acting as proinflammatory cytokines or as transcription factors. Both of these 
cytokines are consistently found in cell nuclei and their precursor forms contain 
nuclear localization sequences in their N-terminal region that can bind to DNA 
(Werman et al., 2004, Carriere et al., 2007).  Intracellular precursor proteins of IL-
1α and IL-33 can be released in situations of cell damage or cell death and 
stimulate early inflammatory responses by acting as DAMPs. These full length 
precursors of IL-1α and pro-IL-33 can bind to their respective receptors and induce 
cell signaling, although their activities are significantly enhanced after protease 
cleavage. IL-1α is processed by calpain, a membrane-associated, calcium-
dependent cysteine protease (Kobayashi et al., 1990). IL-33 is cleaved to its more 
37 
 
potent mature forms by calpain and the neutrophil serine proteases, cathepsin G 
and elastase, whereas caspase-1 cleavage has resulted in a loss of IL-33 activity 
(Garlanda et al., 2013, Netea et al., 2015).   
IL-1α binds to the same receptor (IL-1R) with IL-1β, either as an unprocessed 
precursor or as a processed protein. In practical terms, IL-1α shares similar kinds 
of biological properties as IL-1β. On the other hand, the unique features of IL-1α 
include its role in initiating so-called sterile inflammation by inducing the 
expression of inflammatory cytokines and chemokines and recruiting neutrophils 
when released by dying cells, whereas secretion of IL-1β needs the initial 
activation of the inflammasome and it is more involved with the recruitment and 
retention of macrophages.  (Rider et al., 2011). In contrast to IL-1β, IL-1α is 
constitutely expressed as precursor protein in epithelial cells, endothelial cells and 
keratinocytes (Garlanda et al., 2013). IL-1α is rarely secreted from cells, but its 
membrane-anchored form is fully biologically active and can induce gene 
expression in neighboring cells (Kaplanski et al., 1994). The different effects of 
IL-1α and IL-1β seem to occur more due to the different cell sources of these 
cytokines as well as their distinctive cellular locations and release mechanisms, 
rather than being attributable to differences in downstream signaling following the 
IL-1R engagement (Garlanda et al., 2013). IL-1α has been shown to play a role in 
atherosclerosis and also in some experimental models of brain injury (Dinarello, 
2009, Luheshi et al., 2011).    
    IL-33 is the most recently identified member of IL-1 family and it is expressed 
constitutively or in an inducible manner in several stromal, parenchymal and 
hematopoietic cell types. The dominant biological activity of IL-33 on immune 
cells is to polarize the immune response towards allergic response and the Th2 
direction i.e. inducing the production of Th2 cytokines (IL-4, IL-5, IL-13) and 
triggering the M2-polarization of macrophages. IL‑33 acts directly on mast cells 
and eosinophils may be due to abundant expression of ST2 in these cells. It 
promotes the maturation, survival and cytokine production of mast cells, as well as 
elevates the survival and expansion of eosinophils (Schmitz et al., 2005, Oboki et 
al., 2010, Sims and Smith, 2010, Garlanda et al., 2013). IL-33 plays a role as a 
mediator in the Th2 type inflammatory conditions such as allergic lung 
inflammation, whereas in helminth infections, it seems to have a protective role 
(Garlanda et al., 2013). In addition to its Th2 polarizing effect, it seems to possess 
anti-inflammatory features by reducing the gene transcription of those 
proinflammatory cytokines which are activated by transcription factor NF-κB  (Ali 
et al., 2011).  
The IL-36 is a subgroup of the IL-1 family, but its function has remained 
poorly characterized. It includes three agonists: IL-36α, IL-36β, and IL-36γ.  The 
expression of IL-36 cytokines is mainly observed in keratinocytes, bronchial 
epithelium, monocytes/macrophages and lymphocytes (Gresnigt and van de 
Veerdonk, 2013). IL-36 cytokines are predominantly expressed in skin and there 
are some reports that these cytokines are involved in the pathogenesis of skin 
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diseases such as psoriasis (Johnston et al., 2011, Marrakchi et al., 2011). 
Furthermore, a role in the pathology of pulmonary diseases has been suggested. In 
mice, the gene encoding IL-36γ is located in the locus of allergen induced 
bronchial hyperresponsiveness-1 (Abhr1). Furthermore, the expression of IL-36γ 
in the lung was increased in an animal model where the mice are asthma 
susceptible compared to asthma resistant mice, suggesting that IL-36γ may be 
involved in allergen-induced inflammation in the lung (Ramadas et al., 2006). In 
addition, the intratracheal administration of IL-36α or IL-36γ to mice induced a 
rapid influx of neutrophils into the BALF, one of the hallmarks of inflammation in 
lungs (Gresnigt and van de Veerdonk, 2013). Bronchial epithelial cells express IL-
36γ, when stimulated with proinflammatory cytokines such as IL-1β, TNF, IL-17, 
or microbial substances, whereas IL-36γ induces chemokine IL-8 and the Th17 
chemokine CCL20 in human lung fibroblasts (Vos et al., 2005, Chustz et al., 
2011).  
The IL-36 cytokines, secreted by keratinocytes or other epithelial cells, have a 
significant effect on dendritic cells, inducing the production of many cytokines and 
chemokines such IL-1β, TNF, IL-6, IL-12, IL-23, CXCL1 and GM-CSF in the 
dendritic cells. These mediators are associated with Th1 and Th17 responses, thus 
in this way, IL-36 signaling can promote not only the innate responses but also the 
responses mediated via adaptive immunity by affecting the T-cell polarization 
(Vigne et al., 2011, Mutamba et al., 2012).  
IL-36 cytokines do not contain caspase-1 cleavage sites, however, similarly to 
IL-1β and IL-18, in a recent report it was shown that N-terminal truncation, 
although artificial in this case, increased dramatically the proinflammatory activity 
of IL-36 (Towne et al., 2011). However, currently it is not understood how 
endogenous IL-36 undergoes maturation into its bioactive form and which enzyme 
or enzymes are involved in this processing, and even whether this occurs in 
humans under pathologic conditions. The IL-36 signaling in many respects 
resembles IL-1α and IL-1β signaling, but IL-36 cytokines seem to be expressed in 
a more tissue-restricted manner than either IL-1α or IL-1β. Therefore, they cannot 
be considered to be simple surrogates for IL-1α or IL-1β. It has been proposed that 
they have a role in IL-1α/β independent inflammatory responses and have evolved 
to regulate tissue specific immune responses (Gresnigt and van de Veerdonk, 
2013).  
 
2.1.3. Protein secretion as a response to immune system 
activation  
 
The secretion of immune mediators such as cytokines, chemokines, DAMPs 
and other substances affecting the immune system by both immune and non-
immune cells plays a crucial role in determining the course of the inflammatory 
response. Some cytokines are released in order to maintain homeostasis in tissues 
or when the balance must be restored after combatting an environmental challenge 
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such as the presence of a dangerous pathogen. In contrast, proinflammatory 
cytokines are released in the response to a pathogen or other harmful signals in 
order to promote the inflammatory response and achieve the eradication of this 
harmful stimulus. The production of proinflammatory cytokines in cells is 
regulated at many levels by cell signaling, as well as at the levels of mRNA and 
protein synthesis. Thereafter, an essential role in the activation and release of the 
cytokines is carried out by intracellular trafficking machinery, which performs the 
necessary modifications in proteins and arranges their transport to their final 
destinations. This trafficking machinery and the related secretion pathways of the 
cytokines are complex and highly regulated in many cells, involving specialized 
organelles, membrane structures and multiple participating molecules (Stow and 
Murray, 2013). 
 
2.1.3.1. Conventional and unconventional protein secretion 
 
The vast majority of eukaryotic proteins are secreted through the conventional or 
the so-called classic protein secretion pathway which refers to protein secretion via 
the endoplasmic reticulum (ER)-to-Golgi membrane pathway. These 
conventionally secreted proteins contain an N-terminal or an internal signal-
peptide that directs them into the lumen of the ER. This step is followed by the 
vesicular transport of secretory proteins in COPII-coated vesicles to the Golgi 
membranes and thence to the cell surface where the cargo vesicle is fused with the 
plasma membrane and its contents are released into the extracellular space 
(Dancourt and Barlowe, 2010). One form of conventional secretion is constitutive 
exocytosis, which is the predominant mechanism for cytokine release from 
macrophages and DCs, which do not have the same kind of cytosolic secretory 
granules as eosinophils and cytokines are transferred direct from Golgi to plasma 
membrane via recycling endosomes and secreted into the extracellular milieu. 
Several proinflammatory cytokines such as TNF, IL-6, IL-12 and a group of 
chemokines are secreted via constitutive exocytosis only after being synthesized in 
response to microbial or inﬂammatory stimuli (Lacy and Stow, 2011).   
Proinflammatory cytokines such as IL-1 family members or several DAMPs such 
as calgranulins (S100 proteins) or galectins lack the protein signal sequence 
required for ER entry and are thus released from cells via the unconventional 
protein secretion pathways (Bianchi, 2007, Garlanda et al., 2013). Currently, 
unconventional secretion is distinguished into nonvesicular and vesicular 
pathways, and these are classified further into four subtypes (I-IV) based on their 
detailed secretion mechanisms (Rabouille et al., 2012). The non-vesicular 
pathways involve direct protein translocation across the plasma membrane by 
lipid-induced oligomerization and membrane insertion (type I) or proteins are 
transported through the plasma membrane by ABC-transporters (type II). Type III 
unconventional secretion is based on protein trafficking in vesicles and occurs at 
least in four different ways. The protein cargo can be translocated from the cytosol 
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to the plasma membrane inside the secretory lysosomes or autophagosomes. The 
fusion of these lysosomes or autophagosomes with the plasma membrane leads to 
the release of their protein content into the extracellular space. The cytoplasmic 
proteins might also be packed into the endosomal vesicles; this leads to the 
formation of multivesicular bodies. When these multivesicular bodies fuse with the 
plasma membrane, endosomal vesicles are released into the extracellular space as 
exosomes. Lastly, direct microvesicle shedding from the plasma membrane can 
also capture intracellular proteins in their lumen and lead to the release of these 
proteins. Type IV pathway and the second type of unconventional vesicular 
secretion is a variation within the classic secretory pathway, where the proteins 
bypass the Golgi complex after trafficking in ER and reside in the plasma 
membrane.  Generally, type I-III pathways mediate the secretion of cytoplasmic 
proteins, in contrast, the type IV pathway is used for integral membrane proteins, 
which are not released outside of the cell (Nickel and Rabouille, 2009, Rabouille et 
al., 2012).  
 
2.1.3.2. Secretion of IL-1 via unconventional protein 
secretion pathway 
 
Proinflammatory cytokines of the IL-1 family are known to be secreted via 
unconventional secretion pathways with the secretion of IL-1β being studied most 
extensively (Garlanda et al., 2013). Caspase-1 is one of the so-called inflammatory 
caspases; it contains a CARD-domain in its N-terminus, and plays a role in 
inﬂammation since it is a part of the inflammasome complex and thus it can 
regulate the activation of the proinﬂammatory cytokines pro-IL-1β and pro-IL-18 
(Martinon and Tschopp, 2007). The function of caspase-1 differs from apoptotic 
caspases, such as caspase-3, in that it does not participate in apoptotic cell death. 
However, the pyroptotic type of cell death (pyroptosis) is considered to be mainly 
dependent on caspase-1 (Bergsbaken et al., 2009). Caspase-1 has been proposed to 
participate in the regulation of unconventional protein secretion (Keller et al., 
2008). Secretion of IL-1β and IL-18 is known to be impaired in caspase-1 deficient 
macrophages. Surprisingly, also the release of IL-1α, which is not a substrate for 
caspase-1, seems to be dependent on caspase-1, although not on its protease 
activity (Kuida et al., 1995, Li et al., 1995, Gross et al., 2012). It has been 
suggested that depending on the type of NLR activator (phagocytozed particle or 
soluble NLRP3 agonist such as ATP or nigericin), the release of IL-1α is 
correspondingly either caspase-1 independent or dependent, but in both cases IL-
1α processing depends on calpain protease activity (Gross et al., 2012, Yazdi and 
Drexler, 2013).  
The activation of the inflammasome is associated with the secretion of its 
central components (caspase-1, ASC, NLRP3), as well as the secretion of caspase-
1 substrates IL-1β and IL-18, and also several other proteins, which lack signal 
peptides, into the extracellular milieu (Qu et al., 2007, Keller et al., 2008, Gross et 
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al., 2012). Phagocytosis of secreted inflammasome components such as ASC 
specks by macrophages has been shown to induce an inflammatory response in 
these cells (Franklin et al., 2014), indicating that activation of unconventional 
secretion might be one of the immune mechanisms capable of promoting and 
spreading the inflammatory response. 
The release of IL-1β was one of the earliest discovered examples of 
unconventional protein secretion (Rubartelli et al., 1990) but its secretion 
mechanisms are still being intensely debated. The release of soluble IL-1 β into the 
extracellular milieu has been proposed to occur via ABC transporters (Hamon et 
al., 1997, Ikeda et al., 2007) or through the uptake of secretory lysosomes, which 
fuse with the plasma membrane (Andrei et al., 2004, Carta et al., 2006). 
Nonetheless, there are other studies that point to the secretion of IL-1β packaged 
into the vesicles such as microvesicles (MacKenzie et al., 2001) or exosomes (Qu 
et al., 2007). According to these results, it is very likely that there are multiple 
factors (stimulus, cell type, or culturing conditions) which may play a role in 
dictating the secretory mechanisms used for IL-1β release (Stow and Murray, 
2013).  
Recently, it has been demonstrated that a process called autophagy participates 
in the regulation of unconventional secretion of IL-1β and other proteins (Dupont 
et al., 2011, Ponpuak et al., 2015). The research of autophagy has been the centre 
of attention in 2016 due the award of the Nobel Prize in physiology or medicine to 
biologist Yoshinori Ohsumi for his work in 1990s, which revealed the mechanisms 
underlying autophagy in a yeast model. Autophagy, which is mainly recognized 
via the cytoplasmic autodigestive process during starvation and removal of protein 
aggregates or dysfunctional organelles, also affects protein secretion by a process 
termed secretory autophagy (Ponpuak et al., 2015). Secretory autophagy is known 
to facilitate the unconventional secretion of the cytosolic and leaderless proteins 
such as IL-1 family members IL-1β and IL-18, and DAMPs such as HMGB1 
(Dupont et al., 2011, Piccioli and Rubartelli, 2013). In addition, the autophagic 
machinery plays a role in excreting more complex cytoplasmic cargo and 
particulate substrates, and it has also been shown to influence conventional 
secretory pathways (Ponpuak et al., 2015). Thus, autophagy and autophagic factors 
are closely connected at many levels with secretion and the polarized sorting of 
proteins inside cells. It has recently been reported that the secretory autophagy-
related ATG factors such as Atg5, which govern the biogenesis of autophagic 
membranes, are required for the unconventional secretion of IL-1β (Dupont et al., 
2011), confirming that the secretion of several unconventional secretory proteins 
such as IL-1β involves autophagosome-like vesicular intermediates.  In addition, it 
has been demonstrated that in cells where the autophagy process was induced by 
starvation, the secretion of IL-1β was enhanced when these cells were stimulated 
by known inflammasome activators (nigericin, alum, silica or amyloid-β fibrils) 
(Dupont et al., 2011). However, there are also reports which indicate that 
autophagy suppresses inflammasome activation by maintaining mitochondrial 
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homeostasis by preventing the release of ROS (Zhou et al., 2011) or mitochondrial 
DNA (Nakahira et al., 2011). In addition, the negative regulation of inflammasome 
activation and IL-1β release is also proposed to occur due to the autophagic 
degradation of inflammasome components and IL-1β (Harris et al., 2011, Shi et 
al., 2012). These results indicate that autophagy has a dual role in the regulation of 
inflammatory response. It affects the secretion of IL-1β and other unconventional 
secreted proteins, furthermore, it can reduce the inflammatory response by 
targeting the components and substrates of the inflammasome to be broken down 
and degraded.    
  
2.1.3.3. Extracellular vesicles –as conveyors of the immune 
system  
 
Extracellular vesicles can be formed from the plasma membrane by direct 
shedding; they are then called microvesicles or they can originate from an 
intracellular compartment, the multivesicular bodies (MVB) which are released by 
exocytosis. These latter vesicles, once released into the extracellular environment, 
are called exosomes. It is thought that extracellular vesicles serve as signal 
conveyors in intercellular communication, both locally and systemically, as they 
can transfer their contents into the new cells. Extracellular vesicles may contain 
membrane and intracellular components that include proteins, lipids and 
nucleotides, but their composition can differ with respect to site of vesicle 
biogenesis (Robbins and Morelli, 2014). There are examples of releasing 
molecules such as a Fas ligand which when present in extracellular vesicles, 
experience reduced degradation by surface proteases, augmenting their local 
concentration which may ultimately improve their biological activity by favouring 
their aggregation (Zuccato et al., 2007).  
Exosomes are the best characterized group of secreted membrane vesicles and 
thus their function is discussed in more detail in this chapter. Exosome vesicles 
(50–100 nm) are secreted from viable cells, either constitutively or in an induced 
manner, but they are not released from either lysed or apoptotic cells. Many cell 
types such as hematopoietic cells, intestinal epithelial cells, neuronal cells and 
tumor cells have been described to release exosomes in vitro. Exosomes are 
found in vivo in plasma and several other biological fluids such as urine, saliva, 
breast milk, semen, bronchoalveolar lavage fluid and sputum (Thery et al., 2009, 
Record et al., 2011). Macrophages infected with intracellular pathogens have been 
shown to secrete exosomes (Bhatnagar et al., 2007) and in general, exosome 
secretion is thought to be a response to environmental challenges (pathogen 
encounter, cell stress), and could be considered to be one of the mechanisms used 
by cells and tissues to adapt to these changes (Thery et al., 2009).  The contents of 
lipid and protein in exosomes differ from the contents of microvesicles or 
apoptotic blebs. Exosomes have a high content of proteins and may include many 
different kinds of proteins (Exocarta, a web-based compendium of exosomal 
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proteins, RNAs and lipids hosts currently over 40,000 proteins) (Keerthikumar et 
al., 2015).  The proteins that are frequently seen enriched in exosomes are those 
related to vesicle genesis or their trafficking (TSG101, ALIX, annexins), signal 
transduction (kinases and G-proteins), cytoskeleton organization (actin and 
tubulin), antigen presentation (MHC class I and II molecules, heat shock proteins) 
and vesicle targeting either towards the recipient cells or to the extracellular matrix 
(adhesion molecules such as integrins and tetraspanins) (Robbins and Morelli, 
2014).  
Initially, exosomes were thought to be simply a mechanism for removing 
unneeded proteins from the cells, especially for cells that have poor capacities to 
degrade proteins or are located towards a drainage system such as the kidney 
tubule or gut (Record et al., 2011). Subsequently, it was revealed that exosomes 
have important roles in the regulation of the immune system by promoting or 
suppressing the immune response and thus they possibly are to able to drive 
inflammatory, autoimmune and infectious disease pathology. It is also known that 
exosomes carry both antigenic material and peptide-MHC complexes which can 
activate the recipient cells such as antigen-presenting cells (APCs) or T-cells. 
Exosomes released from Mycobacterium -infected macrophages contained 
pathogen-derived antigens and could stimulate the proinflammatory response in 
vitro and in vivo (Bhatnagar et al., 2007). Tumor-derived exosomes carrying 
tumor-proteins and antigens are emerging mediators of tumorigenesis and can 
activate directly macrophages, NK -cells and also T-cells via dendritic cell 
presentation (Bobrie et al., 2011, Peinado et al., 2012). On the other hand, they 
may also carry ligands such as Fas L or TGFβ which inhibit immune cell 
proliferation or activation (Bobrie et al., 2011). The exosomes that are released by 
APCs contain antigens with surface MHC class I and class II molecules and 
therefore potentially can directly stimulate preactivated CD8+ and CD4+ T cells, 
respectively. In contrast, if they are to activate naïve T cells which require high 
levels of T-cell receptor crosslinking and co-stimulation, the content of exosomes 
must be captured and presented by DCs (Bobrie et al., 2011). Secreted vesicles 
may also possess immunosuppressive properties and induce a kind of tolerance. As 
mentioned before, tumor-derived microvesicles or exosomes have been shown to 
suppress the function of immune cells, for example by inducing T cell apoptosis 
via FasL (Andreola et al., 2002) or galectin-9 (Klibi et al., 2009). In addition, in 
immune cells, activated T-cells can secrete FasL containing vesicles and induce an 
activation-induced cell death (AICD) of bystander T-cells (Monleon et al., 2001). 
Vesicles purified from body fluids with immunosuppressive features have also 
been described, for example exosomes in human breast milk have been 
demonstrated to reduce T cell activation in vitro (Admyre et al., 2007). Exosomes, 
secreted by virally infected cells can also suppress the host immune response and 
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in that way, favour the spread of an infection. Exosomes released by HIV-infected 
cells were able to trigger apoptosis in uninfected bystander T cells (Lenassi et al., 
2010).  
In summary, exosomes carry numerous signals between immune cells or non-
immune cells, resulting in multiple functions affecting our immune response, but 
which of these functions are really important in vivo and which of them could be 
utilized in the clinic, still remain to be elucidated.   
2.2. The innate immune response to fungal particles  
Fungi are present everywhere, thus we are continually inhaling a low level of 
airborne fungal particles from our environment. Fungi are mainly found in soil and 
water, but they can live on materials with even a low level of moisture. Fungi 
belong to our body`s normal flora (microbiome), which have an essential role in 
sustaining our health by preventing the overgrowth and colonization of pathogenic 
microbes. These common environmental or commensal fungi such as Aspergillus 
fumigatus, Cryptococcus neoformans or Candida albicans can cause fungal 
diseases, mycoses, when their recognition by our immune system is defective and 
cannot resist the fungal burden or when the inflammatory response becomes 
overactivated while attacking the fungi and causes widespread damage to the host  
(Romani, 2011, Iliev et al., 2012). Fungi are associated with a wide spectrum of 
diseases, such as respiratory allergy and skin diseases. 
In immunocompromised patients, fungi may cause inflammatory diseases and 
severe life-threatening infections (Romani, 2011). As the population of 
immunocompromised individuals is growing significantly (increased prevalence of 
individuals receiving immunosuppressive treatments or suffering from 
autoimmune diseases), so too has the incidence of fungal diseases and the need for 
effective diagnosis tools and treatments (Pappas, 2010).  
In addition to the mycoses, which are characterized by tissue invasion by fungi 
and their spread and growth in the host, also exposure to the environmental fungal 
particles, which are not infective, has been associated with the development of 
several diseases such as hypersensitivity pneumonitis and damp building–related 
illness. These diseases will be discussed in chapter 2.3.  
 
2.2.1. Fungal cell wall components as activators of innate 
immunity  
 
Fungi are eukaryotic organisms that are traditionally classified, based on their 
morphologic features, into single-celled and multicellular filamentous forms such 
as yeasts and moulds, respectively. The fungal cell wall components represent an 
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important group of fungal PAMPs which are recognized by the PRRs on immune 
cells (Romani, 2011, Becker et al., 2015). For example, about 90% of the cell wall 
of a well-known fungal pathogen, C. albicans is made up of carbohydrate 
structures. The three major polysaccharide components of fungal cell wall, which 
are known to be recognized by the immune system and are found in all medically 
important fungi, are the inner cell wall structures: β-glucans (polymers of glucose) 
and chitin (a polymer of N-acetylglucosamine), and components of the outer cell 
wall: mannans (chains of mannose molecules attached to fungal proteins via N-or 
O-linkage) (Gow and Hube, 2012).  
The composition of the fungal cell wall varies and depends on different factors 
such as the fungal morphotype, the current growth stage of the fungus, as well as 
environmental factors such as temperature, oxygen levels, availability of nutrients 
or the presence of anti-fungal drugs (Verwer et al., 2012, Shepardson et al., 2013, 
Beauvais et al., 2014). After budding, β-glucans are surface-exposed in the bud 
scar, but during the hyphae stage of C. albicans, the β-glucans are masked and 
cannot elicit a strong inflammatory response via their specific PRR, dectin-1 
(Gantner et al., 2005). Other inner layer components of fungal cell wall also 
become exposed on the surface during the budding process. In addition, conidia, 
which usually are immunologically rather inert, expose the polysaccharides of the 
inner cell wall when the outermost rodlet-layer of conidia is degraded, for example 
during germination (Aimanianda et al., 2009). Chitin is the other major 
polysaccharide in the inner cell wall and studies with purified or fungal chitin have 
shown that it is associated with the recruitment of eosinophils and it can also 
promote M2 macrophage activation (O'Dea et al., 2014, Van Dyken et al., 2014). 
In contrast to β-glucan, a specific and distinct recognition receptor for chitin has 
yet not been fully characterized. The outer layer of the cell wall of C. albicans 
contains proteins, which are highly glycosylated with mannose-containing 
polysaccharides. These mannans are recognized by several Toll-like receptors and 
C-type lectin receptors (Netea et al., 2008). Both mannans and mannoproteins of 
C. albicans exert important immunostimulatory activities by stimulating the 
proinflammatory cytokine production and inducing dendritic cell maturation 
(Garner et al., 1994, Pietrella et al., 2006), as well as activating T-cell immunity 
(Mencacci et al., 1994, Gomez et al., 1996). 
 
2.2.1.1. The immunomodulatory nature of 1,3-β-glucan 
 
Beta-glucans are carbohydrate structures (polysaccharides) found naturally in 
fungi, plants and some bacteria. Glucan has a 1,3-β-glucan backbone with varying 
numbers of 1,6-β branches; it is the major glucan structure in the fungal cell wall 
(Figure 3) (Tsoni and Brown, 2008). Fungal 1,3-β-glucans have long been 
recognized as stimulants of innate immunity and thus they are essential fungal 
pathogen-associated molecular patterns (Brown and Gordon, 2005). Large 
particulate (insoluble form) β-glucans are known to activate the innate immune 
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response via dectin-1 receptor after the formation of a phagocytic synapse 
(Goodridge et al., 2011) and in this way, they induce both phagocytosis and the 
production of cytokines and reactive oxygen species (ROS) by leukocytes. In 
contrast, the soluble and small β-glucans seem to inhibit these responses, when 
they become attached to the dectin-1 receptor (Brown and Gordon, 2001, Brown 
and Gordon, 2003, Goodridge et al., 2011). In addition to the effects to the innate 
immunity, particulate β-glucans also influence adaptive immunity by promoting 
dendritic cell maturation and antigen presentation, which trigger the activation of 
T-cells (LeibundGut-Landmann et al., 2007, Leibundgut-Landmann et al., 2008).  
 
 
 
Figure 3. The basic structures of linear (1,3) (A) and branched (1,6) (B) β-glucans  
 
2.2.2. Recognition of fungal particles by innate immunity  
 
The first innate defence mechanisms recognizing the entry of fungi and 
initiating the clearance of the pathogen are constitutively existing molecules: 
defensins, collectins, surfactant and the proteins of the complement system. 
Furthermore, conserved cell wall structures and nucleic acids of the fungi trigger 
activation of phagocytes via PRRs (Table 3). The direct killing and clearance of 
the fungi by phagocytosis is one of the main defense mechanisms in antifungal 
immunity and it is mediated by macrophages, neutrophils and monocytes. In 
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addition, phagocytes produce oxidative (respiratory burst) or nonoxidative 
substances (antimicrobial peptides) to kill the extracellular and intracellular fungal 
pathogens (Brown, 2011). In most cases, in order to achieve the full protection 
against the fungal pathogens, the activation of adaptive immunity is needed. This 
is mainly initiated and directed by dendritic cells, which after uptake of the fungi, 
become mature and promote the differentiation of naïve T-cells into different 
subtypes of T-helper (Th) cells. Th17-cell activation has been shown to play an 
important role in the defense of fungal infections, induced mainly through 
downstream signaling of C-type lectin receptors (CLRs) in phagocytes (Vautier et 
al., 2010). Defects or abnormalities in the Th17 response have been related to 
fungal re-infections, chronic mycosis and autoimmune diseases (Harrington et al., 
2005, Puel et al., 2010, Vautier et al., 2010, Borghi et al., 2014). Several cytokines 
are involved in promoting the Th17 differentiation including IL-1β, IL-6, IL-21, 
IL-23 and TGF-β. In turn, activated Th17-cells produce IL-17 cytokines, which 
increase the antifungal activity of neutrophils and secretion of antimicrobial 
peptides from epithelial cells (Vautier et al., 2012, Borghi et al., 2014). Th1 cells 
also play a key role in the antifungal defense, they are induced by IL-12 cytokine 
and produce IFN-γ and TNF, both of which activate phagocytes (Vautier et al., 
2012, Borghi et al., 2014). Th2 cell activation, induced in response to IL-4 and IL-
13, is associated with the suppression of protective Th1 cell responses and the 
promotion of the alternative activation of macrophages that favour fungal 
infections and allow the development of fungi-associated allergic responses 
(Muller et al., 2007, Borghi et al., 2014). 
   
Table 3. The main groups of pattern-recognition receptors (PRRs) involved in the 
recognition of fungal molecules and the response of innate immunity during a fungal 
infection  
PRRs Receptor localization Selected fungal ligands 
C-type lectin receptors, CLRs 
DC-SIGN Plasma membrane N-linked mannans 
Dectin-1 Plasma membrane β-glucan 
Dectin-2 Plasma membrane α-mannan 
Dectin-3  Plasma membrane α-mannan 
Mannose receptor Plasma membrane N-linked mannans, α-glucan, chitin 
Mincle Plasma membrane α-mannose 
Galectins 
Galectin-3 Extracellular  β-mannosides 
Nucleotide-binding oligomerization 
domain (NOD)-like receptors, NLRs 
NLRP3 Cytosol β-glucan 
Scavenger receptors 
CD36  Plasma membrane β-glucan 
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Toll-like receptors, TLRs 
TLR1 Plasma membrane Phospholipomannan 
TLR2 Plasma membrane Phospholipomannan 
TLR3 Cytosol Unmethylated DNA, RNA 
TLR4 Plasma membrane O-linked mannan 
TLR6 Plasma membrane Phospholipomannan 
TLR7 Cytosol Unmethylated DNA, RNA 
TLR9 Cytosol Unmethylated DNA, RNA 
Complement receptors 
CR3 Plasma membrane β-glucan 
Data derived from (Romani, 2011, LeibundGut-Landmann et al., 2012, Becker et al., 
2015)  
 
Multiple pattern-recognition receptors of innate immunity are involved in the 
recognition of fungal PAMPs during a fungal infection or exposure to fungal 
particles. Activation of these PRRs induces pathogen eliminating responses in the 
cells including phagocytosis, respiratory burst, and cytokine release. The best 
characterized PRRs involved in fungal recognition are Toll-like receptors (TLRs) 
and the C-type lectin receptors (CLRs).  
Three different TLRs have been claimed to be the main TLRs involved in the 
recognition of most fungal pathogens: TLR2, which forms a heterodimer with 
TLR1 or TLR6, TLR4 and TLR9 (van de Veerdonk et al., 2008). However, there 
are contradictory reports concerning the individual TLR receptors and their role in 
the antifungal response against different fungal pathogens (Calich et al., 2008). It 
has been shown that mice lacking the signaling and adaptor protein MyD88, which 
is shared by most TLRs, are susceptible to C. albicans and A. fumigatus infections 
and MyD88 signaling is essential in DCs for promoting the Th1 response aimed at 
eliminating fungi (Bellocchio et al., 2004). TLR polymorphisms have also linked 
to increased sensitivity to fungal infections in humans (Brown, 2011). Despite 
these associations, no increased susceptibility to fungal diseases has been found in 
patients with defects in MyD88 (von Bernuth et al., 2008, Picard et al., 2010), 
indicating that TLRs are not the main PRRs mediating the antifungal response in 
humans.     
CLRs are considered to be the central PRRs for fungal recognition (Hardison 
and Brown, 2012, Plato et al., 2015). CLRs are transmembrane receptors, which 
recognize a wide range of ligands and have at least one C-type lectin-like domain 
(CTLD). CLRs are expressed mainly on myeloid cells such as macrophages and 
DCs. Several CLRs such as dectin-1, dectin-2, mannose receptor, DC-SIGN (DC-
specific ICAM3-grabbing non-integrin) and Mincle can induce intracellular 
signaling after they have recognized the presence of fungi (Hardison and Brown, 
2012). Dectin-1 was the first CLR to be characterized (Figure 4). It is the major 
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CLR for fungal β-glucan and its signaling has been widely studied (Brown and 
Gordon, 2001, Drummond and Brown, 2011). Clustering of dectin-1 is activated 
by aggregated or particulate β-glucan, which leads to a phagocytic synapse and 
activation of signaling molecules downstream of the receptor.  
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Figure 4. Structure of dectin-1. The major receptor for β-glucan is dectin-1, which 
activates intracellular signaling pathways via a cytoplasmic ITAM-like motif. This 
signaling leads to a number of innate immune responses involving the recruitment of Syk 
and Src kinases, the activation of transcription factor NF-kB through CARD9, as well 
signaling which can activate pathways of mitogen-activated protein kinases (MAPKs) and 
nuclear factor of activated T-cells (NFAT). In addition, dectin-1 can signal independently 
from Syk through Raf-1 kinase (Goodridge et al., 2011, Kerrigan and Brown, 2011).  
 
Dectin-3 recognizes α-mannans; when it forms a heterodimeric receptor with 
dectin-2, this complex has even higher sensitivity for fungi, making it possible to 
mount a more potent anti-fungal response (Zhu et al., 2013). Fungal binding to 
these receptors leads most often to phagocytosis of the fungi and the induction of 
antifungal effector mechanisms such as the production of cytokines. In addition, 
these receptors promote the development of an adaptive immune response, 
particularly towards Th1 and Th17 responses (Hardison and Brown, 2012).  
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The primary signal transduction molecule for CLRs is Syk (spleen tyrosine 
kinase). Some of the receptors (Dectin-2, Mincle) couple to Syk via the Fc 
receptor common γ-chain. Syk signaling through PKCδ–CARD9–Bcl-10–MALT1 
leads to activation of transcription factor NF-κB, which facilitates the gene 
transcription and production of inflammatory mediators. Syk signaling may also 
lead to activation of the transcription factor NFAT, which regulates the 
transcription factors of the early growth response genes, as well as those of the 
inﬂammatory mediators (Goodridge et al., 2007). There is also a Syk -independent 
signaling route through Raf-1 (v-raf-leukemia viral oncogene homolog 1), which 
also modulates the function of NF-κB (Hardison and Brown, 2012). The 
importance of CLRs and their downstream signaling components in fungal 
immunity has been highlighted in studies with knockout mice, in which the 
deficiency of CLR signaling led to defective immunity towards fungal pathogens 
(Saijo et al., 2007, Saijo et al., 2010, Strasser et al., 2012). In humans, a deficiency 
in dectin-1 and CARD9 was shown to lead to susceptibility to certain fungal 
infections, especially mucocutaneous candidiasis (Ferwerda et al., 2009, Glocker 
et al., 2009).   
The exact mechanisms through which fungal ligands activate and interact with 
NLRs, especially NLRP3, are still mainly unknown. Mutations in the genes of the 
NLRP3 inflammasome have been linked to elevated susceptibility to vaginal 
candidiasis (Lev-Sagie et al., 2009). The activation of the NLRP3 inflammasome 
is a crucial step for the secretion of biologically effective IL-1β. Furthermore, 
polymorphism in IL-1β gene has been linked with an increased risk for fungal 
disease, e.g. invasive pulmonary aspergillosis (Sainz et al., 2008). 
The recognition of fungi is orchestrated via multiple PRRs, and many of these 
receptors can collaborate with each other to achieve the optimal antifungal 
response (Hardison and Brown, 2012). One of the well-described interactions 
during the fungal infection is dectin-1 collaborating with MyD88-coupled TLRs 
leading to a synergistic increase in the secretion of TNF, IL-10 and IL-23, while 
the release other cytokines such as IL-12, is repressed (Dennehy et al., 2009).  
2.3. Health effects related to exposure of inhaled non-
infective microbial particles 
Microbes are ubiquitous, countless numbers of bacteria and fungi are found in soil 
and water, and even closer, within our own bodies, where they belong to our 
commensal microbiota.  Thus, we are continually exposed to a low level of 
microbial activity and their metabolites, a condition that is usually harmless. In 
certain occupations and surroundings, the exposure to microbial metabolites can be 
significantly elevated or the microbes may be different from normal which may 
lead to adverse health effects.   
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In this chapter, the focus will be placed on the health effects and diseases 
associated to inhalation of non-infectious microbial particles. Agricultural workers 
are routinely exposed to large numbers of environmental factors such as organic 
dust containing microbial cell wall components (bacterial endotoxin and 
peptidoglycan, fungal 1,3-β-glucan), which could lead to adverse respiratory 
health effects that predominately are non-IgE mediated  (Poole and Romberger, 
2012).  
Most of the non-infective microbial particles which are inhaled become 
entrapped in the upper respiratory tract. They do not reach further than the bronchi 
because they are washed away by the mucosa layer with the help of cilia cells. The 
smaller particles (such as fungal hyphal fragments, microbial structure particles) 
less than 10 μm in diameter are tiny enough to reach the terminal bronchioles and 
alveoli (Geiser et al., 2000, Heyder, 2004). The airway macrophages recognize 
dust particles as foreign due to the presence of the PAMP –structures in the 
particles and they start to eradicate them. Depending on the other signals from the 
milieu, they can remove the dust particles as part of the normal maintenance work 
and sustain the homeostasis or they can respond by releasing cytokines that 
promote inflammation, activate epithelial cells and elicit neutrophil recruitment 
(Poole and Romberger, 2012).  
It has been speculated that the inflammatory response elicited by the initial 
exposure to organic dusts becomes partially, but not completely, suppressed, 
leading to the development of the so-called chronic inflammatory adaptation 
response (Poole and Romberger, 2012). This may explain at least to some extent, 
the symptoms associated with diseases with exposure to organic dusts.    
The inflammatory potential of non-infectious microbial particles is based on 
their ability to stimulate the innate immunity through PAMP-structures. Pattern 
recognition receptor signaling pathways involving TLRs (TLR4 and TLR2), 
dectin-1 and nucleotide oligomerization are partially responsible for mediating the 
inflammatory consequences attributable to organic dust environments 
(Charavaryamath et al., 2008, Poole et al., 2011). Genetic polymorphisms in 
pattern recognition receptors may be partially responsible for accounting for the 
variability in disease manifestations among exposed individuals (Poole and 
Romberger, 2012).  
From the pathogenic point of view, these illnesses have features on one hand 
resembling autoimmune diseases (exaggerated immune reaction to harmless 
substance) and on the other hand, reminiscent of infectious diseases (PAMP 
recognition and inflammatory response) (Wolff, 2011). Although the microbial 
components play the major role in eliciting the inflammatory response, on their 
own they do not completely explain the airway inflammatory consequences 
observed after exposure to organic dust. Thus, further research will be necessary to 
elucidate the offending agents (endogenic, exogenic) and the participating 
signaling pathways. 
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Three illnesses associated withn the inhalation of non-infectious microbial 
particles will be discussed in more detail. Organic toxic syndrome serves as an 
example of the acute reaction following a high level exposure to an organic dust. 
In hypersensitivity pneumonitis, the exposure levels are lower and a long-term 
exposure is usually required before the onset or progression of the disease. Damp 
building- related illness represents an illness where the individual is exposed, 
usually over the long-term, to mold and bacterial metabolites and other substances 
related to the conditions of damp buildings.  There is now a consensus that there is 
an association between building dampness and the health effects (WHO, 2009), 
however, no specific causal agent or pathogenetic mechanisms of adverse health 
effects in damp buildings have been identified conclusively (WHO, 2009).  
 
2.3.1. Organic dust toxic syndrome 
 
Organic dust toxic syndrome (ODTS) is an acute febrile respiratory illness 
encountered after exposure to high levels of inhaled organic dusts or aerosols, 
principally bacterial endotoxins or mold (Hendrick et al., 2002, Seifert et al., 
2003). Typically, the exposure occurs in an agricultural context, although other 
occupations involving the handling of dusty organic material poses some risk. The 
syndrome usually begins within hours of the exposure to high concentrations of 
organic dust with the appearance of influenza-like symptoms such as fever and 
myalgias, usually accompanied by nausea, headache, chest tightness and cough. 
The exposure concentrations of fungal spores have been shown to be notably 
higher in ODTS than those associated with hypersensitivity pneumonitis 
(Malmberg et al., 1993).  
The symptoms of ODST are self-limiting, they rarely persist for more than a 
few days and there are no long-term consequences even with recurring episodes 
(Hendrick et al., 2002). Re-exposure to the antigen will often decrease the 
symptoms.  ODTS does not depend on immunological sensitization, so it can 
occur during or immediately after the first exposure (Hendrick et al., 2002). Serum 
IgG antibodies to the suspected etiological agent are not detected (Seifert et al., 
2003). The exact mechanisms of toxicity are not known, but microbial PAMPs: 
bacterial endotoxins, fungal spores, or mycotoxins are believed to play a role in 
triggering this disease.  
The incidence of ODTS is probably declining because of modern working 
techniques in farming (mechanized work, workers protected with dust masks and 
respirators).  
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2.3.2. Hypersensitivity pneumonitis 
 
Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, 
is an inflammatory disease of the lung alveoli resulting from repeated exposure to 
a wide range of airborne substances; thermophilic bacteria, animal proteins, fungi 
and even some inorganic materials such as chemicals. Fungal exposure has been 
implicated in HP in a variety of occupations such as farming, where haymaking 
may expose workers to different species of molds (e.g. Absidia corymbifera and 
Wallemia sebi) but it may also be responsible for a disease acquired in domestic 
environments such as summer-type HP in Japan (Selman et al., 2010). Reports 
from IOM and WHO have concluded that there is clinical evidence to associate the 
onset of hypersensitivity pneumonitis with mold and dampness-associated 
microbiological agents (IOM, 2004, WHO, 2009). Only a small proportion of the 
exposed individuals (1-15%) ever develop HP (Patel et al., 2001, McSharry et al., 
2002). The two-hit hypothesis has been postulated to explain this phenomenon: 
preexisting genetic susceptibility or promoting environmental factors (the first hit) 
associated with repetitive antigen exposure (the second hit) lead to the 
development of HP (Selman et al., 2012). 
Clinically, HP is typically categorized as displaying acute, subacute or chronic 
forms. HP is a complex syndrome, and its clinical forms overlap frequently with 
each other and also with other lung diseases, which make its diagnosis challenging 
(Jacobs et al., 2005, Girard et al., 2009, Selman et al., 2012). In general, acute HP 
is characterized by the appearance of respiratory infection-like symptoms such as 
chills and body aches occurring a few hours after antigen exposure. The symptoms 
gradually decline within some hours or days but often recur with re-exposure to 
the antigen. Furthermore, the acute and also the subacute form of HP can be 
associated with wheezing and bronchial hyperresponsiveness, however, the chest 
radiograph is usually normal. Subacute HP may result from repeated low-level 
exposure to inhaled antigens and its features may overlap with acute and chronic 
stages. It is a progressive disease, with coughing and shortness of breath becoming 
persistent; its classical histopathological features comprise chronic 
bronchiolocentric inflammation and poorly formed non-necortising granulomas. 
Chronic HP occurs with long-term, low level of antigen exposure, and may occur 
without having preceding acute/subacute episodes of HP. The clinical presentation 
includes progressive dyspnea, cough, fatigue and weight loss and often fibrosis 
develops in its chronic stage (Hendrick et al., 2002, Malo et al., 2013).  
The immunopathogenesis of HP has remained poorly understood. The patients 
have often IgG against antigens present in the microbes to which they have been 
exposed, however, these antibodies can also be detected in exposed individuals 
without HP (Hendrick et al., 2002). Immune complexes with this IgG are thought 
to be a central part of the pathogenesis in the acute phase of HP (Selman et al., 
2012). However, there are some reports which dispute this hypothesis by claiming 
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that there are too little clinical data to support it or that antibody complexes alone 
are not sufficient to evoke HP (Patel et al., 2001, Woda, 2008).  
Lymphocytosis, often accompanied by an increase in macrophages, is seen in 
HP patients (Woda, 2008). Following the early influx of CD4+ cells, the 
proportion of CD8+ cells increases (Patel et al., 2001). The current view suggests 
that HP is caused by a cytotoxic delayed hypersensitivity involving CD8+ 
cytotoxic lymphocytes (Patel et al., 2001, Woda, 2008). Some experimental 
studies have shown that mice whose immune response has been skewed toward a 
Th1 response over a Th2 response, are more likely to develop HP (Butler et al., 
2002, Irifune et al., 2003). There are recent studies confirming that IL-17-and IL-
22-secreting Th17 cells are also involved in the immunopathogenesis of HP (Joshi 
et al., 2009, Simonian et al., 2009a). The Th17-polarized immune response seems 
to be associated with disease severity such as the development of lung fibrosis 
(Simonian et al., 2009a, Simonian et al., 2009b).   
 
2.3.3. Damp building -related illness 
 
The concept of “sick building syndrome” (SBS) was first described in the 
1980s to explain the health problems related to indoor air quality in office 
buildings (WHO, 1983). One major, but not the only cause, for SBS is the 
presence of dampness in the buildings.  Damp building- related illness (DBRI) 
represents illnesess associated with water damage in dwellings or workplaces. 
Hypersensitivity pneumonitis is included in these illnesses if it is caused by damp 
buildings, although this happens rather rarely (WHO, 2009). The typical DBRI is 
associated with a prolonged exposure to damp buildings, usually only a portion of 
the exposed population develops symptoms (Straus et al., 2003, Akpinar-Elci et 
al., 2008). There are currently no well-defined diagnostic criteria for the great 
majority of DBRIs. The symptoms tend to be quite diverse but often include fever, 
myalgias, headaches and respiratory symptoms like cough. It was recently 
demonstrated that exposure to water damage in buildings can be associated with an 
increase in the numbers of lymphocytes in BAL, although there was no change in 
the CD4/CD8 ratio, in contrast to the increase of CD8 cells usually seen in HP 
(Wolff et al., 2009).  
There is abundant evidence that building-related exposure to mold and 
dampness results in an increased incidence of respiratory diseases (WHO, 2009).  
Continuation of the exposure to damp building will usually worsen the symptoms 
and result in persistent respiratory symptoms, especially of asthma. A number of 
studies have observed an increase in non-IgE (non-atopic) mediated asthma 
associated with mold and dampness (Cox-Ganser et al., 2009, Karvala et al., 
2010). The symptoms usually diminish when the subject is away from the building 
and conditions associated with damp buildings are avoided. However, some 
patients develop increased sensitivity to many environmental factors with 
symptoms that persist even though the primary source of the exposure has been 
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eliminated from their environment (Redlich et al., 1997, Edvardsson et al., 2008, 
Karvala et al., 2013, Karvala et al., 2014). 
 There is a consensus that there is an association between dampness in 
buildings with health effects (Bornehag et al., 2004, Fisk et al., 2007, WHO, 
2009). An increased moisture level may promote the growth of microbes such as 
fungi and bacteria on indoor materials and on structures within the building. 
Depending on the microbes and their activity, they are capable of emitting spores, 
fragments, microbial volatile organic compounds (mVOCs) and mycotoxins into 
the indoor air, which may be responsible for the health effects seen in individuals 
exposed to dampness in buildings (WHO, 2009). There are studies which suggest 
that the exposure to one structural component in the fungal cell wall, i.e. 1,3-D-
glucan, may be responsible for the airway inflammation and symptoms, but the 
results are mixed, and specific symptoms and potential underlying mechanisms 
associated with exposure have still not been identified (Douwes, 2005).  Moisture 
may also trigger the degradation of building materials and contribute to the release 
of non-microbial chemicals into the indoor air (IOM, 2004).  However, there is no 
specific quantity or quality of microbial particles or other substances related to 
condition of damp building which can be stated to designate an exposure state 
capable of causing significant health effects. In other words, no specific causal 
agent for the adverse health effects associated with damp buildings has yet been 
identified conclusively (WHO, 2009, Mendell et al., 2011).  
Mechanisms underlying the health effects associated with dampness and mold 
are largely unknown and several factors are thought to be involved (WHO, 2009).  
Inflammatory, non-allergic responses have been considered to play a role in the 
development of DBRI (Wolff, 2011). This explanation is biologically plausible as 
inflammation–related diseases such as asthma are associated with exposure to 
damp buildings (WHO, 2009). However, also the development of an allergic 
response against indoor microbial agents has been suggested to be one of the 
disease causing mechanisms (WHO, 2009).   
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3.AIMS OF THE STUDY 
Inhaled fungal and other microbial components can activate the immune response 
in the lung and cause symptoms in the airways The aim of this study was to 
characterize the inflammatory mechanisms and proteomic changes associated with 
the innate immune response triggered by the central cell wall component of fungi, 
β-glucan, in human macrophages. In order to obtain direct information of the 
illnesses associated with the exposure of inhaled fungal particles, the proteomic 
changes in the bronchoalveolar lavage obtained from patients with these illnessess 
were analysed. 
   
The specific aims of the study were:  
 
1. to characterize the β-glucan-triggered pro-inflammatory response by 
analysing the production and secretion of IL-1 family cytokines in human 
primary macrophages (I, IV) 
 
2. to obtain a global view of the innate immune response elicited by β-
glucans; the protein secretion pattern and the associated intracellular 
signaling pathways were characterized in human primary macrophages 
after β-glucan stimulation (II).  
 
3. to reveal the proteomic changes associated with the immune defense in the 
lungs after exposure to inhaled fungal particles we characterized the 
proteomic changes occurring in bronchoalveolar lavage fluid obtained from 
patients with illnessess associated with exposure to inhaled fungal and 
other microbial particles (III) 
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4.SUMMARY OF THE MATERIAL 
AND METHODS 
 
The material and methods used in the study are described here briefly. The more 
detailed descriptions of the protocols can be found in the original publications, 
which are referred in the text with the Roman numerals (I-IV).                                 
4.1. Sample material 
4.1.1. Human macrophages (I,II,IV) 
 
Peripheral blood mononuclear cells (PBMCs) were obtained from healthy blood 
donors (Finnish Red Cross Blood Transfusion Service). PBMCs were isolated 
from leukocyte-rich buffy coats with the low-speed density gradient 
centrifugation as previously described (Pirhonen et al., 1999). PBMCs were then 
plated and non-adherent cells were washed away and adherent monocytes were 
allowed to differentiate into macrophages six days in macrophage serum-free 
medium (Macrophage-SFM, Life Technologies) supplemented with GM-CSF 
(10 ng/ml, Biosource International) and antibiotics. After this six days of cell 
culturing, macrophages were used in the experiments (I, II, IV). Culturing M-
CSF-generated macrophages, GM-CSF was replaced with 50 ng/ml rh M-CSF 
(ImmunoTools) (IV).  
 
4.1.2. Mouse bone marrow-derived dendritic cells (II) 
 
Mouse bone marrow–derived dendritic cells (BMDCs) were derived from bone 
marrow     cells isolated from the femurs of wildtype C57BL/6 (NOVA-SCB 
AB) and dectin-1 knockout mice (Saijo et al., 2007). Briefly, bone marrow was 
flushed out from mice femur, the red blood cells were lysed from the bone 
marrow cell suspension and the remaining bone marrow cells were washed 
before culturing in RPMI 1640 media (BioWest) supplemented with 30 ng/ml 
GM-CSF (Biosource International), 10% FBS, 1% L-glutamine, 1% HEPES, 
0.05 mM β-mercaptoethanol, 1 mM sodium pyruvate, 1% non-essential amino 
acids and antibiotics (Gibco). In general, after nine days of culturing the BMDCs 
were used in experiments. The animal study was approved by the Health 
Services of State Provincial Office of Southern Finland (II).  
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4.1.3. Mouse bronchoalveolar lavage fluid cells (IV) 
 
Female mice, C57BL/6 and dectin-1 knockout mice (Saijo et al., 2007) were 
used at 8 to 10 weeks of age. C57BL/6 or dectin-1 -/- mice were intranasally 
exposed to curdlan (100 μg in 50 μl of PBS) 6 hrs before sacrifice and sample 
collection.  The controls in all studies received PBS only. The lungs were 
lavaged with sterile PBS (800 μl for 13 s) via a tracheal tube. The 
bronchoalveolar lavage (BAL) sample was cytocentrifuged on a slide, and the 
cells were stained using May Grünwald-Giemsa (MGG) and counted under light 
microscopy (Leica DM 4000B). The remaining BAL cell suspension was 
centrifuged, supernatant was removed and stored at -70°C for cytokine analysis, 
whereas the cells were quick-frozen and kept at – 70°C until RNA isolation. The 
animal study was approved by the National Animal Experiment Board and the 
Regional State Administrative Agency for Southern Finland (IV).   
 
4.1.4. Patient samples: bronchoalveolar lavage fluid and 
plasma (III) 
 
Bronchoalveolar lavage fluid samples were collected from patients having 
symptoms compatible with damp building-related illness (DBRI) or symptoms 
related to agricultural exposure (AME) to non-infectious microbial particles 
(NIMPs). The criterion for agricultural NIMP exposure was the handling of an 
organic moldy material. The samples were collected from patients being 
examined in the Finnish Institute of Occupational Health (FIOH). BAL fluids 
from patients with hypersensitivity pneumonitis (HP) served as the reference 
material for an established lung disease associated with NIMPs, and sarcoidosis 
(SARC) served as the reference material for a lung disease with no direct 
association with NIMPs. The reference BAL samples originated from an earlier 
study from the Meltola Hospital (Wolff et al., 2003). The controls comprised 
samples from healthy individuals from the personnel of the Meltola Hospital and 
FIOH. All tested plasma samples (available from control, hypersensitivity 
pneumonitis and sarcoidosis groups) were from the Meltola Hospital. 
Preparation of BAL samples was performed as described in (Taskinen et al., 
1994). Patient studies were approved by The Coordinating Ethics Committee at 
the Hospital District of Helsinki and Uusimaa (III). 
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4.2. Cell experiments in vitro 
 
The main cell model used in vitro studies was a human GM-CSF-differentiated 
monocyte-derived macrophage (I, II, IV). Other utilized cells models were M-
CSF-differentiated monocyte-derived human macrophages (IV), and mouse bone 
marrow -derived dendritic cells (II). 
 
4.2.1. Stimulants (I,II,IV) 
 
The main stimulant in the experiments has been (1,3)-β-glucan, the polysaccharide 
found  ubiquitously in the fungal cell wall. Four different (1,3)-β-glucan products 
were used: curdlan from Alcaligenes faecalis (I,II,IV), glucan from baker´s yeast 
(Saccharomyces cerevisiae) (I,II), paramylon from Euglena gracilis (I) and 
zymosan from Saccharomyces cerevisiae (I). In general, in the secretome analyses, 
the cells were stimulated for 18 hours and the cells subjected to transcriptomic 
analyses for 6 hours. Stimulation times are described in more detail in the original 
publications (I,II,IV). All β-glucans were purchased from Sigma-Aldrich.     
LPS is an endotoxin, which is produced by a variety of gram-negative bacteria. In 
this study, LPS (Escherichia coli O111:B4, Sigma-Aldrich) was used as a control 
of well-known microbial and inflammatory stimulus unrelated to the fungi (I,II). 
The stimulation times for LPS were the same as for β-glucans, which have been 
described above.  
Macrophages were stimulated with influenza A -virus (A/Udorn/72(H3N2) or 
transfected with polyI:C (a cytosolic viral dsRNA analog from Sigma-Aldrich) 18 
hours to obtain  positive controls for cell death assays (II). Influenza A -virus was 
kindly provided by Professor Ilkka Julkunen (National Institute for Health and 
Welfare (THL), Helsinki, Finland). Influenza A -virus was cultured in 
embryonated hen eggs and stored at −70°C. The hemagglutination titer was 256, as 
measured by standard methods. In infection experiments, virus dose of 2.56 
hemagglutination U/ml was used. PolyI:C was used at 10 μg/ml and transfection 
was performed according to the manufacturer´s instructions (Sigma-Aldrich). 
   
Table 4. The main stimulants used in the experiments 
 
 
 
Main stimulants Concentration Used in
Glucan from baker`s yeast 10, 100 μg/ml I, II
Curdlan 10, 30, 100 μg/ml I, II, IV
Paramylon 10, 100  μg/ml I
Zymosan 10, 100 μg/ml I
LPS 100 ng/ml, 1 μg/ml I, II
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4.2.2. Inhibitors (I,II,IV) 
 
The inhibitors used in the in vitro experiments are described in table 5. Generally, 
the inhibitors were added for the cells one or half an hour before the stimulus 
except for Brefeldin A, where the inhibitor was given one hour after stimulus. 
More detailed information about the inhibition times and concentrations is 
described in the original publications. 
 
Table 5. The inhibitors used in the cell studies  
 
 
 
 
4.2.3. Small-interfering RNAs (I,II) 
 
Macrophages were transfected twice with non-targeting control small-interfering 
RNA (SiRNA) and with two different Beclin-1 (Hs_BECN1_1, Hs_BECN-1_3) 
or NLRP3 (Hs_CIAS1_6, Hs_CIAS1_9) siRNAs before the β-glucan 
stimulation. HiPerfect Transfection Reagent was used in the SiRNA 
experiments according to the manufacturer´s instructions. All the reagents for 
siRNA experiments were purchased from Sigma-Aldrich. More details of the 
SiRNA procedure is described in the original publications (I, II).    
 
  
 Inhibitors                            (Description) Concentration Manufacturer Used in
 3-METHYLADENINE, 3-MA  (Inhibition of autophagosome formation) 10 mM Sigma-Aldrich II
 BREFELDIN A                     (Inhibition of ER to Golgi trafficking) 100 ng/ml Sigma-Aldrich II
 BUTYLATED HYDROXYANISOLE, BHA    (ROS inhibitor)  100 μM Sigma-Aldrich I
 CA-074-Me                          (Cathepsin B inhibitor) 10 μg/ml or 25 μM Calbiochem/Millipore I, IV
 CASPASE-1 INHIBITOR VI, Z-YVAD-FMK   (Caspase-1 inhibitor)  50 μM Santa Cruz Biotechnology I
 CASPASE-1 INHIBITOR VI, Z-YVAD-FMK   (Caspase-1 inhibitor)  25 μM Calbiochem/Millipore II, IV
 CYTOCHALASIN D            (Inhibitor of phagocytosis) 1 μg/ml Sigma-Aldrich I
 DECTIN-1 Ab                    (Blocking the Dectin-1-receptor signaling) 9 μg/ml R&D Systems I
 MCC950                            (Inhibitor of NLRP3 inflammasome) 1 μM Avistron IV
 POTASSIUM CHLORIDE, KCl(Used for blocking of potassium efflux) added 1 mM Sigma-Aldrich I
 PP2                                  (Src tyrosine kinase inhibitor) 5 or 10 μM Sigma-Aldrich I, II
 SRC I INHIBITOR              (Src tyrosine kinase inhibitor) 20 μM Sigma-Aldrich II
 SYK II INHIBITOR             (Syk tyrosine kinase inhibitor)  1, 5, 10 μM Calbiochem/Millipore I, II, IV
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4.3. Proteomic methods 
4.3.1.    Isobaric tag for relative and absolute quantification 
(iTRAQ) -labeling and mass spectrometry (II) 
                                                                                 
4plex iTRAQ (AB Sciex) labelling was used for relative quantitation of secreted 
proteins in human macrophages after β-glucan stimulations (curdlan and baker`s 
yeast) or after lipopolysaccharide stimulation (LPS), the latter served as a control 
inflammatory stimulus unrelated to fungi. Before stimulation, the cells were 
washed and the culture media was changed to serum-free RPMI 1640-medium. 
After stimulation, the same amount of cell culture media was collected from every 
study group and concentrated as described in 4.3.3. Next, the proteins from the 
concentrated media fraction were precipitated with 2-D Clean-Up Kit (GE 
Healthcare), followed by protein alkylation, trypsin digestion, and iTRAQ labeling 
of the resulting peptides according to the manufacturer’s instructions (Applied 
Biosystems). After labeling, the samples were pooled and the peptides were 
prefractionated with strong cation exchange chromatography (SCX) using an Ettan 
HPLC system (Amersham Biosciences) connected to a Poly-SULFOETHYL A -
column. Each SCX-fraction containing the labeled peptides was analyzed twice 
with nano-LC-ESI-MS/MS (nano-liquid chromatography-electrospray ionization-
tandem mass spectrometry) using Ultimate 3000 nano-liquid chromatograph 
(Dionex) and QSTAR Elite hybrid quadrupole time-of-flight mass spectrometer 
(Applied Biosystems) with nano-ESI ionization as described previously (Lietzen et 
al., 2011). MS data were acquired automatically using Analyst QS 2.0 software 
(II). 
 
Data analysis for iTRAQ  
 
ProteinPilot 2.0.1 interface (AB Sciex) with Paragon search algorithm (Shilov et 
al., 2007) was used for protein identification and relative quantitation. Database 
searching was done against UniProt human database (version 2008-01-28 with 
20330 human sequences) and ‘decoy’database (the reverse amino acid sequence 
for false discovery rate estimation).The search criteria were: cysteine alkylation 
with MMTS (methyl methanethiolsulfonate), trypsin digestion, biological 
modifications allowed, thorough search, and detected protein threshold of 95% 
confidence (Unused ProtScore > 1.3). The MS/MS results from two biological 
replicates were combined to obtain one list of differentially secreted proteins from 
β-glucan (curdlan and GBY) and LPS stimulated macrophages. For the proteins 
identified (p-values under 0.05) in both replicate experiments, the relative 
quantitation was averaged if the fold change values between the replicates were 
under 2.0 or if both values were over 4.0. In addition, the following criteria were 
used for averaging the fold change values between the replicates: the fold change 
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value in one replicate was under 4.0, the fold change difference was under 3.0 and 
both quantifications had p-values under 0.05. The protein quantitation result from 
an individual experiment was included into the list if the quantitation had a p-value 
less than 0.05.   
The identified proteins were classified based on their Gene Ontology 
annotations using GeneTrail (http://genetrail.bioinf.uni-sb.de/) (Backes et al., 
2007) and GoMiner (http://discover.nci.nih.gov/gominer/index.jsp. SignalP 4.0 
(http://www.cbs.dtu.dk/services/SignalP/) was used to determine the proteins 
secreted via classical pathways, and ExoCarta version 3.2 database (Mathivanan 
and Simpson, 2009) (http://www.exocarta.org/) was used to determine the proteins 
released via exosomal vesicles (II). 
 
4.3.2. 2D-DIGE (two-dimensional difference gel 
electrophoresis) and DeCyder analysis (III) 
 
Approximately 10 ml of each BAL sample was concentrated to 100 μl by 
ultrafiltration (Amicon Ultra-15 tubes with 5000 MWCO, Millipore). The sample 
was then depleted of albumin and immunoglobulin G with ProteoPrep 
Immunoaffinity Albumin and IgG Depletion Kit (Sigma Aldrich) to facilitate 
higher sample loading, and to improve detection of low-abundance proteins. 
BALF proteins were precipitated with 2-D Clean-Up Kit (GE Healthcare) and 
dissolved in DIGE labeling buffer (7 M urea, 2 M thiourea, 4% CHAPS and 30 
mM Tris-HCl, pH 8.8). Then, 10 μl from each sample was taken for the internal 
standard and 40 μg of BALF proteins were labelled using 200 pmol Cy3 or Cy5 
dyes (CyDye DIGE Fluor minimal dyes; GE Healthcare) according to the Ettan 2-
D DIGE instructions. The Cy2 dye was used as an internal standard.  An internal 
standard was used to align spots during the analysis and to decrease technical 
variation. CyDye labelled protein samples were separated by isoelectric focusing 
(IEF) using IPG strips (13 cm, pH 3–10 NL, GE Healthcare). IEF was performed 
using Ettan IPGphor II (GE Healthcare) and the second dimension separation of 
proteins according to their size with polyacrylamide gel electrophoresis (SDS-
PAGE). Gels were scanned and the fluorescence of CyDyes was measured using 
an Ettan DIGE Imager (GE Healthcare). After scanning, the gels were silver 
stained for spot excision. The images of scanned gels were analyzed for 
differences in protein expression by means of internal Cy2 labelled standard using 
DeCyder 2D 7.0 software (GE Healthcare). Gel spots with at least a 1.5-fold spot 
volume ratio change and a Student’s t-test pvalue below 0.05 were picked for 
identification (III). 
 
Protein identification and bioinformatics 
Significantly up- or down-regulated protein spots were in-gel digested and the 
resulting peptides were extracted as previously described (Shevchenko et al., 2006, 
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Rostila et al., 2012). The dried extracts were dissolved in 2% formic acid. Each 
peptide mixture was analyzed with an automated nanoflow capillary LC–MS/MS 
using CapLC system (Waters) coupled to an electronspray ionization quadrupole 
time-of-flight (Q-TOF) mass spectrometer (Waters). The obtained mass fragment 
spectra were analyzed with in-house Mascot v.2.1 (Matrix Science Ltd.) and 
searched against human or mammalian entries in the NCBInr database. One 
missed cleavage was allowed, and the searches were performed with fixed 
carbamidomethylation of cysteines, and variable oxidation of methionine, 
histidine, and tryptophan residues. A minimum number of two matched peptides or 
a Mascot score higher than 70, was considered significant. Multivariate analysis of 
protein expression was performed with DeCyder Extended Data Analysis software 
(Version 7.0, GE Healthcare). The Gene Ontology –classification of the identified 
proteins based on the DeCyder 2D 7.0 software data. Protein enrichment analysis 
was performed with a functional annotation tool: DAVID Bioinformatics 
Resources 6.7. (http://david.abcc.ncifcrf.gov/) (III). 
4.3.3. Enzyme-linked immunosorbent assay (ELISA) and 
Luminex (I-IV) 
The levels of secreted human or mouse cytokines were determined after cell 
stimulation from the cell supernatants with ELISA analysis according to the 
manufacturer`s instructions: hIL-1β (Diaclone) (I,II), mIL-1β (eBisocience) (II) 
and hIL-18 (Bender MedSystems) (I). The total IgG was measured from human 
BAL samples with ELISA assay kit from eBioscience (III). In addition, Luminex 
Bio-Plex Pro immunoassay from Bio-Rad Laboratories was used for measuring the 
secretion of human cytokines and chemokines from the cell supernatants: IL-1α 
(IV), IL-1β (IV), IL-18 (IV), CCL2 (II), CCL5 (II) and TNF (II). The Luminex 
assay was performed according to the manufacturer’s instructions using Bio-Plex 
200 system hardware and version 4.1.1 of Bio-Plex 200 software. 
4.3.4. Immunoblotting (I-IV) 
 
 Samples from macrophage experiments (I,II,IV) 
 
To analyze the secreted proteins, macrophages were stimulated in RPMI-growth 
medium (BioWest) supplemented with L-glutamine, antibiotics and 10 mM 
HEPES. After stimulation, the cell culture media were collected and concentrated 
with centrifugal units with 10 kDa nominal molecular weight cut-off (purchased 
from Millipore) to obtain the enriched fraction of secreted proteins. This enriched 
protein fraction was directly used for immunoblotting.  
To analyze the intracellular proteins, the macrophage cells after stimulation 
were lysed, and homogenized with ultrasound sonicator. The total protein 
concentration of the lysate was determined with Bio-Rad Dc Protein Assay (Bio-
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Rad Laboratories) and 10 μg or 20 μg of protein was used for immunoblotting 
(I,II,IV).     
To confirm equal loading and transfer of the proteins, membranes were 
stripped and              stained with ready-to use SYPRO Ruby Protein Blot Stain 
(Sigma-Aldrich). The major protein band detected and basally expressed was 
utilized as a loading control. Showing the equal expression of GAPDH protein 
served also as a loading control (GAPDH Ab from Santa Cruz Biotechnology). 
 
Patient samples: BAL and plasma (III) 
 
To validate proteins identified from 2-DIGE and DeCyder analysis the relative 
protein expression of semenogelin, histones 2B and 4, α-1-antitrypsin and galectin-
3 in BAL and in plasma were evaluated by Western blot analysis. Volumes of 15 
μl of BALF samples or 1.5 μl of plasma were used for immunoblotting. A pool of 
all of the BALF or plasma samples was used as an internal standard on each gel to 
provide a reference against which to normalize the results. 
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Table 6. The antibodies used for western blot -analysis 
 
 
4.4. Other methods 
4.4.1. Cell death assays (II) 
 
The level of cell death in cultured and stimulated macrophages was monitored 
with three different assays (II). The leakage of LDH, which is the marker of cell 
necrosis was measured with Cytotoxicity Detection Kit Plus (LDH) from Roche 
Diagnostics. To detect the level of cell apoptosis, the cells were treated according 
to the APOPercentage Apoptosis Assay (Biocolor Life Science Assays) and 
Abs against Manufacturer Used in
α1-antitrypsin AbFrontier III
Alix Santa Cruz Biotechnology II
α/β-tubulin Cell Signaling Technology II, IV
Annexin I Santa Cruz Biotechnology II, IV
ASC Chemicon /Millipore I, IV
Atg7 Cell Signaling Technology II
β2-integrin Kindly provided by Prof. Carl Gahmberg II
Caspase-1 Sigma-Aldrich I, II, IV
Caspase-3 Cell Signaling Technology I, II
Cathepsin B Calbiochem /Millipore II, IV
Cathepsin D Santa Cruz Biotechnology II
Dectin-1 Cell Signaling Technology IV
Galectin-3 Santa Cruz Biotechnology II, III
GBP5 Cell Signaling Technology IV
GAPDH Santa Cruz Biotechnology IV
Histone 2B (H2B) Abcam III
Histone 4 (H4) Cell Signaling Technology III
IL-1β Kindly provided by Prof. Ilkka Julkunen (Pirhonen et al, 1999) I, II
IL-1β Cell Signaling Technology IV
IL-18 Kindly provided by Prof. Ilkka Julkunen (Pirhonen et al, 1999) I, II, IV
IL-36γ R&D Systems IV
ITGAX Novus Biologicals IV
LC3 Novus Biologicals II
NLRP3 Abcam IV
Optineurin Santa Cruz Biotechnology II
Semenogelin I Abcam III
Tsg 101 Santa Cruz Biotechnology II
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photographed with an Olympus DP70 Digital microscope camera, connected to an 
Olympus IX71 light microscope, and using software in DP Controller (version 
2.2.1.227) and DP Manager (2.2.1.195). The viability of the cells was determined 
by measuring the intracellular ATP using the CellTiter-Glo Luminescent Cell 
Viability Assay (Promega). 
 
4.4.2. Electron microscopy of extracellular vesicles (II) 
 
The extracellular vesicles were isolated from the supernatants of stimulated and 
control cells. The vesicles were then fixed with 1% paraformaldehyde, transferred 
into the Pioloform-carbon–coated copper grids, and allowed to absorb for 20 min. 
The grids were subsequently washed and contrasted with uranyl acetate to 
visualize proteins and viewed with a Jeol 1200 EX II transmission electron 
microscope (II). 
 
4.4.3. Vesicle enrichment (II) 
 
Macrophages were stimulated in RPMI 1640-media (BioWest) supplemented with 
L-glutamine, antibiotics and 10 mM HEPES, after which the cell culture media 
were collected. Enrichment of the extracellular vesicles was performed using 
centrifugal filter units (100 kDa cut-off, from Merck Millipore), and the flow-
through was further concentrated with 10-kDa centrifugal filter units (Merck 
Millipore). The fractions of enriched vesicles were directly used for Western 
blotting or alternatively the vesicles were further purified by diluting the fraction 
with PBS and ultracentrifuging the diluted fraction twice at 100,000 x g for 1 h. 
The purified vesicles were resuspended in PBS and used for electron microscopy 
or Western blotting (II). 
 
4.4.4. Gene expression microarray (II) 
 
The microarray used in our study was an Agilent Whole Human Genome 4 X 44K 
1-Color Array (Agilent Technologies). The microarray experiments were 
performed at Biomedicum Genomics (Helsinki, Finland). Fold change values of 
the genes were calculated for each stimulation versus the control, after which the 
values from three biological replicates were combined using the median value. 
Gene Ontology enrichment was calculated with Fisher exact test using a genome-
wide reference set for human genes as the reference. SPIA was utilized for 
pathway enrichment analysis (Tarca et al., 2009) (21). All data analyses were 
performed with the freely available Anduril framework (Ovaska et al., 2010). 
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4.4.5. Quantitative real-time RT-PCR assay (I,II,IV) 
 
The total cellular RNA, extracted with RNeasy Plus Mini Kit from Qiagen, was 
reverse transcribed into cDNA by the High Capacity cDNA Reverse Transcription 
kit (Applied Biosystems). The gene expression analysis was performed by 
amplifying cDNA in TaqMan Fast universal PCR master mix (Applied 
Biosystems) or PerfeCta qPCR FastMix (Quanta Biosciences) with Predeveloped 
TaqMan assay primers and probes. The quantitative Real Time-PCR analysis was 
performed with ABI Prism 7500 Fast Sequence Detector using the 7500 Fast 
System SDS Software v1.4 (Applied Biosystems). The amplification values of 
endogenous 18S rRNA were determined from the analyzed samples to control the 
equal amount of added cDNA. The gene expression of the target cytokine genes 
were presented in relative units, which were calculated by a comparative 
CT method (Schmittgen and Livak, 2008). 
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5.RESULTS 
5.1. (1,3)-β-glucans activate the NLRP3 inflammasome 
in human macrophages (I) 
The major cell wall structure present in fungi is (1,3)-β-glucan (Tsoni and Brown, 
2008), which is considered to be one of the main pathogen-associated molecular 
patterns affecting our immune system. The NLRP3 inflammasome is a cytosolic 
protein complex; its activation is associated with the recognition of microbial and 
other compounds released upon infection or cell stress (Bauernfeind et al., 2011). 
The activation of the NLRP3 inflammasome triggers the secretion of biologically 
active pro-inflammatory cytokines IL-1β and IL-18 through the function of 
proteolytic enzyme caspase-1 (Martinon et al., 2002, Bauernfeind et al., 2011). In 
the following experiments, we have studied the pathways and mechanisms which 
are involved in activation of NLRP3 inflammasome by (1,3)-β-glucans in one of 
the most important cell types involved in innate immunity, the macrophage. 
 
   
5.1.1. (1,3)-β-glucans activate the NLRP3 inflammasome via 
dectin-1/Syk pathway (I) 
 
Large particulate (insoluble form) β-glucans are known to be activators of innate 
immunity. First in this study, we compared the pro-inflammatory cytokine 
response of IL-1β in human macrophages towards β-glucan and to another 
microbial cell wall structure, LPS. Both curdlan (large particulate linear (1,3)-β-
glucan) and LPS efficiently activated the transcription of the IL-1β gene (I, Fig. 
1A). In contrast, only curdlan was able to induce the secretion of biologically 
active IL-1β in human macrophages (I, Fig. 1BC). A similar type of effect was 
also seen in human primary dendritic cells (I, Supplemental Fig. 1). In addition, 
other large particulate β-glucans (paramylon, glucan from baker´s yeast and 
zymosan) elicited IL-1β secretion in human macrophages, albeit at a lower level 
than curdlan (I, Fig. 1D). Thus curdlan was mainly used in the following 
experiments as a representative (1,3)-β-glucan.   
Activation of caspase-1 is known to process the pro-form of IL-1β into its 
mature form and to promote its secretion (Martinon et al., 2002, Keller et al., 
2008). Caspase-1 activation was observed after curdlan stimulation, but not with 
LPS, in human macrophages (I, Fig. 6A). In addition, the inhibition of caspase-1 
activation with a specific inhibitor, Z-YVAD-FMK totally blocked the curdlan-
induced IL-1β secretion, even though it did not affect the curdlan-induced IL-1β 
gene transcription (I, Fig. 6BC). These results demonstrate that β-glucan is able on 
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its own to induce IL-1β transcription and trigger the secretion of IL-1β via 
activation of the inflammasome associated caspase-1. 
  Dectin-1 is mainly expressed on the membrane of antigen-presenting cells and 
is the main pattern-recognition receptor for β-glucans (Brown and Gordon, 2001). 
It contains a short cytoplasmic tail with ITAM-like sequences, which utilize a 
spleen tyrosine kinase (Syk) as the signal transduction molecule (Goodridge et al., 
2011, Kerrigan and Brown, 2011). The blocking anti-dectin-1 antibody and the 
specific inhibitor for Syk both diminished the curdlan-induced IL-1β transcription 
and secretion in human macrophages (I, Fig 2ABCD). The other IL-1 cytokine, IL-
18, is constitutively expressed and needs only activation of caspase-1 to be 
processed into its active form which is secreted into the extracellular space. Both 
anti-dectin-1 and the Syk inhibitor totally blocked IL-18 secretion induced by 
curdlan (I, Fig. 5AB). This indicates that, in addition to inducing the IL-1β 
transcription, the dectin-1/Syk signaling pathway is essential for the activation of 
the inflammasome and caspase-1 in response to β-glucan stimulation.  
It has been reported that the activation of cytoplasmic sensor, the NLRP3 
inflammasome complex by MSU and silica is dependent on the phagocytosis of 
these crystals (Hornung et al., 2008). Blockade of the macrophages’ phagocytotic 
properties with cytochalasin D before the curdlan treatment did not exert any 
effect on curdlan-induced IL-1β mRNA levels (I, Fig. 3A), but it abolished totally 
the secretion of IL-1β triggered by curdlan (I, Fig. 3B). This indicates that in 
addition to the recognition of β-glucan with membrane-bound dectin-1, the 
formation of the phagocytic synapse (Goodridge et al., 2011) is also essential for 
the activation of the inflammasome and secretion of IL-1β.  
To confirm the activation of NLRP3 inflammasome after the β-glucan 
stimulus, the NLRP3 gene was silenced with specific NLRP3 siRNAs in human 
macrophages. NLRP3 gene-silencing decreased the levels of secreted IL-1β (I, Fig. 
4B), but had only a marginal effect on IL-1β mRNA levels after β-glucan 
treatment (I, Fig. 4C). Furthermore, NF-κB –dependent upregulation of NLRP3 
has been shown to be essential for the inflammasome activation (Bauernfeind et 
al., 2009). Curdlan treatment led to the induction of NLRP3 mRNA in human 
macrophages, which was also observed with LPS (I, Fig. 4C). Activating the 
NLRP3 gene transcription with LPS-priming and blockade of the dectin-1 pathway 
with a Syk-inhibitor before curdlan-treatment of the same cells abolished the IL-18 
secretion in human macrophages (I, Supplemental Fig. 2.) emphasizing that β-
glucan-induced Syk activation is also needed for NLRP3 inflammasome activation 
and IL-18 secretion for reasons other than simply inducing the NLRP3 gene 
transcription. To summarize, our results indicate that β-glucan activates NLRP3 
inflammasome via the dectin-1 pathway to trigger the IL-1β and IL-18 response. 
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5.1.2. (1,3)-β-glucan- induced NLRP3 inflammasome 
activation is dependent on ROS formation, K+ efflux 
and cathepsin activity (I) 
 
The formation of mitochondrial reactive oxygen species (ROS) induced by 
crystalloid substances (MSU, silica, aluminum) as well as the release of cathepsin 
B into the cytosol after phagocytosis of these crystals have been suggested to be 
triggering events in the activation of the NLRP3 inflammasome (Hornung et al., 
2008, Zhou et al., 2011). To study the roles of ROS formation and release of 
cathepsin B in β-glucan-induced NLRP3 activation, a known ROS inhibitor, BHA, 
or a specific cathepsin B inhibitor, CA-074-Me was added to the human 
macrophages prior to the β-glucan stimulus. Both of these inhibitors had little 
effect on the curdlan-triggered IL-1β mRNA expression (I, Fig. 6D and Fig. 7A), 
but in contrast, they both completely abolished the curdlan-induced secretion of 
IL-1β (Fig. 6D and Fig. 7B). Potassium efflux (K+) and a low intracellular 
potassium concentration have also been associated with NLRP3 inflammasome 
activation in a response to particulate substances ((Munoz-Planillo et al., 2013). 
The effect of potassium efflux in curdlan-induced NLRP3 inflammasome 
activation was studied in the presence or absence of additional potassium chloride 
in the media. The enhanced potassium chloride did not affect the curdlan-induced 
IL-1β mRNA levels (I, Fig. 7C), but it totally blocked the curdlan-induced 
secretion of IL-1β (I, Fig. 7D). These data indicate that ROS formation, K+ efflux 
and cathepsin activity are essential events in the β-glucan- triggered activation of 
the NLRP3 inflammasome.  
5.2. (1,3)-β-glucans activate unconventional protein 
secretion in human macrophages (II, IV) 
 
Many cytokines and chemokines mediating the immune response are secreted 
through the conventional protein secretion pathway. These conventionally secreted 
proteins contain an N-terminal signal-peptide that directs their secretion to occur 
via the endoplasmic reticulum (ER)-to-Golgi membrane pathway. Some proteins 
(IL-1, DAMPs) lack a protein signal sequence required for ER entry and are thus 
secreted from macrophages by unconventional protein secretion pathways. 
Vesicle-mediated protein transport and release into the extracellular space are one 
of the central mechanisms in unconventional protein secretion.  
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5.2.1. Both (1,3)-β-glucans and LPS activate significant 
changes in gene transcription (II)  
 
To analyze the global transcriptional response for β-glucans, human macrophages 
were stimulated either with curdlan or glucan from baker´s yeast (GBY). LPS 
served as a control for a well-known inflammatory microbial particle unrelated to 
fungi. The gene expression analysis was performed with microarray technology. 
The number of identified genes with >2-fold increase or a decrease were as 
follows: 767 for curdlan, 1447 for GBY and 1683 for LPS (II, Supplemental Table 
II). The overall transcription profile of curdlan and GBY resembled each other, 
and this profile of β-glucan differed from LPS, indicating the different downstream 
signaling triggered by β-glucans and LPS in human macrophages (II, Fig. 1B). 
According to the KEGG pathway analysis, both stimulants induced genes related 
to chemokine signaling, cytokine-cytokine receptor interactions and MAPK 
signaling pathways. In contrast, genes related to cytosolic DNA-sensing pathways, 
Jak-STAT signaling pathway and NOD-like receptor signaling pathways were 
overrepresented after LPS and underrepresented after β-glucan stimulation (II, Fig. 
1B).   
 
5.2.2. (1,3)-β-glucans, but not LPS, activate robust protein 
release via vesicle-mediated unconventional secretion 
pathways (II, IV) 
 
To characterize the global secretome response for β-glucans, curdlan or GBY, or 
LPS, which served as a control here, human macrophages were stimulated for 18 
hrs.  
iTRAQ labeling combined with LC-MS/MS analysis was utilized for quantitation 
and identification of the secreted proteins from the cell medium. The protein 
secretion was robust after β-glucan stimulation compared to the LPS stimulus. In 
addition, the secretomes of curdlan and GBY resembled each other (Figure 5).   
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Figure 5. The secretomes of curdlan- and GBY-induced macrophages resembled each 
other. There were 1597 reliably quantified distinct proteins analyzed with the iTRAQ 
method from two independent biological experiments. The results shown here are 
combinations of those two replicates. 
A. The average ratios of total secreted protein compared between stimulated and untreated 
cells B. Secretome of β-glucan. The Venn diagram illustrates the identified proteins with 
relative quantity >2.0 from curdlan-and GBY-induced macrophage secretomes. 
 
Most of these β-glucan induced secreted proteins were classified as intracellular 
proteins according to Gene Ontology analysis (II, Fig. 1A). To confirm that these 
proteins were actively secreted in response to the β-glucan stimuli and not a result 
of cell death, evidence of apoptosis and necrosis was studied and excluded based 
on the results. We could not detect any morphological signs of cell death. On the 
contrary, the cells appeared to be very intact and viable after β-glucan stimulation 
(II, Fig. 2). The characterization of the secretion mechanisms using the SignalP 
software revealed that 26% and 20% of the curdlan- and GBY-induced proteins, 
respectively, had a signal peptide sequence needed for the conventional type of 
protein secretion (II, Fig. 3A, Supplemental Table IIIA). Cytokines and 
chemokines, most of which are secreted through conventional signal-peptide 
mediated pathways, were increased in the β-glucan secretome, as also at a more 
moderate level in the LPS secretome (II, Fig. 4AB). Treating the cells with 
Brefeldin A, which inhibits the transport of signal-peptide including proteins from 
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ER to Golgi, completely prevented β-glucan-induced conventional secretion of 
cytokines and chemokines, but not IL-1β, which is secreted via unconventional 
pathways (II, Fig. 4C).  It is known that proteins lacking the protein signal 
sequence are  released by unconventional protein secretion pathways. One form of 
unconventional secretion is secreting the proteins into the extracellular milieu 
through membrane vesicles called exosomes and microvesicles (Rabouille et al., 
2012). Based on the exosomal protein database Exocarta, 49% of secreted proteins 
after curdlan and GBY stimulation have been reported to be released via exosomes 
(II, Fig. 3A, Supplemental Table IIIB). When these were classified according to 
the biological processes, most of the β-glucan induced proteins were designated to 
those processes where the proteins are known to be released by exosomes: protein 
metabolic processes, vesicle-mediated trafficking, signaling, cytoskeleton 
organization and cell adhesion and migration (II, fig. 3B). To confirm the vesicle-
mediated nature of the β-glucan-induced protein secretion, the enriched fraction 
containing the possible extracellular vesicles was prepared from the cell media 
after β-glucan stimulus. Analysis of this fraction with electron microscopy showed 
exosomal-type vesicles in the sample (II, Fig. 3C). Furthermore, the western blot 
analysis of typical exosomal marker proteins and visualization of the total protein 
amount with silver staining from this vesicle-fraction confirmed that β-glucan 
stimulation increased robustly the secretion of exosomal proteins (II, Fig. 3DE). 
Vesicle-mediated protein secretion (annexin I, ITGAX, α/β-tubulin) was more 
extensive in β-glucan-induced GM-CSF-macrophages than in M-CSF-
macrophages (IV, Fig. 4).    
   
5.2.3. NLRP3 inflammasome activation via dectin-1/Syk 
pathway is crucial for β-glucan-activated 
unconventional protein secretion (II, IV)   
 
Activation of the NLRP3 inflammasome is associated with the secretion of its 
central components and secretion of caspase-1 substrates IL-1β and IL-18 (Qu et 
al., 2007, Keller et al., 2008). Cytokines of the IL-1 family are thought to be 
secreted via unconventional protein secretion pathways (Garlanda et al., 2013). 
The secretion of mature IL-1β and IL-18, and inflammasome components and 
regulators were detected during the β-glucan stimulation (II, Fig. 5A). The 
secretions of IL-1β, IL-18 and caspase-1 were more abundant in GM-CSF-
macrophages than in M-CSF -macrophages, indicating that these former 
macrophages display a more powerful activation of inflammasome after β-glucan 
stimulus (IV, Fig. 3AC). Interestingly, the preform of caspase-1 (p45) was 
expressed at higher levels in GM-CSF- macrophages than in M-CSF-macrophages 
(IV, Fig.5). One other remarkable observation was that β-glucan induced the 
expression of GBP5, the putative regulator of NLRP3 inflammasome activation, in 
GM-CSF-macrophages (IV, Fig. 5). These two results may explain the more 
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efficient activation of the inflammasome in β-glucan stimulated GM-CSF-
macrophages.  
To study in more detail the secretion mechanisms of inflammasome-
components and -regulators after β-glucan treatment, the enriched extracellular 
vesicle fraction was prepared from the cell media and used for secretion analysis. 
Mature forms of IL-1β and IL-18 and all the isoforms of ASC were detected only 
in the flow-through fraction, indicating that these molecules had not been secreted 
inside vesicles after β-glucan stimulus (II, Fig. 5B). In contrast, although the 
preforms of cathepsins were also detected in the flow-through fraction, their 
mature forms were seen only in the fraction containing vesicles (II, Fig. 5B). To 
characterize the effect of β-glucan-induced NLRP3 activation to the 
unconventional protein secretion, a specific inhibitor for caspase-1 (Z-YVAD-
FMK) was used. The caspase-1 inhibitor abolished the β-glucan-induced secretion 
of IL-1β and exosomal marker proteins, but it did not have any effect on cathepsin 
D (II, Fig. 5C). These results indicate that caspase-1 regulates the secretion of IL-
1β and several vesicle-mediated proteins, but not the secretion of molecules, which 
are activated upstream of caspase-1.  
According to our earlier results, β-glucan activates the NLRP3 inflammasome 
via signaling through the dectin-1 pathway in human macrophages. We wanted to 
confirm the role of dectin-1 in the secretion of inflammasome related components 
and vesicle-mediated proteins.  The secretions of mature forms of IL-1β and 
cathepsins were abolished in β-glucan stimulated bone marrow derived dendritic 
cells from dectin-1 -/- mice (II, Fig. 6AB). However, the β-glucan-induced 
increase in the levels of IL-1β mRNA was not totally inhibited in cells from 
dectin-1 -/- mice (II, Fig. 6C). BMDCs were used because mouse bone-marrow-
derived macrophages are not responsive to β-glucans (Goodridge et al., 2009a).  
Src and Syk are kinases, which are linked downstream of dectin-1 signaling 
(Goodridge et al., 2011). Syk inhibition clearly decreased the secretion of the 
mature forms of IL-1β, cathepsins and ASC p10 in macrophages (II, Fig. 6D). In 
contrast, Src inhibitors had no effect on the secretion of these proteins (II, 6D and 
Supplemental Fig. 1A). Exosomal protein secretion of annexin I and tubulin were 
dependent on Syk, whereas the Src inhibitor, on its own, did not have any effect on 
these proteins (II, Fig. 6F).  
 
  
5.2.4. (1,3)-β-glucan –induced unconventional protein 
secretion is dependent on autophagy (II) 
 
Autophagy is a highly conserved process in cells, since it is mainly involved for 
degradation and removal of dysfunctioning organelles and aggregates. It has been 
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previously shown that autophagy can participate in the regulation of protein 
secretion (Ponpuak et al., 2015).   
Our secretome data revealed that many autophagy –associated proteins were 
secreted after the β-glucan stimulus in human macrophages (II, Fig. 7A, 
Supplemental Table IIIC). We also observed that β-glucan increased the 
conversion of LC3-I to LC3-II, which is found on autophagic membranes and is 
indicative of the activation of the autophagy process (II, Fig. 7B). To study the role 
of autophagy on β-glucan induced protein secretion, the process of autophagy was 
blocked with 3-MA, which inhibits the activity of class III phosphatidylinositol-3-
OH-kinase (PI(3)K) and prevents the formation of autophagosomes. The inhibition 
of autophagy suppressed the β-glucan-induced total protein secretion and the 
secretion of proteins related to exosomes, inflammasome and autophagy (II, Fig. 
7DE). The effect of autophagy on the β-glucan secretome was also studied by 
silencing the function of the beclin-1 gene with the SiRNA approach. Beclin-1 is a 
key component of the class III PI(3)K-complex. In line with the 3-MA results, the 
decreased beclin-1 expression led to an inhibition of total protein secretion and 
decreased the secretion of exosomal and inflammasome- and autophagy-related 
proteins during the β-glucan stimulation (II, Fig. 7FG). In contrast, beclin-1 
silencing did not affect the β-glucan-triggered conventional secretion of 
chemokines (II, Fig. 7H). 
To conclude, activation of autophagy is required for β-glucan-induced 
unconventional protein secretion, but not for conventional protein secretion.    
 
5.3. (1,3)-β-glucans activate production of IL-1 family 
cytokines in human macrophages (I, IV) 
 
Cytokines of interleukin-1 family have a key role in innate immunity as inducers 
of local and systemic inflammation. Most of the pro-inflammatory cytokines of IL-
1 family lack the signal peptide and are thus not released via the classical protein 
secretion pathway (Garlanda et al., 2013). The activation of NLRP3 
inflammasome mediated caspase-1 is known to drive the secretion of IL-1β and 
IL-18, but the impact of inflammasome activation in the secretion of other IL-1 
members has remained mainly uncharacterized.  
 
5.3.1. GM-CSF -macrophages are more potent producers of 
IL-1 family cytokines compared to M-CSF -
macrophages (IV) 
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The granulocyte-macrophage colony-stimulating factor (GM-CSF) and 
macrophage colony-stimulating factor (M-CSF) are essential cytokines regulating 
the developing process, survival and function of macrophages (Hamilton, 2008, 
Louis et al., 2015). In this study, we compared the response of pro-inflammatory 
IL-1 cytokines in both GM-CSF -and M-CSF-differentiated human monocyte-
derived macrophages after β-glucan stimulation. The characterization was 
performed by analyzing the transcription and secretion of IL-1 family members. 
After 6 h of β-glucan stimulation, the induction in the mRNA levels of IL-1α, IL-
1β and IL-36γ was seen in both macrophage types (IV, Fig. 1). The induction 
observed in mRNA levels of IL-36α and IL-36β after β-glucan treatment was not 
significant (IV, Fig. 1). The mRNA levels of IL-33 were only increased in β-
glucan-stimulated GM-CSF- macrophages (IV, Fig. 1), in contrast, there were no 
differences in the mRNA levels of IL-18 between the controls and β-glucan 
exposure groups or different macrophage types (IV, Fig. 1).  
The secreted concentrations of IL-1α, IL-1β and IL-18 were higher in GM-
CSF -macrophages than in M-CSF- macrophages after 18 hours’ β-glucan 
stimulation (IV, Fig. 3AC). Beta-glucan-induced secretion and processing of IL-
36γ was studied with immunoblotting in parallel to the assays of IL-1β and IL-18. 
Thus far, IL-36 cytokines have not being reported to contain caspase-1 cleavage 
sites similarly to IL-1β and IL-18. The biologically active form of IL-1β (p17) was 
detected only in β-glucan-stimulated GM-CSF-macrophages (IV, Fig. 3C). In 
addition, the secretions of both the pro-form (p24) and the mature protein of IL-18 
(p18) were more abundant in the supernatant collected from GM-CSF -
macrophages after β-glucan treatment (IV, Fig. 3C). The amount of pro-IL1β was 
at the same level in the lysates collected from the both stimulated macrophage 
types (IV, Fig. 3B). There was little difference in proIL-18 expression in untreated 
cells or in ?-glucan- stimulated GM-CSF -and M-CSF –macrophages (IV, Fig. 
3B).   
IL-36γ was detected only in the supernatant of β-glucan stimulated GM-CSF-
macrophages. The amount of secreted IL-36γ cytokine correlated with the 
intracellular produced cytokine in β-glucan-treated GM-CSF –macrophages (IV, 
Figure 3B and 3C). The molecular weight of the detected IL-36γ protein, both 
inside the cell and in the supernatant, was approximately 19 kDa. These results 
indicate that β-glucan-induced IL-1 cytokine secretion is more efficient in GM-
CSF-macrophages than in M-CSF-macrophages, even though the β-glucan 
induced the gene expression of IL-1-family cytokines in both GM-CSF- and M-
CSF-macrophages.  
 
5.3.2. (1,3)-β-glucan-induced IL-1α and IL-36γ transcription 
is dependent on cathepsin B activity (IV) 
 
The activation of dectin-1 and NLRP3 inflammasome and their effect to the β-
glucan-induced gene transcription of IL-1 family cytokines were studied. Human 
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GM-CSF-macrophages were used in this experiment since according to our earlier 
results, these cells display a more prominent IL-1 response when exposed to by β-
glucan. To examine the role of dectin-1 signaling in the β-glucan induced IL-1 
response, a specific Syk inhibitor was used. This inhibitor blocked totally the β-
glucan induced gene transcription of IL-1α, IL-1β and IL-36γ (IV, Fig. 6A). In 
addition to the human macrophages, the mRNA levels of IL-1 cytokines were 
studied in the bronchoalveolar lavage cells collected from intranasally β-glucan 
exposed C57BL/6 wild type and dectin-1 knockout mice to elucidate the role of 
dectin-1 in the response of IL-1 family cytokines in mouse lung. Treatment with 
β-glucan significantly increased the transcription levels of IL-1α, IL-1β and IL-
36γ in BAL cells obtained from wild type mice (IV, Fig. 2). In contrast, a 
deficiency of dectin-1 impaired the transcription of β-glucan-induced IL-1 
cytokines. These results indicate that the dectin-1 pathway is needed for β-glucan-
activated gene expression of IL-1 cytokines in human macrophages and in vivo 
activated mouse BAL cells.  
To elucidate the role of caspase-1 and cathepsin B in β-glucan-triggered gene 
expression of IL-1 cytokines, the specific inhibitors Z-YVAD-FMK and CA-074-
Me were used, respectively. The caspase-1 inhibition had no inhibitory effect in β-
glucan induced IL-1α, IL-1β and IL-36γ genes (IV, Fig. 6A). In contrast, CA-074-
Me clearly blocked the β-glucan-induced transcription of IL-1α and IL-36γ genes, 
but exerted no effect on IL-1β (IV, Fig. 6A). These results suggest that activation 
of cathepsin B, in addition to its recognized role in the secretion of IL-1β, has an 
effect on the gene expression of IL-1α and IL-36γ.   
 
5.3.3. Secretion of IL-36? is not dependent on NLRP3 
inflammasome (IV) 
 
The inhibition of NLRP3 activation by cathepsin B and caspase-1 inhibitors led to 
a decreased secretion of IL-1β in human macrophages after β-glucan stimulus (I, 
Fig.6, IV, Fig. 6B). We wanted to study the effect of the same inhibitors on the 
secretion of other IL-1 family cytokines, IL-1α and IL-36γ. The cathepsin B-
inhibitor blocked the secretion of IL-1α, in contrast, the caspase-1 inhibitor had 
only a partial effect on the secretion of IL-1α after β-glucan treatment (IV, 
Fig.6B). Cathepsin B -and caspase-1 inhibitors inhibited totally the β-glucan-
induced secretion of mature IL-1β (IV, Fig. 6C). In contrast, the caspase-1 
inhibitor only partially decreased the secretion IL-36γ (IV, Fig. 6C). To confirm 
the role of NLRP3 inflammasome in the secretion of IL-1 family cytokines, we 
used a specific inhibitor for the NLRP3 inflammasome, MCC950 (Coll et al., 
2015). Secretion of β-glucan-induced IL-1α and IL-1β was prevented by NLRP3 
inhibition (IV, Fig. 6DE). In contrast, NLRP3 inhibition did not block the 
secretion of IL-36γ (IV, Fig. 6E). Taken together, these results show that β-glucan-
78 
 
induced secretion of IL-1α, IL-1β and IL-36γ cytokines is differentially regulated 
by cathepsin B, caspase-1 and NLRP3 inflammasome in human macrophages. 
5.4. Proteomic changes of the alveolar lining fluid are 
different between the illnesses related to exposure 
to non-infective microbial particles (III) 
 
Individuals living in certain surroundings or in certain occupations have an 
increased risk of being exposed to microbial dust including non-infective particles 
from fungi and bacteria. These microbial exposures are associated with diseases 
which manifest airway symptoms such as hypersensitivity pneumonitis and damp 
building-related illness (WHO, 2009, Selman et al., 2010), but rather little is 
known about the proteomic changes of the alveolar lining fluid related to these 
diseases.   
  
5.4.1. Protein expression pattern of bronchoalveolar lavage is 
different between the damp-building related illness and 
hypersensitivity pneumonitis-like conditions 
 
In order to identify possible diagnostic markers for illnesses related to exposure to 
non-infectious microbial particles (NIMPs), we collected the BAL samples from 
individuals who had been exposed to NIMPs in the context of DBRI) or in the 
context of agricultural environment and manifesting hypersensitivity pneumonitis-
like symptoms (AME). Samples from patients diagnosed with acute type of HP 
were used as a reference for inflammatory lung disease related to NIMP exposure. 
Samples from healthy individuals served as controls (CTR) and samples from 
sarcoidosis patients (SARC) served as a reference for inflammatory lung disease 
with no direct association with NIMP exposure. More detailed information about 
the patients is provided in Tables 1 and 2 (III). The quantitative proteomic analysis 
was performed for BAL samples utilizing the 2D-DIGE and DeCyder analysis. 
Subsequently, the identification of differentially expressed protein spots was 
performed with LC/MS-MS. A total of 63 protein spots and 34 different proteins 
were identified as being differentially expressed between the control versus one or 
all the other study groups, or between the DBRI and AME (III, Fig. 1 and Table 
S1). According to the Gene Ontology classification analysis, most of the identified 
proteins were grouped as extracellular proteins, had some function in antigen or 
protein binding and were part of certain biological processes such as the immune 
response, the function of platelets, iron homeostasis, transmembrane transport and 
response to reactive oxygen compounds (III, Fig. 2AB). David enrichment analysis 
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showed that extracellular secreted proteins, especially plasma proteins, were an 
abundant group in the analyzed BAL (III, Table S2).  
The hierarchical clustering of the 63 identified proteins from BAL (III, Fig. 
2C) revealed the differences in protein expression patterns between the study 
groups. The abundant expression of most of the identified proteins in both AME 
and HP located them into the same main cluster. The other groups, CTR, DBRI 
and SARC formed their own main cluster, indicating that these groups have a 
different protein expression pattern than hypersensitivity pneumonitis and 
hypersensitivity pneumonitis-like condition. In this latter main cluster, CTR and 
DBRI formed their own subgroup, indicating a similar type of overall protein 
expression between these two. A similar kind of clustering of the groups was also 
seen in the principal components analysis performed for spot maps based on the 
variance in their protein expression (III, Fig. 2D). In addition, the lymphocyte 
percentages of BAL samples chosen for DIGE analysis were compared and 
according to this result, DBRI differed from the control samples, but not from the 
other study groups (III, Figure S2).     
According to the DeCyder analysis, none of the identified 34 proteins (III, 
Table S1) were upregulated spesifically in only one of the study groups. 
Apolipoprotein A1 was the only identified protein upregulated in NIMP-related 
diseases (AME, DBRI, HP) compared to control, but there was no difference 
compared to sarcoidosis.  
    
5.4.2. Semenogelin and histone 4 proteins are more abundant 
in bronchoalveolar lavage of hypersensitivity 
pneumonitis-like conditions than in damp-building 
related illness 
 
We could not identify any protein which was a specific marker for NIMP-exposure 
associated diseases, i.e. none of the identified proteins were upregulated only in 
NIMP-related disease group (AME, DBRI, HP) compared to control and 
sarcoidosis. Thus the proteins for immunoblotting-based validation and 
quantitation were chosen according to their reasonable robustness in disease 
groups compared to healthy controls. The proteins chosen were: alpha-1-
antitrypsin (A1AT), galectin-3 (GAL3), histone H4 (H4) and semenogelin I (SEM) 
(III, Fig. 3AB). The protease inhibitor, A1AT and the unconventionally secreted 
carbohydrate-binding lectin, GAL3 are proteins, which levels are known to 
increase during inflammation. According to immunoblot quantitation results, 
expressions of A1AT and GAL3 were elevated in all disease groups compared to 
control group (III, Fig. 3C). There were no differences in the expression of A1AT 
between the AME and DBRI, but their A1AT expression differed from HP. With 
respect to GAL3, there were no significant changes between the disease groups 
(AME, DBRI, HP, SARC) when they were compared with each other. 
Semenogelin, a protein involved in the formation of sperm coagulum (Lilja, 1985), 
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was more abundant in AME, HP and SARC groups than in controls (III, Fig.3C). 
Semenogelin expression remained at the control level in the DBRI group, which 
differed from its expression in hypersensitivity pneumonitis (p=0.0001 for DBRI 
vs. HP) and hypersensitivity pneumonitis-like condition (p=0.0009 for DBRI vs. 
AME). Histones can elicit an inflammatory response functioning as endogenous 
danger signals (Chen et al., 2014). The immunoblot validation was performed for 
histone 4, from a protein band of approximately size of 50 kDa. This size is 
aberrant for histone, thus this particular protein band was confirmed by mass 
spectrometric analysis from the immunoblot membrane. The increased amount of 
histone 4 was found in BAL of AME, HP and SARC (III, Fig. 3C). The levels 
were different between DBRI and AME/HP (p=0.01 for DBRI vs. AME, and 
p=0.0031 for DBRI vs. HP). 
All the samples used in this study were obtained from patients with a non-
smoking background. When six BAL-samples collected from healthy controls with 
a smoking background were included in the immunoblot validation and the results 
were compared to non-smoking controls, only GAL3 levels were increased in the 
group of smokers (p=0.0482).   
Furthermore, the immunoglobulin response was determined from the study 
groups with the ELISA assay. The concentrations of total IgG were increased in 
BAL collected from AME, HP and SARC groups (III, Fig. S4). In addition to 
BAL, plasma samples were available from control, HP and SARC groups. It was 
possible to quantify the expression levels of galectin-3 and histone 2B (H2B) by 
immunoblot from the samples without any interference by the abundant plasma 
proteins. In plasma, the detected size of H2B protein band was predicted to be 17 
kDa. There were no differences between the groups in the expression of galectin-3 
(III, Fig. 4A). Levels of H2B were elevated in HP and SARC groups compared to 
control (III, Fig. 4B). The difference in abundance of H2B between HP and SARC 
was not statistically significant (data not shown).   
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6.DISCUSSION 
The invasion and proliferation of pathogenic microbes can lead to tissue damage 
and disease. These microbes are recognized by our immune system via their 
conservative and unique microbial structures (pathogen-associated molecular 
patterns, PAMPs). The microbial structural components can trigger different kinds 
of responses in our immune system when recognized by pattern recognition 
receptors (PRRs). Macrophages are the central defense cells of innate immunity, 
and usually the first cells to confront the pathogen or pathogenic particles. The 
recognition of pathogenic substances or danger signals released from damaged 
tissue may lead to activation of signal cascades downstream in the macrophage’s 
PRRs as well as the production of pathogen killing compounds (ROS, NO) and the 
secretion of chemokines and cytokines. These latter agents promote the 
inflammatory response by activating and recruiting the immune cells into the site 
of microbial encounter and tissue damage. Furthermore, antigen presentation to the 
lymphocytes by activated macrophages may lead to the initiation of adaptive 
immune response. In contrast to the role of macrophages as activators of 
inflammation, macrophages also sustain the body homeostasis by taking care of 
tissue repair, dampening the inflammatory reaction by secreting anti-inflammatory 
factors and having a certain threshold for environmental signals that will initiate 
the inflammatory cascades.  
The exposure to inhaled non-infective microbial particles in certain 
occupations and environments is associated with diseases manifesting airway 
symptoms. These particles contain the same pathogen-associated molecular 
patterns as an intact pathogen, and thus may trigger the immune response. The 
innate immunity system is the first line of defense for pathogens; it is involved in 
the initiation of inflammatory response and for the most part, it is sufficient on its 
own to eradicate the threat. Thus it is important to characterize the mechanisms by 
which these microbial structures affect our innate immune system and furthermore 
to determine whether these activated mechanisms could explain the pathogenesis 
behind the diseases associated with the exposure of microbial particles or infection 
with viable pathogen.  
6.1. NLRP3 inflammasome is activated by β-glucan via 
dectin-1 signaling pathway in human macrophages 
NLRP3 inflammasome is a cytosolic protein complex, which is an important 
sensor of the innate immune system for recognizing the invading pathogens, host-
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derived danger signals or other harmful substances. The induction of the NLRP3 
inflammasome triggers activation of caspase-1 enzyme, which catalyses the pro-
inflammatory cytokines of IL-1β and IL-18 into their biologically active forms 
(Martinon et al., 2002, Bauernfeind et al., 2011).  
A deficiency of NLRP3 or other inflammasome components (ASC, caspase-1) 
is associated with increased susceptibility to fungal diseases, highlighting their 
importance in antifungal defense. Mice lacking a functional NLRP3 
inflammasome or IL-1 receptor were more susceptible to infections of most 
common fungal pathogen, Candida albicans (Gross et al., 2009, Hise et al., 2009, 
Joly et al., 2009). In contrast to NLRP3, deficiency for other Nlrps (Nlrp1, Nlrc4, 
Nlrp6, Nlrp12) did not change the IL-1β response of the cells to C. albicans (Gross 
et al., 2009, Joly et al., 2009). The activation of NLRP3 inflammasome was also 
crucial for the antifungal immune response against Aspergillus fumigatus in a 
human monocyte cell line (Said-Sadier et al., 2010).    
The major carbohydrate structure of the fungal cell wall and the crucial 
immunostimulatory PAMP of fungi is (1,3)-β-glucan (Tsoni and Brown, 2008). 
Concurrently with our studies, the activation of NLRP3 inflammasome by fungal 
β-glucan was shown in mouse thioglycolate-elicited peritoneal macrophages and 
bone marrow-derived dendritic cells (Kumar et al., 2009). In our study, we 
characterized the potential of (1,3)-β-glucan to activate pathways and mechanisms, 
which are involved in the activation of NLRP3 inflammasome and secretion of IL-
1β in human primary macrophages.  
It has been postulated that the secretion of IL-1β in macrophages requires two 
different signals (Bauernfeind et al., 2011). The first signal, providing the so-called 
priming step, is mediated by the membrane-bound PRR and leads to upregulation 
of IL-1β and NLRP3 gene expression via transcription factor NF-κB (Bauernfeind 
et al., 2009, Dinarello, 2009). In in vitro experiments, the priming of the 
macrophages is typically induced by LPS, which binds to TLR4 and triggers the 
NF-κB signaling. After priming, the second and usually distinct signal, for 
example mediated by microbial toxin or DAMP, is required for activation of 
NLRP3, which leads to the assembly of the inflammasome complex and the 
secretion of mature IL-1β.  
Our results revealed that both β-glucan and other microbial PAMP, bacterial 
LPS induced the gene expression of IL-1β in human macrophages. In contrast, 
only β-glucan activated the secretion of IL-1β, which was abolished when the 
activation of caspase-1 was inhibited or the gene for NLRP3 was silenced. 
Moreover, we observed that β-glucan triggered IL-1β secretion in human dendritic 
cells, the main APCs, which may have an influence in activation and polarization 
of adaptive immunity during fungal infection or exposure to β-glucans. These 
results show that in contrast to LPS, β-glucan is capable of providing both of these 
signals for NLRP3 inflammasome activation and secretion of IL-1β. This indicates 
that a major component of the fungal cell wall on its own can trigger the 
inflammatory response by inducing the secretion of IL-1β in human macrophages.  
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The membrane-bound C-type lectin receptor, dectin-1 is the main PRR for β-
glucans; it is known to facilitate phagocytosis and the oxidative burst, and activate 
expression of pro-inflammatory cytokines via the NF-κB signaling (Brown and 
Gordon, 2001, Drummond and Brown, 2011). The importance of dectin-1 receptor 
and its downstream signaling components in fungal immunity has been 
demonstrated in studies with human and mice, where the deficiency of dectin-1 
has led to increased susceptibility to fungal infections, especially a higher 
prevalence of mucocutaneous candidiasis in humans (Saijo et al., 2007, Ferwerda 
et al., 2009, Glocker et al., 2009, Strasser et al., 2012). Our results revealed that 
the dectin-1 receptor was required for β-glucan-induced increase of IL-1β mRNA 
and secretion of IL-1β in human macrophages. In β-glucan-stimulated mouse bone 
marrow-derived dendritic cells, dectin-1 deficiency blocked the secretion of IL-1β, 
but did not totally prevent the induction of IL-1β mRNA, indicating that also other 
receptors may be involved in the β-glucan-induced IL-1β transcription in mice. 
These additional receptors may include scavenger receptors such as CD36 and 
SCARF1 (Means et al., 2009) or complement receptor CR3 (Goodridge et al., 
2009b), which have been reported to recognize β-glucan and mediate the 
antifungal response. Other CLRs, such as dectin-2, are known to activate NLRP3 
inflammasome in response to helminth antigens (Ritter et al., 2010), and when 
forming a heterodimer with dectin-3, it facilitates an effective antifungal response 
via the same downstream signaling components (Syk tyrosine kinase, NF-κB 
transcription factor) as dectin-1. However thus far, these receptors have been 
linked with the recognition of fungal α-mannans, not β-glucans (Zhu et al., 2013).     
The spleen tyrosine kinase (Syk) is the main molecule mediating the signal 
transduction after dectin-1 activation (Kerrigan and Brown, 2010). Recent studies 
have shown that Syk controls both the synthesis of pro-IL-1β and inflammasome 
activation during C. albicans or A. fumigatus stimulation (Gross et al., 2009, Said-
Sadier et al., 2010). Our results revealed that the activation of Syk signaling was 
needed for β-glucan-induced increase of IL-1β mRNA and secretion of IL-1β in 
human macrophages. Moreover, Syk inhibition abolished β-glucan-induced 
secretion of IL-18. The pro-form of IL-18 is known to be expressed constitutively 
in macrophages. It has been shown that NF-κB dependent upregulation of NLRP3 
expression is needed for inflammasome activation (Bauernfeind et al., 2009). 
Priming human macrophages with LPS, to ensure Syk-independent upregulation of 
NLRP3 mRNA, did not rescue the defect in secretion of IL-18 in Syk-inhibited 
and β-glucan stimulated cells. This suggests that Syk signaling has also other roles 
in the activation of the inflammasome. This has also been observed in other 
studies, where NLRP3 ligands such as malarial hemozoin or carbon nanotubes 
have failed to activate the NLRP3 inflammasome, when Syk is inhibited (Shio et 
al., 2009, Palomäki et al., 2011), which points to a more general role for Syk in 
activating the inflammasome. According to recent studies, Syk is involved in the 
phosphorylation of the inflammasome component, ASC, during the activation of 
NLRP3, with signaling being triggered by several NLRP3 ligands such as ATP, 
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nigericin, MSU and alum. Phosphorylation of ASC is believed to control the 
formation of ASC specks and subsequently to the activation of inflammasome-
mediated caspase-1 (Hara et al., 2013, Lin et al., 2015).  
In addition to Syk, the activation of Src kinase in upstream of Syk has been 
linked to dectin-1 signaling and activation of NLRP3 (Shio et al., 2009, Kerrigan 
and Brown, 2010). In our macrophage experiments, the src inhibitors exerted no 
effect on the β-glucan induced gene transcription or protein secretion of IL-1β. 
This suggests that Syk can act also independently of Src kinases. To summarize, 
the dectin-1/ Syk pathway not only controls the production of pro-IL-1β cytokine, 
but is also crucial for activating the NLRP3 inflammasome and IL-1β secretion as 
a response for β-glucans in human macrophages.  
Previous studies have revealed that crystalloid structures such as MSU and 
silica are phagocytized into the cell cytosol prior to activation of NLRP3 
inflammasome (Hornung et al., 2008). Dectin-1 has been shown to be the primary 
receptor for initiating the phagocytosis of fungi exposing the cell wall β-glucans 
(Goodridge et al., 2012). Blockade of the internalization of β-glucan in human 
macrophages prevented the secretion of IL-1β, but not the transcription of IL-1β 
mRNA. This indicates that the formation of the phagocytic synapse is involved in 
dectin-1 signaling. Dectin-1 has been demonstrated also to induce the release of 
IL-1β independently of pathogen internalization via a non-canonical caspase-8 
inflammasome in human dendritic cells (Gringhuis et al., 2012). Our results, where 
blockade of antigen internalization totally prevented the secretion of IL-1β, imply 
that there are differences between macrophages and dendritic cells in activating the 
canonical and noncanonical inflammasome pathways.  
The exact molecular mechanisms, which trigger the activation of NLRP3 are 
mainly unknown. Ligands activating the NLRP3 inflammasome have been shown 
to induce cellular events which lead to NLRP3 assembly and subsequently to 
caspase-1 activation.  
The main phenomena linked to the activation of canonical NLRP3 include 
changes in cell ion balance (K+ efflux) (Munoz-Planillo et al., 2013), redox state 
(release of oxygen radicals, ROS) (Zhou et al., 2011) and lysosomal 
destabilization and cathepsin activity (Hornung et al., 2008).  
Phagocytosis of particulate matter has been shown to cause the disruption of 
the lysosomal membrane and the leakage of lysosomal cathepsins into the cytosol 
which led to the activation of the NLRP3 inflammasome (Hornung et al., 2008). 
Cathepsins are protease enzymes, which are involved in the proteolytic 
degradation of lysosomal compartments (Turk et al., 2012). In addition to silica 
crystals and aluminum salts, several other particulate substances such as amyloid-β 
(Halle et al., 2008), cholesterol crystals (Duewell et al., 2010, Rajamäki et al., 
2010), long needle-like carbon nanotubes (Palomäki et al., 2011) and monosodium 
urate crystals (Välimäki et al., 2013) have been shown to activate NLRP3 
depending on cathepsin-B activity.  In line with this, by inhibiting the event of 
phagocytosis, or inhibiting the activity of cathepsin B with CA-074-Me, it was 
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possible to inhibit completely the β-glucan-induced release of IL-1β in our 
experiments with human macrophages. Some other studies using cathepsin B-
deficient cells or pharmalogic inhibitors have reported different results, with a role 
of cathepsin B in activation of NLRP3 (Halle et al., 2008, Hornung et al., 2008, 
Dostert et al., 2009, Gross et al., 2009, Joly et al., 2009, Riteau et al., 2012). The 
reasons for these discrepancies might be differences in cell models being used 
(Gross et al., 2009, Joly et al., 2009) and possible off-target effects (targeting also 
other cellular proteases) by the inhibitor being used (CA-074-Me) (Newman et al., 
2009). It is also possible that cathepsin B ablation in knockdown models is 
compensated by alterations in the functions of other cellular cathepsins. To 
summarize, our results confirmed that lysosomal destabilization is needed for β-
glucan induced NLRP3 activation. However, in the future, it would be beneficial 
to clarify the role of cathepsin B in β-glucan induced NLRP3 activation, and 
exclude the possible effect of other proteases with additional methods.  
The production of ROS is a conserved reaction of macrophages and it is 
associated with phagocytosis of the pathogen. In addition, ROS are also involved 
in sensing stress and cellular damage, thus suggesting that the release of ROS may 
be a potential signal for activating the inflammasome. Many known NLRP3 
activators such as microbial toxins and crystalloid substances have been shown to 
trigger the formation of ROS (Dostert et al., 2008, Martinon et al., 2009, Schroder 
and Tschopp, 2010, Zhou et al., 2011, Latz et al., 2013). There are previous studies 
that ROS, especially those released from mitochondria, are involved in the 
activation of the NLRP3 (Dostert et al., 2008, Zhou et al., 2011, Heid et al., 2013). 
In our experiments, inhibition of ROS abrogated the β-glucan induced IL-1β 
release, pointing to a role for ROS in β-glucan induced inflammasome activation.  
However, several studies have questioned the role for ROS or mitochondrial 
perturbation in the activation of NLRP3 (Munoz-Planillo et al., 2013, Allam et al., 
2014). Instead, there are studies implying that these NLRP3 triggering substances, 
which have been described to activate the inflammasome via lysosomal disruption 
or ROS, could share a common signal for activating the NLRP3: potassium efflux 
(Petrilli et al., 2007, Munoz-Planillo et al., 2013). This suggests that compromised 
membrane integrity could represent the common feature leading to activation of 
NLRP3 since this has been observed with almost all stimuli examined thus far. In 
addition in our studies, β-glucans induced NLRP3 activation via the K+efflux 
dependent mechanism. Recently, it has been postulated that potassium efflux could 
act as the principal trigger for NLRP3 activation in both canonical and 
noncanonical pathways (Rivers-Auty and Brough, 2015). Suppression of 
potassium efflux blocked the noncanonical activation pathway of NLRP3, by 
diminishing the release of IL-1β triggered by transfected LPS (Rivers-Auty and 
Brough, 2015). The exact mechanism to explain why this change in ion balance 
affects the NLRP3 assembly and activation via canonical and noncanonical 
pathways still remains to be determined.  
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Pyroptosis, the caspase-1 or mouse caspase-11 (caspase-4/5 in humans) activity 
dependent form of cell death is triggered by many canonical and noncanonical 
inflammasome activating substances (Lamkanfi and Dixit, 2014). The activation of 
caspase-1 is needed for the production of active inflammatory cytokines such as 
IL-1β, but occasionally it can lead to pyroptosis, characterized by rupture of the 
plasma-membrane and leakage of proinflammatory intracellular contents 
(Bergsbaken et al., 2009). Interestingly, in our studies, β-glucan induced a robust 
secretion of proinflammatory cytokines, as also intracellular proteins, but no signs 
of active cell death were observed with assays measuring the levels of cell death. 
One possible explanation may be the robust secretion of growth factors (GM-CSF, 
M-CSF) during the β-glucan stimulation (Article II, Figure 4). In addition to their 
role in the myeloid developing process, GM-CSF and M-CSF are essential 
cytokines regulating the survival and function of macrophages, both in steady-state 
and during inflammation (Hamilton, 2008, Louis et al., 2015).  
This observation makes β-glucan an even more interesting study target 
compared to other non-infective microbial components since it on its own provides 
all of the signals, which are needed for activation of NLRP3 and secretion of 
proinflammatory cytokines. At the same time, it boosts the viability of the 
macrophages preventing them from undergoing pyroptosis and presumably, in that 
way, it strengthens the level of the immune reaction.  
6.2. Unconventional protein secretion as an innate 
immune response to the β-glucans 
Production and secretion of proteins in macrophages are regulated at many levels 
within the cell such as gene transcription, protein synthesis, and intracellular 
protein trafficking.  
In our study, we analyzed the global transcriptional and secretional responses 
to β-glucans (curdlan or GBY) in human macrophages. LPS, a TLR4 ligand was 
used as a control, representing a well-known inflammatory microbial structure 
unrelated to fungi. We demonstrated that the activation of dectin-1 pathway 
induced significant changes in gene expression and robust protein secretion 
utilizing both conventional and unconventional protein secretion pathways. LPS 
induced also significant expression of genes, which was different from the type of 
expression activated by β-glucans.  
The level of protein secretion after LPS stimulus was less robust compared to 
that seen with the β-glucans and the most extensively secreted proteins were 
mainly classical agents such as chemokines and cytokines, which are primarily 
regulated at the level of gene expression. This is line with the previous results of 
Meissner and co-workers where two third of the secreted proteins were reported to 
possess a signal peptide or transmembrane region after LPS stimulus in human 
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macrophages (Meissner et al., 2013). There was a notable group of proteins among 
the β-glucan-induced proteins; these are reported to be released through 
extracellular vesicles (EVs). This vesicle-mediated form of unconventional 
secretion is assumed to deliver signaling molecules more efficiently to adjacent 
cells than conventional secretion, where the proteins readily diffuse throughout the 
extracellular milieu (Record et al., 2011). One major group of inflammatory 
proteins identified in our β-glucan secretome data were the proteins that have been 
demonstrated or suggested to act as danger-associated molecular pattern molecules 
(DAMPs) (e.g., galectins, heat shock proteins, HMGB-proteins, S100-
proteins)(Gallucci and Matzinger, 2001, Bianchi, 2007).  
DAMPs are host molecules, which normally have a well-defined intracellular 
function, but they are released or become exposed following a tissue injury, cell 
death or a stress. 
Apart from their passive release during cell injury and death, many of the 
endogenous danger signal proteins are known to be secreted from activated 
inflammatory cells through the unconventional pathways (Bianchi, 2007). 
Caspase-1 activation related cell death, pyroptosis, is linked to leakage of 
intracellular proteins into the extracellular space (Bergsbaken et al., 2009). 
However, no signs of active cell death were observed during the stimulation 
evoked by β-glucan, therefore the identification of large amount of the DAMPs in 
the β-glucan secretome was considered to reflect the active secretory processes 
occurring in β-glucan-induced macrophages. All the DAMPs identified in the β-
glucan secretome, except for HMGBs, can be found in the database of ExoCarta 
(Article II, Supplemental Table IIIB, link to ExoCarta). This confirms that these 
particular DAMPs are secreted in exosomes utilizing unconventional secretion 
mechanisms. Galectin-3 was one of the DAMPs, the secretion of which was 
robustly activated after β-glucan stimulus. Galectin-3 can facilitate 
chemoattraction and elicit the oxidative burst in leukocytes, and act also as a PRR, 
which recognizes the carbohydrate structures on the cell wall of Candida albicans 
(Sato et al., 2009). In addition, a recent report revealed that galectin-3 directly 
associates with dectin-1 and has an essential role in proinflammatory response 
induced by pathogenic C. albicans (Esteban et al., 2011). It is likely that the β-
glucan-induced active secretion of DAMPs leads to enhanced antifungal defense 
e.g. DAMPs can act as chemottractants, they can also activate signaling of PRRs 
(dectin-1,TLRs, RAGE) or even boost the adaptive immunity reponse by binding 
to antigenic peptides and facilitate their transport to the antigen presenting cells 
(Srivastava, 2002, Bierhaus et al., 2005, Sato et al., 2009, Esteban et al., 2011).  
In our study, the other major group of proteins for which β-glucan clearly 
induced secretion were proteins involved in leukocyte migration. These proteins 
included a significant amount of adhesion proteins such as integrins and proteins 
that regulate the reorganization of the actin cytoskeleton. This robust release of 
integrins and related cytoplasmic cargo proteins in extracellular vesicles upon β-
glucan stimulation of macrophages has also been confirmed by Cypryk and co-
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workers (Cypryk et al., 2014). These proteins are vital for the surveillance 
functions of leukocytes, especially for their ability to migrate from blood to tissue 
into site of infection. In addition, the same proteins are believed to mediate the 
interaction between the secreted vesicles and recipient cells, and thus to facilitate 
cell-cell communication (Thery et al., 2009). The interaction between the vesicle 
proteins and cell surface of the recipient cell may lead to the fusion of the 
membranes and to the release of vesicle cargo into the cytoplasm of the recipient 
cell, which then can affect the function of the recipient.   
The main cell model used in our studies was the human GM-CSF-induced 
monocyte-derived macrophages. The phenotype of GM-CSF-macrophages has 
been reported to resemble one of the human alveolar macrophages (Akagawa et 
al., 2006), which normally take care of the cleansing of inhaled noxious particles 
in the alveolar space of the lung. However, there are some discrepancies 
encountered with the GM-CSF–macrophage model, implying that it better 
represents dendritic cells than macrophages. Nonetheless, based on the results 
obtained from bioinformatics analyses of macrophage and dendritic cell 
transcriptomes (Robbins et al., 2008, Crozat et al., 2010), it has been postulated 
that GM-CSF-generated cells are closer to macrophages than dendritic cells. M-
CSF–generated macrophages have been widely used as a representative in vitro 
model for tissue macrophages (Martinez et al., 2006, Way et al., 2009). It was 
reported that mouse bone marrow-derived macrophages, cultured in the presence 
of M-CSF growth factor, were not responsive to β-glucans, because the dectin-1-
CARD9 signal route failed to activate NF-κB (Goodridge et al., 2009a); these 
results favored the usage of the mouse GM-CSF-generated dendritic cells in β-
glucan studies.  
The present study compared the β-glucan-induced protein secretion between 
the human GM-CSF-differentiated macrophages and M-CSF-differentiated 
macrophages.  The protein markers of exosomal secretion were more abundant in 
β-glucan induced GM-CSF macrophages, as were also cytokines of IL-1 family, 
which are also known to be secreted via unconventional pathways. These results 
are in line with the knowledge that M1-type macrophages, so-called classically 
activated macrophages, usually mount a strong inflammatory reponse against 
microbial ligands (Wynn et al., 2013). Mimics of these M1- macrophages can be 
derived from monocytes by culturing them with GM-CSF. In contrast, M2-type 
macrophages, so-called alternatively activated macrophages, are typically thought 
to participate in the re-establishment of homeostasis and are involved in the 
suppression of inflammatory responses (Wynn et al., 2013). The growth factor M-
CSF is used to aid in their culturing in vitro. One reason for more efficient protein 
secretion in GM-CSF macrophages can be that GM-CSF enhances the expression 
and function of dectin-1 in GM-CSF-differentiated macrophages (Willment et al., 
2003, Serezani et al., 2012). In addition, it is believed that the GM-CSF provides 
the additional signal for β-glucan by boosting its immunomodulatory activity and 
capabilities to initiate a robust cytokine and chemokine response (Min et al., 
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2012). According to our results, human monocyte-derived GM-CSF-macrophages 
represent an optimal cell model for in vitro studies investigating the inflammatory 
response induced by β-glucans.  
Activation of vesicle-mediated unconventional protein secretion has been 
reported to occur after exposure to several pathogens and disease-associated 
substances such as influenza A (Lietzen et al., 2011), herpes simplex virus 1 
(Miettinen et al., 2012) and monosodium urate crystals (Välimäki et al., 2013). 
Our study revealed that also β-glucan activates robust secretion of proteins via 
vesicle-mediated unconventional pathways. This was confirmed in the study of 
Cypryk and co-workers, where they characterized in greater detail, the proteomics 
of vesicles released during the β-glucan stimulation in human macrophages 
(Cypryk et al. 2014) Our results (Article I), in conjunction with other reports 
(Kumar et al., 2009), have highlighted that β-glucans are potent activators of the 
NLRP3 inflammasome. MSU has also been reported to activate NLRP3 
inflammasome and induce release of IL-1β (Martinon et al., 2006). LPS provides 
only the first priming signal for activation of NLRP3, and is not capable of 
delivering the second signal for activation of NLRP3 inflammasome in human 
macrophages (Bauernfeind et al., 2011). Thus, it is convenient to speculate that 
activation of the NLRP3 inflammasome is required for activation of vesicle-
mediated unconventional protein secretion. Indeed, active caspase-1 has been 
shown to be a regulator of unconventional protein secretion (Keller et al., 2008). In 
our study, the inhibition of caspase-1 in β-glucan-induced macrophages abolished 
the release of unconventionally secreted proteins, IL-1β, and also inhibited that of 
exosome-transported tubulin and annexin I. Caspase-1 inhibition had no effect on 
conventionally secreted proteins (TNF, chemokines), indicating that activation of 
the inflammasome via the dectin-1 pathway triggers unconventional secretion, but 
is not essential for the release of classically secreted proteins.  The secretion of the 
inflammasome’s central components is followed by inflammasome activation 
(Keller et al., 2008). This was in line with our results, where β-glucan induced 
secretion of caspase-1 and ASC, and cathepsins B and D, i.e. core components and 
regulators of NLRP3 inflammasome, respectively.  Further analysis revealed that 
the mature forms of cathepsins had been secreted in exosomes after the β-glucan 
stimulus. Thus, exosomes may facilitate the transport of these active proteases to 
adjacent cells and result in NLRP3 inflammasome activation also in these 
recipients.  
To confirm the role of the dectin-1 signaling pathway in β-glucan induced 
unconventional secretion, the participation of dectin-1 receptor, and Src and Syk 
kinases downstream of dectin-1 were investigated.  The experiment with bone 
marrow-derived dendritic cells from wild and dectin-1 knockout mice revealed 
that secretions of mature forms of IL-1β and cathepsins were dectin-1 dependent. 
Src-family kinases have been shown to act upstream of Syk and this kinase 
signaling pathway has been linked to NLRP3 inflammasome activation (Shio et 
al., 2009, Kerrigan and Brown, 2010, Hara et al., 2013, Lin et al., 2015). Inhibition 
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of Syk kinase completely prevented the β-glucan induced secretion of IL-1β, and 
via vesicles-secreted mature forms of cathepsins, tubulin and annexin. In contrast, 
the results obtained after Src inhibition revealed that Src kinases have only a minor 
role in the β-glucan-induced unconventional secretion. Thus indicating that Syk 
can act independently of Src and it has a more crucial role in signaling pathway, 
which triggers the unconventional secretion after dectin-1 activation.  
To conclude, dectin-1/Syk kinase-signaling pathway and inflammasome activity 
are essential for β-glucan–induced unconventional protein secretion.  
Recently, it was demonstrated that autophagy participates in the regulation of 
unconventional protein secretion (Ponpuak et al., 2015). Autophagy is an 
evolutionary conserved process involved for removal of long-lived proteins, 
insoluble protein aggregates or dysfunctional organelles. This kind of selective 
autophagic degradation is activated in response to these latter mentioned 
components or alternatively by the other cellular stress factors such as cytosol-
invasive bacteria and viruses (Kuballa et al., 2012). During starvation, when the 
amount of nutrients is limited, autophagy is activated, leading to cytoplasmic 
autodigestion (Rubinsztein et al., 2012). Autophagy is believed to be involved in 
the defense of many bacterial infections, however, very little is known about its 
role in antifungal defense. The process through which autophagy affects protein 
secretion is called secretory autophagy (Ponpuak et al., 2015). This secretory 
autophagy is known to facilitate unconventional secretion of the leaderless 
proteins such as IL-1 family cytokines, DAMPs, or cytoskeletal proteins (Ponpuak 
et al., 2015).  
Our data demonstrated that the β-glucan stimulus increased the amount of 
lipid-associated LC-II, which is located on autophagy membranes and is a well-
known marker of an activated autophagic process. In addition, the activation of 
dectin-1 elicited a robust secretion of autophagy-associated proteins. These results 
indicate that the dectin-1/syk -signaling pathway activates autophagy. 
Furthermore, inhibition of autophagy after β-glucan treatment blocked IL- 1β 
release and the other proteins known to be secreted via unconventional routes. 
However, inhibition of autophagy did not affect the β-glucan-induced conventional 
protein secretion in this study. In line with our results, it has recently been shown 
that unconventional secretion of IL-1β requires secretory autophagy-related ATG 
factors, which are involved for the biogenesis of autophagic membranes (Dupont 
et al., 2011). In addition, another recent study detected the enhanced secretion of 
IL-1β in cells, where the autophagic process was induced by starvation, and the 
cells were treated by known NLRP3 inflammasome activators (i.e. alum, amyloid-
β fibrils, nigericin, or silica fibrils) (Dupont et al., 2011). However, there are also 
reports which indicate that autophagy negatively regulates secretion of IL-1β and 
suppresses the activation of the inflammasome. The autophagic process has been 
shown to prevent release of ROS or mitochondrial DNA by maintaining the 
mitochondrial homeostasis and in this way, it suppresses the organelle stress–
mediated activation of inflammasome (Zhou et al., 2011, Saitoh and Akira, 2016). 
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In addition, the autophagic process negatively regulates the activation of the 
inflammasome and inhibits the IL-1β release by targeting the ubiquitylated 
inflammasome components and IL-1β for autophagic degradation (Harris et al., 
2011, Shi et al., 2012, Saitoh and Akira, 2016). In addition, a deficiency in the 
autophagic process in myeloid cells has been shown to evoke an aberrant 
activation of the inflammasome and to promote the development of inflammatory 
diseases (Saitoh and Akira, 2016).  
These recent studies emphasize the dual role for autophagy in the regulation of 
inflammation. First, it is required for secretion of proteins via the unconventional 
pathway, second, it can reduce the inflammatory response by targeting the 
components and substrates of the inflammasome so that they are broken down by 
degradation.  
In conclusion, autophagy has a role in antifungal defense by affecting the 
unconventional protein secretion and secretion of inflammatory factors induced via 
dectin-1 signaling pathway.  
6.3. The pro-inflammatory response of IL-1 cytokines 
induced by β-glucans 
Members of the interleukin-1 family are the main pro-inflammatory cytokines in 
innate immunity but this family also has members with anti-inflammatory features 
(Garlanda et al., 2013). The most widely studied and best known IL-1 cytokine is 
the highly inflammatory IL-1β. It triggers inflammation in multiple ways by 
mediating the development of fever, vasodilation and recruitment and function of 
leukocytes. Our study, as well as others, has shown IL-1β to be one of the 
cytokines released during the exposure of fungal component (Article I)(Kumar et 
al., 2009), which playes a crucial role in the immune response against fungal 
infections (Vonk et al., 2006, Sainz et al., 2008, Gross et al., 2009, Hise et al., 
2009, Lev-Sagie et al., 2009). IL-1β, with other IL-1 family members, IL-1α and 
IL-36, has been reported to participate in the induction of adaptive immunity and 
development of Th17 cells, which are involved in the host’s protective immunity 
against fungi (Gresnigt et al., 2013, Underhill and Pearlman, 2015).  
Cytokines of the IL-1 family exert widescale effects and thus their production 
and signaling are tightly regulated at many levels (Palomo et al., 2015). In our 
study, we focussed on the proinflammatory agonists of IL-1 family (IL-1α, IL-1β, 
IL-18, IL-33, IL-36α, IL-36β, IL-36γ) and in their expression after a β-glucan 
stimulus.  
The mRNA levels of IL-1α, IL-1β and IL-36γ were increased in both GM-
CSF- and M-CSF-derived macrophages after β-glucan treatment. Accordingly, the 
induction of IL-36γ was also observed previously in human PBMCs after infection 
with fungi (Gresnigt et al., 2013). In contrast, β-glucan induced the transcription of 
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IL-33 only in GM-CSF- macrophages. Interestingly, this recently identified 
member of the IL-1 family is associated with immune cell polarization towards an 
allergic response and the Th2 direction as well as promoting the M2-polarization 
of macrophages (Schmitz et al., 2005, Oboki et al., 2010), whereas cytokines IL-
1α/β and IL-36 are more linked to the Th1-and Th17 responses.  
The importance of dectin-1 signaling in β-glucan induced transcription of IL-1 
genes was revealed in an in vivo-model utilizing mice with wild type or dectin-1 
knockout genotype. Curdlan exposure via the intranasal route induced 
transcription of IL-1α, IL-1β and IL-36γ cytokines in BAL cells sampled from 
these animals. A deficiency of dectin-1 decreased the levels of β-glucan-induced 
IL-1 cytokines, but did not block completely the transcription, suggesting that also 
receptors other than dectin-1 may be involved in the induction of IL-1 family 
cytokines after β-glucan exposure.  
In addition, the role of dectin-1 signaling in β-glucan induced IL-1 expression 
was studied in human GM-CSF- macrophages by inhibiting the function of Syk 
kinase. This blocked totally the β-glucan activated transcription of IL-1α, IL-1β 
and IL-36γ. This indicates that the gene transcription of IL-1 family cytokines 
triggered by β-glucan is predominantly dependent on the dectin-1/Syk pathway.  
Pro-inflammatory cytokines of IL-1 family lack an N-terminal signal sequence 
and thus are not secreted via the conventional route involving the endoplasmic 
reticulum-golgi pathway (Sims and Smith, 2010, Garlanda et al., 2013). According 
to our results, the secretion of IL-1 family cytokines was much higher in GM-CSF 
-macrophages compared to M-CSF -macrophages after β-glucan stimulus. The 
secretion of both IL-1β and IL-18 are known be controlled by activation of the 
inflammasome and caspase-1 (Martinon et al., 2002, Bauernfeind et al., 2011). 
Caspase-1 has also been associated with the regulation of unconventional protein 
secretion (Keller et al., 2008). In addition to IL-1β and IL-18, secretion of central 
components of the inflammasome has been reported to follow the activation of the 
inflammasome (Qu et al., 2007, Keller et al., 2008).  
In our study, GM-CSF –macrophages were more efficient than M-CSF-
macrophages at secreting IL-1β, IL-18 and the active form of caspase-1 in their 
response to the β-glucan stimulus. These results are evidence of more efficient 
activation of the inflammasome in GM-CSF-macrophages after β-glucan 
recognition. Interestingly, there were no clear differences after β-glucan treatment 
in the levels of intracellular NLRP3, ASC, or in the preform of IL-1β between the 
cell types. The preform of IL-18 was even more abundant in M-CSF-marophages. 
In contrast, the inactive form of caspase-1 (p45) was considerably more abundant 
in GM-CSF-macrophages. This may explain the more powerful outcome of GM-
CSF-macrophages with respect to the secretion of active caspase-1 and IL-1β and 
IL-18.  
Furthermore, β-glucan induced a clear expression of GBP5 protein in GM-
CSF-macrophages, which may boost the activation of the NLRP3 inflammasome. 
GBPs are guanylate-binding proteins, which belong to the family of interferon-
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induced GTPases (Kim et al., 2012). They have recently been reported to be 
regulators of canonical and noncanonical inflammasome activation and to be an 
important component of host defense (Kim et al., 2012, Kim et al., 2016). GBP5 is 
known to facilitate the activation of NLRP3 inflammasome in a response to 
soluble material and live bacteria, but not to particulate matter (Shenoy et al., 
2012). It has been proposed that GBP5 affects the inflammasome activation via a 
physical interaction. GBP5 has been demonstrated to bind to NLRP3 and promote 
the formation of the inflammasome complex through its own self-assembly 
(Shenoy et al., 2012). There is another theory suggesting that GBPs lyse either 
pathogen-containing vacuoles or bacteria directly to release ligands for recognition 
by central components of canonical or noncanonical inflammasome activation 
pathways (Kim et al., 2016). Although NLRP3 responses to particulate and sterile 
DAMPs such as alum and monosodium urate are largely unaffected by IFN-γ and 
seem to be regulated without GBP5 (Shenoy et al., 2012, Kim et al., 2016), there is 
a need to clarify the role of GBP5 in β-glucan induced NLRP3 inflammasome 
response since β-glucan represents a particulate-like PAMP.   
GM-CSF is a well-known growth factor recently shown to possess pro-
inflammatory features. It was reported to enhance the expression and function of 
dectin-1 (Willment et al., 2003, Min et al., 2012, Serezani et al., 2012). The basal 
level of dectin-1 was higher in GM-CSF-macrophages than in M-CSF-
macrophages and this may partially explain the different responses between the 
macrophage types in our study. Recently, it was demonstrated that GM-CSF could 
elevate the expression of Rab39a (Khameneh et al., 2011), the GTPase, which is 
involved in caspase-1 dependent IL-1β secretion (Becker et al., 2009). Thus, GM-
CSF was speculated to enhance the exocytosis and unconventional secretion of IL-
1β (Khameneh et al., 2011). In addition, Khameneh and co-workers suggested that 
GM-CSF could enhance the synthesis of the preform of IL-1β and in that way, it 
could modulate the level of secretion by strengthening the LPS-induced NF-kB 
signaling. A similar kind of synergism has been revealed also between the dectin-1 
and GM-CSF in mouse dendritic cells (Min et al., 2012). However, there were no 
dramatically differences between the two human macrophage types examined here 
with respect to either β-glucan-induced gene transcription or the production of 
preforms of IL-1β and IL-18.  
Most of the IL-1 cytokines need to be cleaved in their N-terminal region before 
they can achieve their full biologically active form capable of inducing cellular 
responses via IL-1 receptors.  The pro-peptides of IL-1β and IL-18 must be 
cleaved by caspase-1 enzyme, and its function is triggered by the activation and 
assembly of inflammasome (Martinon et al., 2002, Bauernfeind et al., 2011). 
Cytokines of IL-36 do not contain caspase-1 cleavage sites, however recently it 
was shown that artificial N-terminal truncation clearly increased the 
proinflammatory activity of these cytokines (Towne et al., 2011). It is still 
uncertain if the endogenous IL-36 protein undergoes maturation in humans during 
pathological conditions. Thus, we studied the secretion and processing of IL-36γ 
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protein, in parallel to those of IL-1β and IL-18, after β-glucan treatment in human 
GM-CSF-and M-CSF-macrophages. The secretion and intracellular production of 
IL-36γ were more efficient in β-glucan-induced GM-CSF-macrophages. The 
molecular weight was the same for the secreted and the intracellular forms of IL-
36γ, indicating that β-glucan-induced IL-36γ is not cleaved before secretion in 
human macrophages. The production of a similar size of IL-36γ protein has been 
observed after Mycobacterium tuberculosis infection in human macrophages 
(Ahsan et al., 2016), where dectin-1 is known to be involved in the recognition of 
the mycobacterium (Yadav and Schorey, 2006). M. tuberculosis expresses α-
glucan intead of β-glucan within their outer capsule, however, the exact ligand of 
M. tuberculosis for dectin-1 has not yet been identified. 
The NLRP3 inflammasome is known to control the activation of caspase-1 and 
via the release of IL-1β (Bauernfeind et al., 2011). We determined whether 
inflammasome activation also plays a role in secretion of IL-1α or IL-36γ. 
Secretion of these cytokines was induced by β-glucan in GM-CSF-macrophages. 
The release of IL-1α has been associated with the activation of caspase-1, albeit 
independently of its catalytic activity (Gross et al., 2012).  Even less is known 
about the impact of the NLRP3 inflammasome or caspase-1 in IL-36 secretion. 
The presence of particulate matter has been shown to activate the NLRP3 
inflammasome and induce the secretion of IL-1β depending on cathepsin-B 
activity (Hornung et al., 2008, Rajamäki et al., 2010, Palomäki et al., 2011, 
Välimäki et al., 2013). Human macrophages preincubated with CA-074-Me 
secreted less IL-1α and IL-36γ after the β-glucan stimulus. We previously 
observed similar results with IL-1β. It has been reported that IL-1α secretion, 
activated by particulate matter, is blocked when cathepsin activity is impaired 
(Gross et al., 2012). To confirm that CA-074-Me does not exert any effect on gene 
transcription, we analyzed the β-glucan-induced mRNA levels of IL-1 cytokines in 
CA-074-Me treated macrophages. Interestingly, CA-074-Me did not have any 
impact on IL-1β transcription, whereas this inhibitor prevented the transcription of 
IL-1α and IL-36γ. Cathepsin B is a cysteine protease, which is involved in the 
degradation of proteins, by targeting them to the lysosomal system of the cell. 
According to our current knowledge, the involvement of cathepsins in the 
regulation of β-glucan-induced transcription of IL-1 genes is a novel observation.  
Cathepsins have been reported to play a role in NF-kB activation in vivo and in 
vitro studies (Schotte et al., 2001, Wang et al., 2013, Ni et al., 2015). Our results 
suggest that cathepsin B regulates the transcription of β-glucan-induced IL-1 
cytokines in different ways. This may be due to its impact of NF-κB signaling or 
other signaling pathways, which are known to trigger IL-1 expression after dectin-
1 activation.      
Inflammasome NLRP3 and caspase-1 play a central role in the processing and 
secretion of IL-1β. Accordingly, GM-CSF -macrophages preincubated with the 
specific NLRP3 inhibitor, MCC950 (Coll et al., 2015) or a caspase-1 inhibitor (Z-
YVAD-FMK) totally blocked the secretion of IL-1β after the β-glucan stimulus. 
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The caspase-1 inhibitor diminished partially and the NLRP3 inhibitor prevented 
completely the β-glucan-induced IL-1α response. In contrast to IL-1? and IL-1?, 
neither caspase-1 nor NLRP3 inhibition blocked the secretion of IL-36??in 
response to ?-glucans. 
IL-1α is not a substrate for caspase-1, instead it is processed by calpain 
cysteine protease. However, the release of IL-1α has been associated with the 
activation of inflammasome, albeit independently of caspase-1’s catalytic 
properties (Gross et al., 2012). IL-1α secretion induced by ATP, nigericin toxin or 
viable C. albicans was shown to be dependent on the components of the NLRP3 
inflammasome, whereas the secretion pathway of IL-1α induced by particulate 
matter was independent of the NLRP3 inflammasome (Gross et al., 2012). Our 
results with β-glucan suggest that the activation of IL-1α secretion is majorly 
inflammasome-dependent. IL-1α binds to the same receptors, IL-1RI and 
IL1RAcP with IL-1β (Garlanda et al., 2013) and in practical terms, they share 
similar kinds of biological properties. In contrast to IL-1β, the cytokine IL-1α is 
constitutively expressed as a precursor protein in epithelial cells and is mainly 
released in situations of cell damage or cell death, and seldom via active secretion 
(Garlanda et al., 2013). The role of IL-1α in regulating the inflammatory response 
of lungs against fungal pathogens is less well understood than the role of IL-1β. 
IL-1α has been postulated to orchestrate the recruitment of leukocytes, especially 
neutrophils, in mice with pulmonary Aspergillus fumigatus infection (Caffrey et 
al., 2015). Our study revealed that IL-1α was secreted in human macrophages after 
β-glucan stimulus, implying that the activation of dectin-1 pathway can trigger the 
secretion of IL-1α during the pulmonary fungal infection.   
The impaired secretion of β-glucan-induced IL-36γ observed after blockade of 
the activities of inflammasome and caspase-1 was consistent with a previous 
report; in that study, caspase-1 inhibition or its deficiency decreased the levels of 
produced IL-36γ after mycobacterium infection (Ahsan et al., 2016). The Ahsan 
and colleagues also suggested that endogenous IL-1β and IL-18 could further 
amplify production of IL-36γ (Ahsan et al., 2016). This elevating impact of 
inflammasome-regulated IL-1β and IL-18 on the synthesis of IL-36γ could thus 
explain the possible indirect effects of the inflammasome and caspase-1 on the 
secretion of IL-36γ. Cytokines of the IL-36 family are known to play a prominent 
role in inflammation and neutrophil recruitment in the lungs independently from 
IL-1α and IL-1β (Chustz et al., 2011, Ramadas et al., 2011). Furthermore, they 
have been associated with allergen-inflammation in the lung (Ramadas et al., 
2006). The effect of IL-36 signaling in many ways is reminiscent of IL-1α and IL-
1β signaling, but the expression of the IL-36 cytokines seems to more tissue-
restricted. Therefore, cytokines of the IL-36 family cannot be considered to be 
simple substitutes for IL-1α or IL-1β. Most likely they have a role in regulation of 
tissue specific immune responses, which might be potentiated by endogenous IL-
1β and IL-18. Our studies highlighted the induction of IL-36γ in human 
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macrophages in the response for fungal β-glucan. Further studies will be needed to 
reveal the role of IL-36γ in fungi-induced lung inflammation.    
6.4. Proteomic profiles of alveolar lining fluid are 
different in the illnesses associated with exposure to 
non-infective microbial particles  
To obtain information from real-life examples of microbial exposures, we 
investigated the proteomic changes associated with immune defense of the lung in 
NIMP –related diseases. We also attempted to identify possible diagnostic markers 
for diseases related to exposure of inhaled NIMPs. 
The proteomic profile of BAL collected from individuals with exposure to 
NIMPs in the context of DBRI or AME was studied. Patients in this latter group 
manifested HP-like symptoms. BAL samples from patients with a diagnosis of 
acute type of HP were used as a reference. Samples from SARC patients served as 
a reference for inflammatory lung disease with no direct association with NIMP 
exposure. In addition, BAL from healthy individuals served as controls.   
Our results from the proteomic analysis revealed a substantial difference in 
protein expression in bronchoalveolar lining fluid between DBRI and HP / HP-like 
conditions. The pattern of protein expression in DBRI resembled more the patterns 
of healthy controls and SARC than that observed in HP and AME. A part of the 
explanation could be that exposures of microbial dust are usually known to be less 
intense among individuals with DBRI than with HP. The symptoms commonly 
reported for HP are fever, cough and dyspnea (Hendrick et al., 2002). In contrast, 
the symptoms related to DBRI are very variable including asthmatic symptoms 
associated with proximal airways or irritation of mucous membrane in the nasal 
area in the upper airways and irritation of eyes and skin have also been reported 
(WHO, 2009). Generally, HP is an illness known to preferentially affect the 
alveolar space of the lung, while DBRI seems to have a greater impact in the 
proximal airways. It seems that these two diseases affect the alveolar space to 
different extents, which serves as one further explanation for the differences seen 
in the protein expression patterns between HP and DBRI. Thus our proteomic 
results suggest that the DBRI, at least with respect to its typical clinical 
presentation, is different from HP. The symptoms related to DBRI typically 
develop after prolonged exposure to the conditions present in water-damaged 
buildings. It is possible that the proteomic pattern from the initial phase of DBRI 
could display greater similarities with the acute type of HP, especially because it is 
known that conditions of damp building can sometimes cause clinical HP 
(Enriquez-Matas et al., 2007).  
Four different proteins (alpha-1-antitrypsin, galectin-3, histone 4/2B, 
semenogelin I) were analyzed in more detail according to their well-known status 
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in inflammation or their novelty value in lung inflammation. All of these proteins 
were detected with reasonable robustness in the disease groups in contrast to the 
healthy controls, although none of them seemed to be a specific biomarker for 
NIMP-exposure related diseases.  
The expression of alpha-1-antitrypsin and galectin-3, which are considered as 
markers of inflammation, was increased in BAL collected from all conditions, 
DBRI, HP and SARC. Alpha-1-antirypsin (A1AT) is a traditional and well-known 
biomarker for lung inflammation. A1AT protects lungs against proteolytic 
destruction by inhibiting the activities of serine proteases such as leukocyte 
elastase (Greene et al., 2008). In addition, it has also been reported to have other 
anti-inflammatory and tissue-protective properties (Petrache et al., 2006, Pott et 
al., 2009). A1AT deficiency is known to associate to hyper-responsiveness of the 
lung in cases when there has been organic dust exposure (Sigsgaard et al., 2000). 
Different pulmonary exposures increase levels of A1AT (Gomzi et al., 1989) and 
elevated levels have been detected in BAL of patients with interstitial lung disease 
(Wattiez et al., 2000, Kriegova et al., 2006, Okamoto et al., 2012).  
The other inflammatory protein detected, galectin-3, has been linked to 
inflammation and microbial infection in lungs. In addition, it has been reported to 
play a role in the development of lower airway hyperresponsiveness (Zuberi et al., 
2004, Ge et al., 2010). Galectins are beta-galactoside binding lectins (Barondes et 
al., 1994), which are released passively from the cytosol of dying cells or actively 
secreted by immune cells during inflammation (Sato et al., 2009).  This active 
secretion of galectin-3 is known to utilize the unconventional routes of protein 
secretion (Bianchi, 2007). Interestingly, in our previous study, we demonstrated 
that β-glucan could activate a robust unconventional protein secretion and galectin 
was one of the molecules, the secretion of which was induced by β-glucan in 
human primary macrophages (Article II). Galectin-3 is involved in many processes 
activating innate immune response (e.g. chemoattraction of leukocytes, activation 
of oxidative burst in neutrophils (Yamaoka et al., 1995, Sano et al., 2000). In 
addition to its function as a damage-associated molecular pattern (DAMP), it can 
also act as a PRR, which binds to the glycan structures of microbes (Sato et al., 
2009). This increased expression of A1AT and galectin-3 suggests that an 
inflammatory response has been activated at some level in all of these conditions, 
both in interstitial lung diseases and in diseases associated with the exposure to 
NIMPs. This is in line with earlier published findings with HP, which detected an 
increase in macrophage numbers and the levels of cytokine IL-1β in BAL of HP 
patients (McSharry et al., 2002).  
 In our proteomic study, we investigated another DAMP capable of triggering 
inflammation, i.e. histone. Histones form the structural unit and component called 
the nucleosome with nucleotides (Kornberg and Lorch, 1999) and are located in 
the nuclei of eukaryotes. High levels of histones in blood have been detected in 
diseases associated with enhanced cell death (Holdenrieder and Stieber, 2009). 
Histones play a role in hyperinflammatory syndromes, and have been shown to 
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mediate death in a mouse model of sepsis (Xu et al., 2009, Huang et al., 2011). In 
lung diseases, elevated levels of histones have been observed in patients with 
chronic obstructive pulmonary disease (COPD) (Hacker et al., 2009). In our study, 
the expression of histone H4 was increased in the BAL samples in all disease 
groups other than DBRI.      
In plasma, where samples were available from CTR, HP and SARC, the levels 
of histone H2 were elevated in two groups, HP and SARC. This may indicate that 
H2B could be viewed as a marker for the inflammation in the lungs. In the future, 
it would be interesting to analyze histones in blood also from DBRI patients and 
examine if this inflammatory protein could be detected with an elevated expression 
also in that group. Based on our results of a high level of histone expression in 
BAL and plasma samples obtained from HP and SARC patients, it can be 
speculated that histones may play at least some role in the pathogenesis of 
interstitial lung diseases. The molecular weight of the detected histones in BAL 
samples was aberrant. This might be due to alterations in normal post-translational 
modifications such as phosphorylation, acetylation, methylation and ubiquination. 
These are processes which regulate chromatin structure and gene expression. It 
needs to be clarified whether factors leading to development of interstitial lung 
disease can cause the appearance of aberrant size histones in BAL fluid and 
possibly altered activation of post-translational modification. 
 One of the novel findings in this proteomic study was the detection of high 
levels of semenogelin protein in BAL of HP, AME and SARC patients. 
Semenogelins I and II are the major proteins secreted from glandular epithelium 
and epididymis; they are involved in the formation of the gel-like structure of 
semen (Lilja, 1985). Fragments of semenogelin have been reported to possess also 
antimicrobial effects and they also display a high zinc ion binding capacity 
(Bourgeon et al., 2004, Jonsson et al., 2005, Edström et al., 2008). Thus far, it 
seems that our proteomic study is the first to have identified semenogelin in BAL 
fluid of two groups of patients i.e. those with SARC and those exposed to inhaled 
non-infectious microbial particles. If one considers the reported features of 
semenogelin, this protein may play a role in the regulation of mucus viscosity.  For 
example, deficient mucus clearance in the airways and lungs has been associated 
with microbial infections and other respiratory diseases (Randell et al., 2006). 
Another putative role for semenogelin might be in the regulation of zinc 
homeostasis. The perturbation of zinc homeostasis has been linked with allergic 
inflammation (Truong-Tran et al., 2002). In addition, it has been reported that 
airway epithelial cells are highly susceptible to oxidant-induced apoptosis when 
labile zinc is depleted (Carter et al., 2002, Bao and Knoell, 2006).  
 Taken together, our results showed that the proteome of alveolar lining fluid in 
DBRI was different from HP/HP-like conditions thus suggesting they represent 
different disease entities. We did not find that the expression of any of the studied 
proteins could be considered as specific for a NIMP-associated illness. However, 
one interesting and novel finding was the increase in the levels of two well-known 
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markers of inflammation in the alveolar lining fluid of DBRI patients, indicating 
that there is an activation of inflammatory mechanisms also in this condition.   
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7.CONCLUDING REMARKS AND 
FUTURE PERSPECTIVES 
Fungi are ubiquitous in the environment and belong to our normal microbiological 
flora. Sometimes, fungi manage to cause an infection due to an alteration in the 
microbiota, breach in the integument barrier or since the individual is receiving 
immunosuppressive therapy. Exposure to the non-infective components of fungi or 
other microbes such as can occur in agricultural work or water-damaged buildings 
is also sometimes associated with illnesses.  
This thesis focused on the characterization of the immune reaction triggered by 
fungal components at two different levels. First, the innate immune response and 
especially, inflammation related mechanisms activated by the fungal cell wall 
component, (1,3)-β-glucan, were studied in the key innate immune defence cell, 
the macrophage. Second, the immune response of lungs were characterized by 
studying the proteomic changes in bronchoalveolar lavage collected from patients 
with illnesses related to exposure of fungal and other microbial components. 
One major result of the study was that β-glucan stimulates a strong response of 
cytokines from the IL-1 family in human macrophages. These cytokines are 
crucial inducers of local and systemic inflammation, thus their secretion is highly 
regulated. The secretion of IL-1β requires the activation of two signaling 
pathways, the first via a membrane-bound receptor and the second through an 
intracellular protein complex, the inflammasome. This is the first evidence 
indicating that on its own β-glucan could trigger both of these pathways in human 
macrophages, via activation of the dectin-1/ Syk –signaling pathway and the 
NLRP3 inflammasome. Beta-glucan-induced activation of NLRP3 inflammasome 
was stimulated by the production of ROS, cathepsin release and potassium efflux. 
Today, these findings from our group`s first β-glucan related study have been 
widely cited (Article I). In the latest study in this series, we demonstrated that β-
glucan-induced the secretion of two other IL-1 family members, IL-1α and IL-36γ, 
and this process was totally blocked by inhibition of cathepsin B. However, the 
secretion of IL-36γ was not dependent on the NLRP3 inflammasome. In summary, 
our results suggest that IL-1 cytokines play a role in the inflammatory response 
induced by fungi, even when the activation of inflammasome is impaired.  
Beta-glucan induced a robust secretion of many classically secreted proteins 
such as chemokines and cytokines, which contributes to the innate immune 
response during a microbial infection. Furthermore, an extensive secretion of 
proteins via the unconventional secretion pathway was activated by β-glucan in 
human macrophages. In addition to the IL-1 cytokines, dectin-1 activation led to 
the efficient secretion of vesicle-mediated proteins, which are known to mediate 
inflammation, such as danger-associated molecules or cell adhesion and migration 
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proteins. It has been postulated that if molecules are secreted via vesicles, then 
they reach the target in adjacent cells more efficiently than classically secreted 
proteins, which have to diffuse throughout extracellular milieu. Despite the 
efficient activations of protein secretion and the inflammasome, the latter structure 
being known to facilitate pyroptosis, no extensive cell death was observed during 
the β-glucan treatment. This indicates either the presence or the activation of 
factors sustaining the viability of human macrophages. Further investigations will 
be needed to characterize these factors; they could well provide us with useful 
tools for influencing the direction of the response of the immune system.   
Inhibition of inflammasome activity or the process of autophagy suppressed 
dectin-1-induced IL-1β and vesicle-mediated protein secretion. Autophagy is an 
evolutionary conserved lysosomal pathway involved in the degradation of cellular 
substances during starvation; under normal conditions, it may function as an 
intracellular disposal process. Selective autophagic degradation is emerging as a 
part of antimicrobial defense; this phenomenon is activated in response to cytosol-
invasive bacteria and viruses or other cellular stress signals. Our results indicate 
that autophagy is activated during β-glucan stimulation and it acts through the 
unconventional secretion of proteins, evidence that the process of autophagy is one 
of the mechanisms regulating the immune response against fungi in human 
macrophages. 
The function of macrophages is affected by many factors present in the 
environment, some potentiating, some counteracting their effects. Colony-
stimulating factors are long-known for their ability to generate mature myeloid 
cells from precursor cells. Recently, they have been shown to be also essential 
cytokines, regulating the survival and function of macrophages, both under steady-
state conditions and during inflammation. In our study, the GM-CSF-generated 
macrophages demonstrated a more efficient secretion of IL-1 and other 
unconventionally secreted proteins than M-CSF-generated macrophages in 
response to the stimulation with β-glucan. The more abundant expression of pro-
caspase-1 and GBP5, which are the central component and the regulator of NLRP3 
respectively, in β-glucan-stimulated GM-CSF-macrophages may explain the 
difference between these cell types. These results imply that GM-CSF is one of the 
cytokines boosting the inflammatory response of macrophages activated by β-
glucan. There is already some preclinical data suggesting that manipulating the 
biology of colony-stimulating factors might be beneficial in inflammatory and 
autoimmune diseases (Wicks and Roberts, 2016). Further investigation will be 
needed to unravel the role of colony-stimulating factors in fungal-related diseases 
and if they will confer any therapeutic benefits. 
The results (Figure 6.) highlight the importance of β-glucan as a crucial 
immunomodulatory structure of fungi and signaling pathways of dectin-1 and the 
NLRP3 inflammasome in the immune response triggered by fungi. Furthermore, 
these results favor the exploitation of β-glucan as a potential adjuvant in vaccines 
or treatments where the immune response needs to be enhanced. 
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Figure 6. The activation of the inflammatory response by fungal component, 1,3-β-glucan 
in human macrophages. The detection of β-glucan by dectin-1 tiggers significant 
transcriptional changes and activates both conventional and unconventional secretion of 
inflammation promoting factors. The unconventional protein secretion induced by β-
glucan was affected by activation of NLRP3 inflammasome, active autophagy process and  
myeloid growth factors (GM-CSF, M-CSF).   
 
  
Inflammatory symptoms have been described in individuals who have been 
exposed to fungal components when handling moldy hay in agricultural work or 
who have worked or lived in water-damaged houses where fungal components can 
be found in the building materials and the indoor air. We studied the proteomic 
changes present in bronchoalveolar lavage collected from patients exposed to 
fungi in these kinds of surroundings, and who were manifesting symptoms of acute 
type of HP or symptoms associated with DBRI. The proteomic profiles of HP and 
DBRI were different, the proteomic changes being more robust in HP than in 
DBRI when compared to healthy controls. We were able to differentiate between 
these two conditions both of which are associated with an exposure to microbial 
particles and at the same time, we observed increases in the levels of two markers 
of inflammation (α-1-antitrypsin, galectin-3) in both HP and DBRI. In addition, an 
increase in a novel protein, semenogelin, was detected in samples of HP and 
SARC. It could be argued that its main role might be to regulate mucus viscosity, 
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which is an important factor in the clearance of inhaled matter from the respiratory 
tract.  
This thesis attempts to clarify the immunological mechanisms behind the 
symptoms experienced by the individuals, who have been exposed to fungal 
components. Its results provide novel knowledge about the inflammatory response 
triggered by the major cell wall structure of fungi, β-glucan, which is an immune-
stimulating ligand; cells are exposed to this compound not only during fungal 
infections but also if exposed to noninfectious fungal components. When 
macrophages encounter β-glucan they activate different secretory pathways and 
secrete copious amounts of chemokines, DAMPs and multiple members of IL-1 
family cytokines, highlighting the importance of fungal components in this regard. 
We were also able to study the inflammation induced by microbial components in 
a real life situation, however, much additional work will be required before we can 
bridge the gap between in vitro -studies and human illnesses. 
Future research efforts could be directed at elucidating the mechanisms which 
regulate the initiation and the strength of inflammation such as the recently 
reported noncanonical activation of NLRP3 inflammasome resulting in pyroptosis, 
whose role in fungal infections still needs to be clarified. Another interesting 
question is the recent findings of memory in innate immunity, designated as 
trained immunity. This finding has the potential to be fundamental in 
understanding the illnesses associated with exposures to microbial components. 
Genetic and epigenetic factors are also likely to affect the propensity of an 
individual to suffer these illnesses and require further studies.   
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